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Regenerative medicine strategies restore function to damaged tissues by 
delivering factors that stimulate endogenous cells to undergo repair processes, by 
providing exogenous cells that will themselves facilitate repair, or by a combination of 
these two methods.  Embryonic stem cells (ESCs) are able to differentiate into all somatic 
cells, and as such, are a promising cell source for therapeutic applications.  In vitro, ESCs 
can be cultured to spontaneously differentiate via the aggregation of cells into clusters 
termed embryoid bodies (EBs).  EBs recapitulate various aspects of early development, 
including expression of morphogenic cues necessary for tissue growth, as well as 
differentiation processes, such as the epithelial to mesenchymal transition.  The 
embryonic environment harbors a unique reservoir of cues critical for tissue formation 
and morphogenesis.  Importantly, embryonic healing responses to external insults appear 
to employ the same intrinsic machinery used for tissue development, and these 
morphogenic cues may be captured within the EB microenvironment.  Recent studies 
have shown that when injected into injury or defect models in vivo, ESCs synthesize and 
secrete extracellular factors that ultimately contribute to wound repair, suggesting that 
these molecules may be as important for regenerative therapies as functional 
differentiation of the cells.  Despite such recognition of the potential of endogenous 
matrix molecules synthesized by differentiating ESCs, however, surprisingly little is 
known about its composition.  The overall objective of this project was to develop novel 
acellular matrices derived from differentiating ESCs undergoing morphogenesis.  The 
central hypothesis was that embryonic matrices contain complex mixtures of extracellular 
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factors that, when isolated, retain bioactivity and enhance wound healing in an adult 
environment.     
 To further elucidate the expression profile of endogenous ECM synthesized by 
differentiating ESCs, we analyzed the temporal gene profile of matrix molecules and 
growth factors expressed in ESCs and EBs using Extracellular Matrix (84 adhesion 
molecules, basement membrane constituents, structural components, and proteases) and 
Growth Factor (84 angiogenic growth factors, apoptosis regulators, development 
controllers, and morphogenic factors) PCR arrays.  During early EB differentiation, 
approximately 30% of the molecules examined retained expression values similar to ESC 
levels, but increased significantly by later time points, while a smaller subset (~12%) 
exhibited a significant increase earlier in differentiation and continued increasing.  
Interestingly, by the end of the differentiation time course examined, almost no molecules 
decreased significantly compared to earlier time points, all together suggesting that an 
onset of specification events later in EB differentiation is coincident with a surge of 
matrix synthesis.  Importantly, gene ontology analysis of ECM and growth factor 
expression values highlighted that matrix synthesis alone is a reliable indicator of 
differentiation events occurring within the EBs, further emphasizing the underlying role 
of ECM in ESC differentiation.   
While gene array studies provided global insight into ESC matrix synthesis, 
additional in-depth investigation of versican, which appeared in network analyses, was 
performed to more specifically examine its different isoforms.  Of the four splice 
variants, gene expression of V0 and V1 dominated over the course of differentiation and 
increased significantly with time.  Interestingly, the glycosaminoglycan hyaluronan (HA) 
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was found to co-localize with versican, and the HA/versican spatial localization patterns 
in EBs strengthened the notion that ECM molecules play a role in cell differentiation 
events.  Importantly, the cell morphology in areas rich in HA and versican appeared to be 
distinctly different from those excluded from the region, and when examined more 
closely, those cells were found to be N-cadherin-positive, indicative of mesenchymal 
cells.  Cells excluded from the versican-rich region stained positive for the epithelial 
marker E-cadherin.  These results suggested that HA and versican are associated with an 
epithelial-mesenchymal transition within the EBs, which more broadly implies that the 
temporal expression of ECM molecules is linked to cell differentiation events.   
In order to isolate the complex matrices synthesized by differentiating ESCs, a 
variety of reagents were tested to assess their efficacy in decellularizing EBs.  Based on 
established protocols developed for decellularizataion of other tissue types, Triton X-100, 
peracetic acid (PAA), and sodium dodecyl sulfate (SDS) were tested alone and in 
combination with DNase.  A combination of Triton X-100 and DNase significantly 
reduced cell viability and DNA content while maintaining a greater protein:mass ratio 
than either PAA or SDS treatments.  More in-depth studies indicated that longer Triton 
durations significantly reduced protein content, and lower DNase concentrations were 
less efficient at DNA removal.  In addition, greater solvent volumes were effective for 
decellularizing a range of EBs, up to ~6000 EBs.  The combination of lower 
concentrations of Triton X-100 (0.1 -1 %) and higher concentrations of DNase (1 - 2 
mg/mL) applied for relatively short durations (15 – 30 minutes) was found to be 
sufficient for decellularizing thousands of EBs simultaneously.  The effect of Triton X-
100 and DNase were further examined on EBs harvested at different differentiation time 
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points.  In all cases, the decellularization protocol efficiently inhibited cell viability, 
reduced DNA content, and retained a substantial portion of the initial EB mass and 
corresponding protein content.  Histological and ultrastructural analysis clearly indicated 
a lack of cellularity within acellular matrices compared to native EBs, and 
immunostaining results confirmed the retention of extracellular matrix components, such 
as collagen IV, laminin, fibronectin, and hyaluronan in the EB-derived acellular matrices. 
The matrix resulting from the decellularization of EBs was then examined in an in 
vivo dermal wound healing model.  Acellular EBs were applied to wounds either alone or 
using fibrin as a delivery vehicle and were compared to wounds left untreated or treated 
with fibrin alone.  Matrix-treated wounds (delivered with fibrin) exhibited significantly 
greater percent wound closure during the 2-week post-wounding examination period than 
untreated wounds.  In addition, compared to both fibrin-treated and untreated groups, 
wounds treated with matrix alone had significantly greater blood vessels per area that 
extravasated towards the epithelial layer.  Similar observations in other studies have been 
linked to improved healing, which, along with the wound closure data, demonstrates that 
matrix derived from differentiating ESCs significantly improve dermal wound healing 
compared to untreated wounds.  These promising results suggest that acellular EB-
derived matrices can be a clinically relevant therapy for a variety of wound healing 
applications. 
In summary, this work has examined the previously unexplored dynamic nature of 
ECM synthesized by ESCs and its relevance to differentiation events.  Studies 
investigating the development of novel techniques to obtain matrices from EBs have 
resulted in an acellular ESC-derived matrix that significantly enhances wound healing in 
 xxx
vivo.  While other work has alluded to the importance of the extracellular factors 
synthesized by differentiating ESCs, no other studies have derived matrices that harness 
the potency of these molecules for therapeutic applications.  These studies lay the 
foundation for future work that can further examine the direct role of endogenous matrix 
on ESC differentiation and investigate the utility of a stem cell-derived matrix for a 











Embryonic stem cells (ESCs) are a pluripotent cell source derived from the inner 
cell mass of the pre-implantation blastocyst [1-4].  ESCs are able to differentiate into all 
three germ layers (endoderm, ectoderm, and mesoderm), giving rise to all somatic cells of 
the body, as well as germ cells.  This remarkable capacity for specialization renders them 
an invaluable and unique cell source for regenerative medicine and tissue engineering 
applications where researchers are continually seeking to replace endogenous cells that 
have been lost due to injury or disease.  In vitro, the differentiation of ESCs typically 
progresses via the spontaneous aggregation of cells into three-dimensional clusters 
termed embryoid bodies (EBs).  EBs recapitulate the dynamic molecular machinery that 
elicits tissue organization and morphogenic responses during early embryonic 
development.  Insults to embryonic tissues during this period of early development are 
met with intrinsic regenerative mechanisms and potent molecular factors that return the 
injured site to its original condition.  Since EBs mimic aspects of embryogenesis, these 
inherent cues may be captured within the EB microenvironment. 
Due to the difficulties of accessing and studying mammalian embryo systems, 
manipulations of ESCs and EBs have often been used to provide insight into early 
development processes [5-7].  More recently, tissue engineers and scientists seeking to 
exploit the pluripotential of ESCs for the design of cell-based therapeutics have used 
existing knowledge of early embryonic events to identify key regulators for directing the 
differentiation of the heterogeneous stem cell populations [8, 9].  As this work has 
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progressed, the importance of extracellular matrix (ECM) molecules in both 
differentiation and embryology studies has emerged.  Knockdown studies of specific 
molecules demonstrate the resulting direct impact on ESC differentiation in vitro [10, 
11], while others have investigated the often embryonic lethal consequences of inhibiting 
production of certain ECM components in vivo [12-19].  Despite these findings, however, 
there is surprisingly little information available about the complex mixture of matrix 
molecules (growth factors, glycosaminoglycans, proteoglycans, etc.) synthesized by 
differentiating ESCs. 
A significant portion of ESC research has thus far focused on directing 
differentiation of the cells into specific cell types relevant for the disease or injury of 
interest, partly due to the belief that ESCs can contribute to and stimulate injured tissues 
via functional differentiation.  In recent years, however, this notion has been challenged 
with a significant paradigm shift that has focused more attention on the beneficial effects 
of stem cell-derived molecules.  In a landmark study, ESCs were injected into Id 
knockout blastocysts (a cardiac defect mouse model), and subsequent rescue of the 
otherwise embryonic lethal phenotype was observed [20].  Upon further investigation, the 
mechanism of repair was reported as the synthesis and release of extracellular factors by 
the injected ESCs, suggesting that stem cell-produced biomolecules could be as 
important, if not more so, than the functional differentiation of the cells themselves for 
therapeutic applications.  Subsequent studies have provided supporting evidence of the 
potency of ESC trophic effects, ranging from anti-apoptotic cues [21, 22] to the release of 
anti-inflammatory molecules [23].   
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All together, recent studies suggest that the matrix factors naturally synthesized 
by differentiating ESCs and captured within the EB microenvironment may be rich in 
morphogenic cues that could be applied to regenerative medicine therapies.  Therefore, 
the objective of this project was to develop novel acellular matrices derived from 
differentiating ESCs undergoing morphogenesis.  The central hypothesis was that 
embryonic matrices contain complex mixtures of extracellular factors that, when isolated, 
retain bioactivity and enhance wound healing in an adult environment.  The overall 
objective was accomplished by testing the hypothesis through the following specific 
aims:   
  
Specific Aim 1.  Investigate the production of extracellular matrix by differentiating 
embryonic stem cells as a function of differentiation time.  The working hypothesis 
was that ESCs would produce extracellular matrix (ECM) components whose expression 
profiles shift with the progression of differentiation.  This hypothesis was examined by 
using a PCR SuperArray to assess the expression profiles of 168 ECM components, 
adhesion molecules, and growth factors in ESCs differentiating for 4, 7, 10, and 14 days 
in culture.  Temporal gene expression profiles were analyzed using hierarchical 
clustering, k-means analysis, statistical evaluation, and gene ontology software (Ingenuity 
Pathway Analysis) to assess the dynamic global expression of matrix synthesized by 
differentiating ESCs.  In order to more thoroughly investigate the relationship between 
ECM and differentiation, two matrix molecules, hyaluronan and versican, were further 
analyzed via quantitative PCR, immunostaining, enzyme-based quantification, and 
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Western blot.  The relationship between these molecules and cell differentiation was 
investigated by co-immunostaining with E-cadherin and N-cadherin antibodies. 
 
Specific Aim 2.  Assess the ability of solvents to efficiently decellularize embryoid 
bodies.  The working hypothesis was that a combination of detergents and enzymes 
would allow for cellular permeabilization and extraction/digestion of cellular material, 
while retaining ECM protein content.  This hypothesis was examined by evaluating 
combinations of Triton X-100, peracetic acid, sodium dodecyl sulfate, and DNase for 
their ability to remove cellular material in EBs while maintaining protein content.  The 
degree of decellularization was assessed quantitatively based on cell viability, mass 
retention, DNA retention, and total protein content, and qualitatively based on histology.  
A combination of Triton X-100 and DNase was subsequently evaluated for optimal 
volume and concentration values using on the same multi-parametric measures as before.  
The ability of the Triton X-100/DNase combination to decellularize EBs cultured for 
different amounts of time was also investigated.  Retention of structural and adhesive 
proteins was examined using immunostaining. 
 
Specific Aim 3.  Evaluate the healing response elicited by acellular matrices derived 
from embryoid bodies in an in vivo dermal wound healing model.  The working 
hypothesis was that the ESC-derived acellular matrix would elicit improved healing 
responses in vivo as compared to untreated controls.  Two bi-lateral 6-mm excisional 
wounds were placed on the dorsum of mice and were treated with decellularized day 10 
EBs delivered alone or using fibrin as a delivery vehicle.  Matrix-treated wounds were 
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compared to wounds treated with fibrin alone (vehicle control) or those left untreated.  
Wounds were analyzed quantitatively for rate of wound closure over a two week period 
and were excised at 7 and 14 days post-wounding to assess re-epithelialization and tissue 
structure (via hematoxylin and eosin staining), as well as vascularization (PECAM-1 
immunostaining). 
 
 This work is significant because it developed a novel means of isolating 
extracellular factors naturally synthesized by differentiating ESCs.  First, it evaluated an 
array of matrix molecules produced by ESCs in EBs and highlighted the possible 
relationship between ECM components and cellular differentiation patterns.  Second, it 
established a protocol for removing cellular components from EBs and retaining the 
naturally produced ECM.  Third, it evaluated the ability of stem cell-derived matrices to 
elicit improved wound healing responses in vivo.  This work is innovative because it 
established a novel means of harnessing the therapeutic potential of ESCs.  The 
combination of stem cell therapy and decellularization techniques could lead to a unique 
method of presenting the potency of stem cell factors in a cell-free manner.  Due to the 
inherent pluripotency of the starting cell source, this robust new technology could be 
broadly applicable to the treatment of a variety of chronic diseases and traumatic injuries 







Embryonic Stem Cells 
Embryonic stem (ES) cells are a pluripotent cell source derived from the inner 
cell mass of a pre-implantation blastocyst [1-4].   The ability of ESCs to differentiate into 
all somatic cells of the body, as well as germ cells, renders them an ideal cell source for 
applications where endogenous cells are lost due to injury or disease.  As such, tissue 
engineering strategies have used ESCs in technologies targeted towards cardiac [24], 
neural [25], and diabetes [26] therapies, among others.  In addition, ESCs have been 
explored for their uses in studying developmental biology events.  Thus far, ESCs have 
been used to improve our understanding of broad developmental events such as the 
epithelial-mesenchymal transition [27], early pancreatic differentiation [28], and 
mechanisms of early embryonic blood vessel development [29].  ESCs have also been 
exploited to probe more specific questions, including epigenetic mechanisms of human 
disorders and birth defects [30, 31], the effect of nicotine exposure to embryos [32, 33], 
and the role of phosphoinositide 3-kinase signaling in early development [34].  This wide 
range in which ESCs have been used to engineer therapies for regenerative medicine as 
well as to probe early developmental events has taken advantage primarily of the cells’ 
differentiation potential, but has also in recent years considered the internal intricacies of 
cell-cell and cell-matrix signaling within differentiating ESCs.  Conventional methods of 
initiating ESC differentiation in vitro rely on suspension culture systems in which the 
cells spontaneously aggregate to form clusters of differentiating cells typically referred to 
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as embryoid bodies (EBs) [35, 36].  Individual EBs recapitulate the temporal sequence of 
molecular signaling and cell differentiation events of embryonic pre-gastrulation tissues, 
culminating in the differentiation of the cells into the three germ lineages (ectoderm, 
endoderm, and mesoderm) from which all other somatic cells are subsequently formed [6, 
37-40].   
In early mammalian embryonic development, the pluripotent inner cell mass cells 
from which ESCs are derived reside in the blastocyst (Figure 2.1).  The cells lining the 
cavity differentiate into the primitive endoderm, while the internal cells (termed the 
primitive ectoderm) remain pluripotent [41].  Subsequent to the appearance of a 
proamniotic cavity, the remaining primitive ectoderm cells differentiate into a 
pseudostratified columnar epithelium with distinct differentiation potential [42-44], 
typically called the epiblast [7].  Finally, the primitive endoderm cells differentiate into 
either visceral or parietal endoderm [45], while the epiblast serves as the substrate for 
gastrulation from which all three germ layers will form.  ESCs and their EB 
differentiation model recapitulate these early embryonic events (Figure 2.1), from the 
formation of an epithelial layer to the mechanism of cavity formation [46].  As such, 
researchers have used ESCs as a model system of development to gain further 
















Figure 2.1. Early embryonic events and ESC differentiation. ESC differentiation via 
EB formation recapitulates the early events of embryonic development (modified from 
[7]). 
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Paracine actions of ESC populations 
Since the derivation of ESCs, a significant portion of stem cell research has been 
focused on directing the differentiation of the cells into a phenotype of therapeutic 
interest.  However, a recent paradigm shift has drawn attention to the synthesis of 
endogenous factors and subsequent secretions by ESCs in vivo that may directly 
contribute to the observed output in the absence of functional differentiation.  In a 
landmark study, ESCs injected into Id-knockout embryos were able to rescue the 
otherwise lethal cardiac defect through the secretion of molecular factors [47].  
Importantly, there was also a partial rescue of the cardiac phenotype when ESCs were 
injected into female mice bearing Id mutants, demonstrating the presence of long-range 
factors secreted by the ESCs, as the cells themselves would not have been able to cross 
the placenta barrier.  In separate studies, ESCs were found to suppress seizures through a 
paracrine mode of action [48] and were also shown to release extracellular factors into 
their medium that significantly decreased apoptosis in a cardiomyocyte-derived cell line 
[21, 22].  In addition, hearts subjected to ischemic conditions recovered significantly 
when treated with ESCs, due in part to protection conferred by stem cell release of anti-
inflammatory molecules (e.g. interleukin (IL)-10) [23].  Importantly, mesenchymal stem 
cells derived from ESCs deposited fetal-like tendon matrix as well as a host of growth 
factors that likely contributed to improved healing responses in an in vivo tendon repair 
model [49].  All together, these significant observations suggest that biomolecules 
produced by stem cells may be at least as important as differentiation of the cells to 
achieve cell restoration and functional tissue repair.  Curiously, little is known about the 
actual molecular composition of the extracellular factors synthesized within EBs during 
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the course of in vitro differentiation.  Since EBs provide a snapshot into the earliest 
stages of morphogenesis, analysis of the proteins, glycosaminoglycans, and 
proteoglycans they produce would lend insight into the potential regenerative nature of 
embryonic extracellular matrices (ECMs). 
 
Extracellular Matrix 
 Tissue engineering and regenerative medicine have long relied on the use of 
extracellular molecules to aid in the culture or delivery of cells for therapeutic purposes.  
Extracellular matrix (ECM) is a mixture of structural and adhesive proteins, growth 
factors, glycosaminoglycans (GAGs), proteoglycans, and matricellular proteins that is 
secreted by the local cell population and organized in a network associated with those 
cells.  Collagens constitute 25% of total protein mass in mammals and are a primary 
component of both skin and bone.  Collagen molecules contain three polypeptide α 
chains rich in proline and glycine that are folded into a helical conformation.  Of the 20 
distinct collagens that have been identified, collagen I is the most abundant [50].  
Collagens I, II, and III assemble into fibrillar structures, whereas collagen IV molecules 
form a mesh-like network that comprise a significant portion of the basment membrane in 
tissues.  Along with collagen IV, laminin-1 is one of the key components constituting the 
basal lamina and is composed of three polypeptide (α1, β1, and γ1) chains.  There are 
seven individual laminin molecules (laminins-1 to -7), each containing different 
combinations of eight genetically separate laminin chains, although laminin-1 is perhaps 
the most well-characterized [51].  Fibronectin, another well studied multidomain 
adhesive glycoprotein, is found in blood plasma and can also be synthesized by local 
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cells [52].  Matricellular proteins, which regulate interactions between cells and matrix, 
include secreted protein acidic and rich in cysteine (SPARC), thrombospondin 1 and 2, 
and osteopontin [52].  
GAGs are negatively charged polysaccharide chains whose anionic and 
hydrophilic properties cause them to swell and occupy large volumes, thereby allowing 
the GAGs to withstand high compressive forces [50].  They are composed of repeating 
disaccharide units: an amino sugar (N-acetylglucosamine or N-acetylgalactosamine) and 
typically a uronic acid (glucuronic or iduronic).  GAGs are generally categorized into 
four groups, based on the sugars, sugar linkages, and sulfate groups: hyaluronan, 
chondroitin sulfate and dermatan sulfate, heparan sulfate, and keratan sulfate.  Of the 
different GAG classifications, hyaluronan (HA) is particularly abundant in embryonic 
tissues.  Unlike the other GAGs, it contains no sulfated sugars and is typically not linked 
to a core protein.  Several of HA’s functions, however, rely on the interactions between 
HA and proteoglycans, which are GAG chains linked to a core protein.   
GAGs also serve as reservoirs for growth factors that play important roles in cell 
signaling as well as ECM synthesis.  Growth factors can regulate matrix production by 
stimulating resident cells to synthesize matrix molecules or augment production of matrix 
metalloproteinases (MMPs) that degrade the ECM.  In turn, growth factor activity can be 
directly controlled by the ECM, which can either sequester the growth factors and hinder 
their activity, or can harbor molecules such that they are protected from degradation and 
their activity is concentrated [52].  
Primarily, exogenous ECM has been used in studies as substrates for cell culture 
as well as for scaffolds for in vivo implantation, but little emphasis has been placed on the 
 12
endogenous matrix being supplied by more primitive cell sources.  As mentioned above, 
in the case of ESCs, matrix synthesis may be particularly important to characterize due to 
its potential to actively participate in and contribute to regenerative or healing processes. 
 
Extracellular molecules in tissue engineering 
 For stem cell-based tissue engineering strategies, matrix proteins have been 
widely used for substrate coatings to influence the progression of cell differentiation.  In 
some key studies, an array platform was used in which mixtures of fibronectin, laminin, 
collagen I, collagen III, and collagen IV were spotted onto wells and subsequently seeded 
with ESCs to allow for an extensive examination of the combinatorial effect of multiple 
ECM proteins on stem cell fate [53, 54].  While previous studies tended to focus 
primarily on one particular molecule, the results of these studies demonstrated the effects 
that a complex mixture of matrix molecules can have on differentiation. 
 In an effort to take advantage of the potency of ECM molecules and growth 
factors, researchers have employed tissue engineering strategies to mimic matrix 
function.  For example, growth factor delivery systems have been engineered for the local 
release of heparin-binding growth factors coincident with enzymatic activity in wound 
healing applications [55].  Inkjet printing methods have also been developed in order to 
present growth factors in a biologically relevant manner, with examinations of growth 
factor concentration gradients as well as combinations of different growth factors 
contributing to identification of cell fate influences [56].  Biomimetic adhesive peptides 
have also been engineered to promote cell surface interactions [57] and influence matrix 
mineralization [57, 58], while exogenous additions of growth factors and cytokines to 
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culture media or the use of conditioned media have been shown to promote cell 
proliferation [59], survival [60], and differentiation [61, 62]. 
 
Extracellular matrix in ESC populations 
As discussed above, several studies have investigated the effects of culturing cells 
on different ECM substrates or subjecting cells to exogenously added growth factors and 
cytokines; however, less emphasis has been placed on examining the role of the 
endogenous matrix on stem cell maintenance and differentiation.  In recent years, 
however, the stem cell niche has received increasing attention from researchers seeking 
to understand the interplay of the cells and ECM within the microenvironment of 
differentiating cell clusters.  As research has progressed, the presence of endogenous 
matrix molecules has been found to have a significant influence on subsequent 
differentiation patterns.   
As interest has grown in this area, researchers have largely focused on individual 
molecules of specific interest to them.  Reports on specific molecules synthesized by 
differentiating ESCs have recently surfaced, gradually developing the story of ESC 
endogenous matrix production.  Laminin in particular has been the focus of several 
studies and in EBs has been found to correlate with the induction of epiblast 
differentiation and cavitation, possibly with some of the cell-cell and cell-matrix 
interactions mimicking those in vivo [63].  Specifically, laminin-γ1 (LAMC1) was found 
to be necessary for laminin assembly, which was essential for basement membrane 
formation in both EBs and in vivo [12].  The addition of exogenous laminin-1 to cultures 
was able to rescue LAMC1-/- knockouts [64] that otherwise could not cavitate or form an 
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epiblast layer or basement membrane [11].  In addition, a recent study demonstrated that 
matrix proteins synthesized by ESCs, specifically collagen I, are essential for ESC 
survival and differentiation and cannot necessarily be rescued by exogenous addition of 
the protein [65].  These results are perhaps not surprising, as studies from developmental 
biology have shown the appearance of laminin-1 at the 2-cell stage [66] and fibronectin 
and collagen IV in the inner cell mass of 3-4 day-old blastocysts [67], suggesting a role 
for matrix proteins in the earliest embryo stages.  Other studies have also looked 
specifically at the role of certain molecules in differentiating ESCs [10, 68], while some 
have focused on conditioned media studies wherein ESCs were found to release specific 
growth factors and cytokines [60].  As discussed previously, such studies that examine 
the release of ESC-derived factors have elucidated paracrine mechanisms by which ESCs 
or EBs contribute to the repair of wounded tissue.  The majority of studies investigating 
endogenous ECM in ESCs have examined specific molecules of interest, but importantly, 
a few researchers have now begun to examine endogenous ECM production at a more 
global level [69, 70], thereby identifying possible candidates for future studies. 
 
Acellular Biomaterials 
Decellularization methodologies have been developed as a means of separating 
cells from tissues.  This technology arose as researchers investigated the potential of the 
complex mixture of matrix molecules found naturally in tissues.  Before the use of such 
tissues would be clinically applicable, however, it was necessary to eliminate or 
significantly reduce elements in the tissue that would elicit immune reactions in the host.  
Consequently, decellularization technologies arose as a means to remove cells from 
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tissues without disrupting the native composition of its matrix.  Examples of tissues that 
have been decellularized include small intestinal submucosa (SIS), peripheral nerve, 
arteries, pericardium, skin, tendon, placenta, and bladder [71-78].  Some of these 
acellular scaffolds have been applied to aid in the repair of the same tissue from which it 
was derived, whereas others have been used in different sites, such as SIS for 
tendon/ligament repair, myocardial healing, or as a reparative wound dressing [79-82].  
In addition, acellular tissues are not only capable of stimulating neovascularization and 
eliciting a minimal host immune response, but can also promote tissue repair in vivo [83-
85].  These benefits could perhaps be amplified if the original tissue contained 
morphogenic cues naturally embedded within its matrix. 
 
Decellularization methods   
Given the wide variety of tissues in the body, different decellularization methods 
must be optimized to account for the range in matrix composition and tissue density [86].  
Common protocols typically involve both physical and chemical means of disrupting 
membranes and removing cellular components.  Physical methods can involve freeze-
thaw, pressure, and sonication techniques [87, 88].  General mechanical agitation has also 
been used, though optimal cellular removal combines physical disruption with chemical 
extraction treatments [73].  A variety of chemicals have been used to decellularize 
tissues, including alkaline or acid treatments, non-ionic or ionic detergents, and 
enzymatic treatments.  Acid/alkaline treatments, such as peracetic acid (PAA), and 
ammonium hydroxide are used to solubilize cellular cytoplasmic components and disrupt 
nucleic acids.  PAA in particular has been found to be effective as a disinfectant and at 
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removing cellular material while maintaining matrix proteins, GAGs, and growth factors 
of thin tissues [80, 89, 90].  Ionic detergents, such as sodium dodecyl sulfate (SDS), have 
been used for solubilization of nuclear and cytoplasmic membranes, although they tend to 
significantly disrupt ECM components [91].  In contrast, non-ionic detergents can lyse 
cellular membranes in a gentler manner without significantly disrupting lipid-lipid and 
lipid-protein interactions.  Triton X-100 is a common non-ionic detergent used for 
decellularization, although some studies have reported variable success in its ability to 
remove cellular material and retain ECM components after treatment [91-93].  Finally, 
enzymatic treatments such as trypsin and DNase have been used to extract cellular 
proteins and nucleotides [85, 92].  The conflicting evidence on the varying successes of 
similar decellularization treatments on diverse tissues indicates that different reagents and 
combinations of reagents must be optimized for each tissue by controlling the 




In recent years, developmental biology and regenerative medicine have reached a 
crossroads as tissue engineers have realized the importance of examining early 
morphogenic processes to gain insight into potential treatment strategies [94].  The 
regenerative potential of humans is highest in the earliest embryonic stages, where ECM 
composition and signaling molecules provide a forgiving template for developing tissues.  
For example, adults who are subjected to external wounding will not regenerate the 
damaged skin; they will instead repair the injured area imperfectly, leaving a scar.  On 
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the contrary, when embryos are wounded, the morphogenic cues present within their 
structures are able to completely regenerate the injured tissue.  As such, wound healing is 
one area where clear differences between embryonic and adult responses to injury are 
leading to a greater mechanistic understanding of possible approaches to developing 
regenerative therapeutics. 
 
Wound healing and animal models 
Wound healing responses in adult animals involve a cascade of events beginning 
with an inflammatory response, re-epithelialization of the wound, formation of 
granulation tissue, and final healing with scar.  After injury, a fibrin clot is formed and 
platelets aggregate and release various inflammatory mediators, such as platelet-derived 
growth factor (PDGF), transforming growth factor (TGF-α and –β), fibroblast growth 
factor (FGF), epidermal growth factor (EGF), and insulin-like growth factor (IGF) [95].  
These factors, as well as chemokines, recruit inflammatory cells (e.g. neutrophils and 
monocytes) to the site of injury, with macrophage infiltration peaking 3-5 days post-
wounding.  During the reparative phase of wound healing, fibroblasts lay down a 
provisional matrix consisting mainly of collagen and fibronectin, leading to scar 
formation, and further differentiate into myofibroblasts, which aid in wound contraction 
during the secondary phase of healing.  These events are also accompanied by the 
migration of keratinocytes from the wound edge, re-epithelialization, and vascularization 
[96].   
The two main injury models typically used to examine treatments for dermal 
wound healing are the incisional and excisional models, which can be performed on large 
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(e.g. lamb) or small (rat, mouse, rabbit) animals.  In the incisional model, 1-cm cuts 
penetrating the epidermis, dermis, and panniculus carnosus are made along the dorsum of 
the back.  Similarly, excisional cuts penetrate through the three layers, but are performed 
using a dermal biopsy punch.  Comparable analyses can be performed on the two models, 
although incisional wounds are more amenable to tensile testing, while wound closure 
data is easier to obtain with excisional wounds.  These models offer several methods of 
parameter quantification, including a combination of staining and image analysis to 
quantify re-epithelialization and vascularization.     
 
Embryonic versus adult wound healing 
The primary and well-studied difference between embryonic and adult wound 
healing is the ability of early fetal skin injuries to heal scarlessly.  This remarkable 
capability does not translate to all tissues of the fetus, as full thickness incisional wounds 
in the stomach, intestine, and diaphragm heal with a scar [97].  Differences between 
embryonic and adult dermal injury healing have been widely studied, and several key 
differential features have emerged.  In the ECM deposition of embryonic wounds, 
hyaluronic acid (HA) increases more rapidly and is more sustained [98], and collagen is 
characterized by a fine reticular pattern and has a higher ratio of type III to type I [99].  
Embryonic wounds also heal with fewer inflammatory cells, decreased expression of 
PDGF, FGF, TGF-β1, TGF-β2, interleukin-6 (IL-6), and IL-8, and increased expression 
of TGF-β3 and VEGF [100-104].  Finally, fetal and adult fibroblasts behave differently, 
with fibroblasts in the adult environment differentiating into myofibroblasts, which have 
an essential role in wound contraction [105].  Importantly, addition of specific molecules, 
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such as IL-10 [106], TGFβ3 [107], and hyaluronan [108], to an adult wound results in an 
improved healing response, suggesting that exogenous effector molecules can alter the 
typical course of healing and more closely mimic fetal regeneration.  The myriad of 
differences between the embryonic and adult environments, which are independent of the 
in utero extra-embryonic milieu [109], help elucidate the mechanisms by which an 
embryonic dermal wound can heal scarlessly, and may therefore also provide insight into 
potential methods to elicit tissue regeneration in the adult. 
Studies that compare mechanisms of tissue movements in embryonic 
development and adult wound healing processes have uncovered many parallels, such as 
dorsal closure in Drosophila and ventral enclosure in C. elegans, that involve the re-
epithelialization of tissue gaps [110].  Embryonic healing and subsequent regeneration 
may be the result of a response that essentially recapitulates developmental dynamics 
wherein the tissue insult triggers typical morphogenic mechanisms in the embryo [110].  
Therefore, therapies that provide cues present in an embryonic environment may 
similarly be able to stimulate a morphogenic response in an adult. 
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CHAPTER 3 
DYNAMIC PATTERNS OF EXTRACELLULAR MATRIX AND 
GROWTH FACTOR EXPRESSION BY PLURIPOTENT 






Embryonic stem cells (ESCs) have been widely used as a model of embryonic 
morphogenesis to examine the differentiation of pluripotent cells into mature 
differentiated phenotypes.  Typically, ESC research focused on the differentiation 
potential of the cells as a source of therapy where endogenous cells have been lost due to 
injury or disease.  More recently, however, the molecules synthesized and secreted by 
ESCs have been investigated for their potent paracrine morphogenic effects [21, 47, 111].  
In vitro, ESCs can be cultured to differentiate via the spontaneous aggregation of cells 
into clusters termed embryoid bodies (EBs).  The inherent and spontaneous 
differentiation that occurs by ESCs within EBs recapitulates aspects of embryogenesis, 
including ESC differentiation towards all three germ lineages – ectoderm, endoderm, and 
mesoderm [5, 36].  Typically, ESC differentiation studies have focused on the phenotypic 
outcomes towards a more restricted cell fate through characterization of the resulting cell 
types, such as endothelial cells [112, 113], hepatocytes [113, 114], and neurons [115, 
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R Nair†, A Ngangan†, ML Kemp, and TC McDevitt. Dynamic patterns of extracellular matrix and growth 
factor expression by pluripotent embryonic stem cells undergoing embryoid body differentiation, in 
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116].  The molecular composition of the extracellular microenvironment associated with 
the differentiation process can influence these phenotypic outcomes, yet is generally 
overlooked. 
 The dynamic expression of extracellular matrix (ECM) molecules and growth 
factors during differentiation can provide feedback to the cells that in turn can modulate 
cell phenotype, thereby affecting the outcome of cell specification events.  The addition 
of exogenous ECM and growth factor molecules has also been shown to affect cell 
phenotype during directed differentiation schemes.  For example, exogenous vascular 
endothelial factor (VEGF) or bone morphogenetic protein (BMP)-4 [117] encourage cells 
towards a vascular phenotype, while the addition of laminin to culture media can enhance 
neural progenitor differentiation from human ESCs [118].  Despite these and other 
successes relating to the promotion of differentiated phenotypes via exogenous matrix 
additions, curiously little is known about the inherent ECM and growth factors produced 
during early spontaneous differentiation of ESCs within developing EBs.  Some studies 
have begun to examine the gene expression profile of early EBs using microarrays [119-
121], while others have investigated aspects of the EB transcription factor [122] and 
glycomics [123] profiles.  These studies typically analyzed hundreds or thousands of 
genes, including a subset of ECM genes, yet little work has specifically extracted and 
analyzed that matrix data or examined the endogenous expression of the ECM and 
growth factors in differentiating ESCs.  The molecules produced within EBs can provide 
direct feedback to the ESCs as they differentiate; thus, the profile of extracellular factors 
could offer further insight into the self-regulation of ESC differentiation via extracellular 
cues.  
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 The focus of this study was to globally assess the dynamics of ECM and growth 
factor expression associated with the differentiation of ESCs within the EB 
microenvironment using gene expression and pathway analysis.  Gene expression was 
examined using low density RT-PCR arrays specific for ECM components, including cell 
adhesion molecules, matricellular proteins, integrins, and proteases, as well as growth 
factors, including members of the BMP, fibroblast growth factor (FGF), transforming 
growth factor β (TGFβ), and interleukin (IL) families.  Gene expression analyses 
included hierarchical clustering, k-means clustering, and significance testing that 
contrasted different patterns of expression and determined similarities among specific 
molecules.  Subsequent pathway analyses highlighted signaling pathways reconstructed 
solely from ECM and growth factor content information.  This study investigates the 
dynamic relationship between ECM/growth factor expression and differentiation time 
using novel analytical approaches and provides insights into the extracellular 
microenvironment of pluripotent stem cell matrix biology.   
 
Methods 
Embryoid Body Culture 
Mouse embryonic stem cells (ESCs; D3 cell line) were cultured on 0.1% gelatin-
coated 150 mm polystyrene cell culture dishes (Corning) with Dulbecco’s modified eagle 
medium (Mediatech), supplemented with 15% fetal bovine serum (HyClone), 2 mM L-
glutamine (Mediatech), 1x MEM non-essential amino acid solution (Mediatech), 
antibiotic/antimycotics (Mediatech), and 0.1 mM β-mercaptoethanol (MP Biomedicals, 
LLC).  Undifferentiated cells were expanded prior to EB formation in the presence of 103 
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U/mL leukemia inhibitory factor (LIF) (ESGRO), which was added to the culture media 
upon each re-feeding.  Cells were passaged every two to three days before reaching ~70% 
confluence.  To initiate EB culture, ESCs were trypsinized from the gelatin-coated dishes 
using 0.05% Trypsin/0.53 mM EDTA (Mediatech).  A density of 400,000 cells/mL was 
used to inoculate 10 mL EB cultures in 100 mm bacteriological grade polystyrene Petri 
dishes (Corning) using differentiation media (media without LIF).  Cultures were placed 
on rotary orbital shakers (Barnstead Lab-Line, Model 2314) at 40 rpm at 37oC in 5% CO2 
for the entire duration of suspension culture.  Previous work from our lab has 
demonstrated that rotary orbital suspension culture methods result in greater yields of 
homogeneous populations of EBs [124].  EBs were cultured in suspension for up to 14 
days and re-fed every other day after collecting the EBs via gravity-induced 
sedimentation in 15 mL conical tubes.  Spent media was aspirated, and the cultures were 
replenished with 10 mL of fresh differentiation media before being placed back in the 
Petri dishes and returned onto the rotary orbital shakers. 
 
Microscopy and histological analysis 
Phase images of the EBs were taken at each day of EB differentiation (up to 14 
days) using a TE2000 microscope and a Spot Flex camera (Diagnostic Instruments, Inc.).  
For histological analysis, EBs collected at different stages of differentiation (4, 7, 10, or 
14 days) were fixed with 10% formalin for 30 minutes and embedded in Histogel® 
(Richard-Allan Scientific).   Each Histogel® block was processed for histological 
sectioning through a series of xylene and alcohol rinses prior to paraffin embedding.  
Sections of EB samples (5 μm each) were obtained using a Microm HM 355S rotary 
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microtome and stained with hematoxylin and eosin (H&E) using a Leica AutoStainer XL.  
Each slide was coverslipped using low viscosity mounting medium (Cytoseal™ 60) and 
imaged on a Nikon 80i microscope. 
 
Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) 
RNA was extracted from undifferentiated ESCs and EBs at days 4, 7, 10, and 14 
of differentiation (n = 3 for each sample) using the RNeasy Mini Kit (Qiagen).  
Complimentary DNA was reverse transcribed from 1 μg of total RNA using the iScript 
cDNA synthesis kit (Bio-Rad), and real-time RT-PCR was performed using SYBR Green 
technology on the MyiQ cycler (Bio-Rad).  Beacon Designer software was used to design 
forward and reverse primers for pluripotency marker Oct-4, endoderm differentiation 
marker α-fetoprotein (Afp), and housekeeping gene glyceraldehyde-3-phosphate 
dehydrogenase (Gapdh), which were validated with appropriate positive controls.  
Relative levels of Oct-4 gene expression were calculated compared to undifferentiated 
ESC samples using the Pfaffl method [125], whereas Afp concentrations were calculated 
based upon standard curves and normalized to Gapdh expression levels.   
 For SuperArray RT2 Profiler™ PCR array analysis, cDNA synthesis was 
performed using the SuperArray RT2 First Strand kit (SABiosciences).  A genomic DNA 
elimination mixture was prepared by first mixing 0.5 μg RNA with 5x gDNA 
Elimination Buffer and RNase-free water and then incubating at 42oC for 5 minutes.  The 
RT cocktail (4 μL 5x RT Buffer 3, 1 μL Primer & External Control Mix, 2 μL RT 
Enzyme Mix 3, and 3 μL RNase-free water) was prepared and added to the elimination 
buffer mixture.  Each sample was synthesized in an iCycler Thermal Cycler (Bio-Rad) 
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(15 minutes at 42oC, 5 minutes at 95oC) and diluted with RNase-free water after synthesis 
was complete.  RT-PCR was performed by first preparing the experimental cocktail 
(1275 μL 2x SuperArray RT2 qPCR Master Mix, 102 μL diluted first strand cDNA 
synthesis reaction, 1173 μL RNase-free water) and equally distributed into all of the 
individual wells of the PCR 96-well array (Mouse Extracellular Matrix and Adhesion 
Molecules array or Mouse Growth Factors array).  Each array was tightly sealed with 
optical thin-wall 8-cap strips and run in a MyiQ cycler (Bio-Rad) with a two-step cycling 
program (1 cycle, 10 minutes, 95oC; 40 cycles, 15 seconds, 95oC; 40 cycles, 1 minute, 
60oC).  Fold changes in gene expression were analyzed using the ΔΔCt method of 
quantitation, whereby samples of EBs from different time points (days 4, 7, 10, and 14) 
were compared relative to undifferentiated ESC values after individual sample values 
were normalized to internal GAPDH levels.   
 
Gene clustering analysis: hierarchical clustering and k-means 
 Differences in gene expression over time in differentiating EBs were calculated as 
fold change increases or decreases compared to ESCs, calculated as described above.  
Triplicate fold change values obtained from the ECM and Growth Factor arrays were 
separately input into the array analysis software Genesis (Release 1.7.5).  Hierarchical 
clustering was then performed across both genes and time points on log2-transformed 
data using average linkage clustering.  The clustering was visualized via a heat map and 
dendrogram, with green indicating decreased expression compared to ESCs and red 
indicating increased expression.  The color intensity corresponds to the magnitude of 
decreases or increases. 
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 The average fold change values of ESCs (fold change = 1) and EBs from both 
array sets were merged and input into Genesis for k-means clustering analysis.  Based on 
a trial-and-error process in which different cluster numbers were qualitatively evaluated 
for the optimal number that captured the different profile possibilities, parameters were 
set as 12 clusters and a maximum of 300 iterations.  Expression profiles of each gene 
across the 14 day time course were generated in gray for each of the 12 clusters, with the 
centroid for each cluster depicted in pink. 
 
Ingenuity Pathway Analysis (IPA) 
Pathway analysis was performed using Ingenuity Pathway Analysis (Version 7.5, 
Ingenuity® Systems) to examine the biological functions and signaling pathways that 
were implicated in EB development over time.  For each time point (days 4, 7, 10, and 
14), fold change ratios (values: 0 to +513.58) were inputted into IPA and converted to 
fold changes (-46.25 to -1 and 1 to +513.58).  Genes with a minimum of 3-fold change 
were input into IPA software analysis to filter the dataset and obtain “focus” genes.  The 
results of the “core analysis” consisted of top “biological functions” and “networks” for 
each time point using the eligible “focus” genes.  The association of a specific gene to 
other genes, either by interaction or in a functional annotation within IPA’s knowledge 
base, determined a gene’s eligibility.   Biological functions were tested for significance (p 
< 0.01) using the Benjamini-Hochberg (B-H) multiple testing correction to account for 
false-positives and ranked most to least significant (–log B-H p-value).  The networks for 
each observation were generated based on the interaction of “focus” genes found in IPA’s 
knowledge base. Each resulting networks included up to 35 genes, to maintain a 
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manageable size, and was scored based on the probability of finding a “focus” gene in 
that network, with higher scores indicating a lower chance of finding a “focus” gene 
within that network. 
 
Statistics 
Significance testing was conducted using SYSTAT (Version 12) software.  For 
each gene, expression fold change comparisons across time points were conducted using 
a one-way analysis of variance (ANOVA) with subsequent post-hoc Tukey analysis to 




Prior to performing the PCR array analysis for ECM and growth factor 
expression, the time course of EB differentiation was evaluated by histological analysis 
and phenotypic gene expression.  The size and morphology of the population of EBs 
remained relatively uniform over the time course examined (Figure 3.1A-D) using rotary 
orbital suspension culture, similar to previously published results [124].  Evidence of 
progressive differentiation was indicated by changes in the organization and morphology 
of the cells within EBs (indicated by black arrows), as well as the increasing appearance 
of cystic cavities (red arrows) (Figure 3.1E-H).  The eosinophilic (pink) staining apparent 
by day 10 and accumulating by day 14 was visible primarily in regions of EBs with a 
lower cell density and was suggestive of increasing matrix deposition by the cells.  Over 
time, the ESCs expressed significantly less Oct-4, a pluripotent transcription factor 
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(Figure 3.1I), and conversely, expressed significantly increasing levels of the endoderm 
differentiation marker α-fetoprotein (Afp) (Figure 3.1J), as well as several genes 
indicative of ectoderm (Nestin) and mesoderm differentiation (Gata4, Nkx2.5, myocyte 
enhancer factor-2c, alpha myosin heavy chain, myosin light chain-2 ventricle) (data not 
shown) [124, 126], thus further confirming the expected time course of differentiation.  
By day 10 of differentiation, Oct-4 decreased significantly compared to day 4 EBs (p = 
0.03) and by day 14 exhibited significantly lower expression than both day 4 and day 7 
EBs (p = 0.002, 0.005, respectively).  Afp was significantly greater in day 14 EBs 
compared to all other time points examined (p = 0.001).  The coincident series of 
morphological and phenotypic changes over the course of EB differentiation are 
consistent with previous studies from our laboratory [124, 126, 127], as well as others. 
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Figure 3.1. EB morphological and gene expression analyses over the course of 
differentiation. EBs cultured on a rotary orbital shaker remain relatively homogeneous 
in size and shape throughout differentiation (A-D).  Noticeable differences in cell 
morphology (black arrows) and the onset of cavitation (red arrows) indicate the 
progressive differentiation of cells within EBs through H&E histological analysis (E-H).  
The significant decrease of the pluripotent marker Oct-4 (I) and steady increase of the 
endoderm differentiation marker a-fetoprotein (J) assessed through RT-PCR 
demonstrates the gradual progression of differentiation with time. # Significantly 
different from day 4 EBs, p ≤ 0.03; Significantly different from day 7 EBs, p = 0.005; * 
Significantly different all other time points, p = 0.001. 
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Gene clustering based on expression profiles  
 Two-dimensional hierarchical clustering of the individual experimental replicates 
as a function of time was initially performed independently for both the Extracellular 
Matrix and Adhesion Molecules array (referred to subsequently as the ECM array; Figure 
3.2A) and the Growth Factors array (Figure 3.2B).  Importantly, independent samples for 
each of the individual time points clustered together, and both the earlier (4 and 7 days) 
and later (10 and 14 days) time points clustered more closely together, demonstrating the 
reproducibility of experimental samples and distinct shifts in gene expression occurring 
over time with differentiation.  For each array, two patterns of increased (red signal) or 
decreased (green) gene expression over time were evident, whereas most of the 
remaining genes were relatively unchanged compared to undifferentiated ESCs.  In the 
ECM array, 16 molecules clustered together that tended to decrease in expression relative 
to ESC levels, while 14 molecules that consistently increased over the course of 
differentiation clustered together.  The remaining 59 molecules, which included 
housekeeping genes such as heat shock protein 90kDa alpha (cytosolic) class B member 
1 (Hsp90ab1), Gapdh, glucuronidase beta (Gusb), and β-actin (Actb), exhibited baseline 
values that increased or decreased only slightly compared to ESCs.  The housekeeping 
genes were similarly clustered in the Growth Factors array, indicating the consistency of 
analysis across the separate, independent arrays.  In contrast to the ECM array, more of 
the genes from the Growth Factor array clustered together in both the increasing (26 
molecules) and decreasing groups (28 molecules).  Within these relatively broad 
classifications, a few visibly distinct clusters emerged from both arrays, including five 
sharply increasing molecules in the ECM array that exhibited 46- to 513-fold increases 
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compared to ESCs by day 14 (catenin alpha 2 (Ctnna2), periostin (Postn), hyaluronan 
proteoglycan link protein 1 (Hapln1), collagen III alpha 1 (Col3a1), vitronectin (Vtn)).  In 
the growth factor array, 13 molecules (including bone morphogenetic protein 8a/8b 
(Bmp8a/8b) and fibroblast growth factor (Fgf17)) clustered together that exhibited as 
much as a 25-fold decrease compared to ESCs, while 7 molecules increased (including 
Bmp5 and insulin-like growth factor (Igf2)) up to 240-fold over ESCs.  Hierarchical 
clustering provided a visual depiction of general patterns of gene expression by 
differentiating EBs and identified specific genes that were highly increased or decreased 





Figure 3.2. Hierarchical clusters and dendrograms of ECM and growth factor 
arrays.  Two-dimensional hierarchical clustering was performed on ECM (A) and 
Growth Factor (B) arrays.  Genes were clustered as either increasing (red) or decreasing 





Table 3.1. Genes in each cluster represented in Figure 3.3A. 















































































































































































The average fold change values of the individual replicates from the independent 
arrays were also combined to generate a heat map of the entire set of experimental data 
(Figure 3.3A).  Based on hierarchical clustering, five groups of genes were identified 
whose expression pattern increased or decreased to varying degrees compared to ESCs 
(Table 3.1).  Similar to the hierarchical clustering in Figure 3.2, Groups I and IV 
contained genes whose expression increased over the course of differentiation, while 
genes in groups II and V decreased, and those in group III remained relatively unchanged 
compared to the ESCs.  In order to more clearly define the temporal expression patterns 
embedded within the data, k-means analysis of the average log2-transformed fold 
changes was performed (Figure 3.3B-M).  Groups identified in the heat map were 
represented in the k-means plots by the corresponding colors, clearly showing the ability 
of k-means analysis to further parse out groups identified by hierarchical clustering.  K-
means analysis was performed using 12 clusters; analysis with fewer clusters (4-8) did 
not distinguish different patterns of expression as clearly, whereas larger numbers of 
clusters yielded independent groups with as a few as 1-2 genes.  Thus, 12 clusters 
captured an array of different patterns of expression with a range of 6-29 genes (Table 
3.2).   
In the k-means graphs, the x-axis at zero represents the undifferentiated ESC 
baseline, and the centroid of each cluster is indicated by the black line.  Overall, genes 
that fell into groups II and V in the hierarchical cluster were represented below the 
baseline in the k-means plots (Figure 3.3B-E).  In addition, all but eight of the genes that 
clustered with other molecules around the baseline in the k-means plots (Figure 3.3F-I) 
also fell into group III.  Genes that were separated into groups I and IV from the 
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hierarchical clustering tended to cluster together in multiple k-means plots (Figure 3.3J-
M).  In general, k-means clustering further divided the groups generated by hierarchical 
analysis by accounting for differences in the slope magnitudes between time points.  For 
example, genes that appeared to change nominally over time by hierarchical clustering 
analysis (group III) were split into four different k-means plots, depending on whether the 
gene profile (or the centroid of the gene cluster) increased or decreased by day 7 and the 
corresponding specific expression pattern between days 7 and 14.  Overall, k-means 
cluster analysis more clearly highlighted temporal expression patterns not readily 
identified by hierarchical clustering.   
A total of 43 genes (~25% of the total genes examined) were clustered in the first 
four k-means plots (Figure 3.3B-E), with their expression patterns generally falling below 
the ESC baseline, while ~41% (71 genes) remained around the baseline (Figure 3.3F-I) 
and ~34% (58 genes) tended to increase over the course of differentiation (Figure 3.3J-
M).  Clusters B, H, and M all contained genes solely from groups II, III, and I, 
respectively, whereas clusters E, G, and K contained a mixture of genes from three 
hierarchical cluster groups.  Clusters F, I, and J each contained one “outlier” molecule 
from a different group (Fgf8, Figf, and Tnc, respectively).  Importantly, a subset of genes 
that fell into cluster B (genes that exhibit a gradual decrease in expression with 
differentiation) is known to be associated with pluripotent phenotypes, specifically Fgf4, 
Lefty1, Lefty 2, and teratoma-derived growth factor 1 (Tdgf1).  These markers have all 
been shown in other studies to decrease gradually with differentiation [128-130], thereby 
independently confirming the expression of this gene subset.  Similarly, although some 
interleukins were dispersed between clusters, six of them were concentrated in H, 
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indicating a coordinated temporally-regulated role for the subclass.  Other groups of 
molecules, however, were distributed among a variety of clusters.  The 11 Bmp genes, for 
example, fell into five clusters, while the eight collagens were dispersed among six 
clusters.  This variety of temporal gene expression profiles within classes of molecules 
suggests that each of them may play different roles in the stem cell differentiation 
process.  Interestingly, with the exception of colony stimulating factor 1 (Csf1) and S100 
calcium binding protein A6 (S100a6), all the genes in clusters C and J (initially decreased 
compared to ESCs, but steadily increasing after day 4) were from the ECM array, raising 
the possibility that matrix molecules, as opposed to growth factors, play stronger roles 
particularly at later differentiation time points.  By visualizing gene profiles via k-means 
analysis, sets of genes with similar trends in specific temporal expression patterns 
emerge, highlighting, for example, genes that increase between days 7 and 10, regardless 
of their expression trend prior to that time point.  Therefore, k-means analysis is able to 
identify groups of genes whose expression trends follow similar (or diverging) patterns at 
each time point, which could importantly allow for subsequent analysis of these specific 
















Figure 3.3. Hierarchical and k-means clustering analyses.  Heat maps were generated 
for combined ECM and Growth Factor arrays using hierarchical clustering (A), and the 
resulting clusters were further grouped qualitatively into five groups, marked I – V.  K-
means analysis was performed on the same group of data (B-M), with the colors of the 
genes in each k-means plot corresponding to the hierarchical cluster group of the same 
color.  K-means analyses parsed out temporal similarities and differences between genes 
that remained grouped together in the hierarchical clusters. 
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Table 3.2. Genes in each k-means plot represented in Figure 3.3B. 
 

















































































































































































Parallel analysis of variance (ANOVA) significance testing 
In order to determine statistically significant changes (p < 0.05) in gene 
expression over the course of differentiation for individual genes, parallel one-way 
ANOVA analyses were performed.  Significant changes in gene expression between each 
time point were depicted with a branch schematic, with increasing or decreasing slopes 
representing positive or negative fold changes, respectively, while non-significant 
changes were illustrated as horizontal lines (Figure 3.4A).  As EB differentiation time 
progressed, the number of genes with significant changes increased with time.  Between 
ESCs and day 7 EBs, approximately 16% of the genes examined significantly change at 
day 4 and 10% at day 7; whereas, at day 10 approximately 22% genes significantly 
change in expression, and by day 14 about 44% of all the genes examined change 
significantly.  Initially, molecules that changed significantly primarily decreased 
compared to ESCs by day 4, with the majority of genes remaining unchanged.  Of these 
141 molecules that were initially not significant, only 9 genes (5 increasing and 4 
decreasing) significantly changed between days 4 and 7.  Interestingly, over the course of 
differentiation no gene continually increased significantly past day 7.  By days 10 and 14, 
however, larger numbers of genes (30 and 47 genes, respectively) significantly changed 
that previously were not significant, with one small subset (10 genes) significantly 
decreasing at day 10.  In contrast, at day 14 all the significant changes, except one gene 
(Fgf5), increased in expression.  A list of genes grouped according to significant 
expression profiles by day 14 (Figures 3.4B-F) are listed in Table 3.3. 
 Approximately a third of the genes examined did not change significantly 
throughout the entire 14-day EB culture period (Figure 3.4B), including the housekeeping 
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gene Hsp90ab1, Fgf2, and matrix metalloproteinase 2 (Mmp2).  Significant decreases in 
fold change were observed in 24 genes between ESCs and day 4 EBs (Figure 3.4C), 
including platelet-derived growth factor A (PdgfA, ~2-fold difference), inter-cellular 
adhesion molecule 1 (Icam1, ~2-fold difference), and S100a6 (~18-fold difference).  
Genes with the most significant change in decreased gene expression were Col1a1 (~46-
fold difference), S100a6 (~18-fold difference), and Csf1 (~13-fold difference) between 
ESCs and day 4 EBs.  Within this subset of 24 genes that significantly decreased in 
expression by day 4, 7 genes did not changed significantly in the remaining time period 
examined (Figure 3.4C), and 10 genes significantly increased between days 10 and 14 
(Figure 3.4D).  Genes with the largest significant increase between 10 and 14 days of EB 
differentiation were Csf1, thrombospondin 1 (Thbs1; both ~5-fold difference), connective 
tissue growth factor (Ctgf), and integrin β3 (Igb3; both ~4-fold difference). 
Another third of all the genes in the arrays only increased significantly in fold 
change between days 10 and 14 (Figures 3.4E, F).  The group of genes with the 
expression profile depicted in Figure 3.4E significantly increased from days 7 through 14, 
ranging from ~2-fold to ~50-fold between days 7 and 10 (20 genes) and  from ~1.5-fold 
to ~4-fold between days 10 and 14 (12 genes).  The genes with the largest fold difference 
between days 7 and 10 include Igf2 (~50-fold difference), Bmp5 (~20-fold difference), 
and transforming growth factor β2 (Tgfb2) (~18-fold difference); the genes with the 
largest fold differences between days 10 and 14 were Bmp5, Gdf11 (both ~4-fold 
difference), Igf2, and Spock1 (both ~3-fold difference).  The expression profile of 
molecules illustrated in Figure 3.4F exhibited significant increases in expression at later 
stages of EB differentiation, with 47 genes that did not significantly change until day 14 
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with fold differences of ~2-fold to ~50-fold.  The genes with the largest significant 
increases were Col3a1 (~50-fold difference), Vcam1 (~16-fold difference), Gdnf, and 
Figf (both ~14-fold difference).  
 Of the subsets of molecules identified through statistical analysis (Table 3.3), 
several genes from certain families of molecules appeared in the same groups.  Within 
the 58 genes not changing significantly over 14 days of EB culture (Figure 3.4B), several 
gene families are present, including the cadherins (4/4 genes analyzed in the array), 
fibroblast growth factors (6/17 genes), interleukins (10/10 genes), and matrix 
metalloproteinases (4/12 genes).  Gene families that increased significantly between days 
10 and 14 (Figure 3.4E and 3.4F) included transforming growth factors (5/5 genes), 
laminins (3/6 genes), and collagens (5/8 genes).  Overall, analyzing the significant 
changes in decreased or increased gene expression clearly identifies groups of genes with 
similar expression profiles.  By including significant changes between consecutive time 
points in the analysis of the arrays, the progression of certain genes involved in EB 







Figure 3.4. Statistical analysis of ECM and Growth Factor expression values.  
Parallel one-way ANOVAs were performed to evaluate the progressive statistical 
significance of gene expression values at each day compared to the previous time point 
(A).  Branches with positive or negative slopes represent genes that respectively 
increased or decreased significantly (p < 0.05), while horizontal lines indicate no 
statistical significance.  Particular trends are noted with corresponding molecules that fall 
into each specific group (B-F). 
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Table 3.3. List of genes represented in Figure 3.4B-F. 
 
Figure 4B Figure 4C Figure 4D Figure 4E Figure 4F 
58 genes 24 genes 10 genes 20 genes 47 genes 
Actb  Il18 Adamts8* Bmp4 Bmp2 Adamts1  Hapln1 
Adamts2 Il1a  Bmp4  Col1a1 Bmp5† Bdnf Igf1 
Amh   Il1b  Bmp8a*  Csf1 Bmp7 Bmp1 Inha 
Artn Il2  Bmp8b*  Ctgf Fgf10† Bmp3 Itga2 
Bmp10  Il3  Col1a1  Fgf13 Fgf14 Bmp6 Itga4 
Cdh1 Il4  Csf1  Itga3 Gdf11† Cd44 Lama1 
Cdh2 Il6  Ctgf  Itgb3 Igf2† Cntn1 Lama2 
Cdh3  Il7  Fgf13  Itgb4 Itgb2 Col3a1 Lamb2 
Cdh4 Inhba  Fgf17*  Lamc1 Kitl† Col4a1 Lif 
Csf2  Itga5 Fgf18  Thbs1 Lamb3 Col4a2 Mdk 
Csf3  Itgae  Hprt1*   Mmp15 Col5a1 Mmp11
Ctnna1  Itgav Icam1   Rabep1† Col6a1 Mmp9 
Ctnnb1  Itgax  Inhbb*   Sgce Ctnna2 Ntf5 
Egf  Itgb1 Itga3   Spock1† Cxcl1 Pgf 
Ereg  Lefty2 Itgal   Tgfa† Cxcl12 Postn 
Fgf11  Lep  Itgb3   Tgfb1† Ecm1 Tgfb3 
Fgf2  Mmp13  Itgb4   Tgfb2† Emilin1 Tgfbi 
Fgf22  Mmp14 Lama3   Timp2† Entpd1 Timp3 
Fgf6  Mmp2 Lamc1    Vegfb Fbln1 Tnc 
Fgf7  Mmp8  Pdgfa    Zfp91† Fgf3 Vcam1 
Fgf9 Ncam1  S100a6      Figf Vcan 
Gdf10  Ngfb  Spp1     Fn1 Vegfa 
Gdf5  Ntf3 Syt1*     Gdnf Vegfc 
Gdf8  Sele  Thbs1       Vtn 
Hc Sell           
Hgf  Sparc         
Hsp90ab1  Tff1          
Il11  Thbs3         
Il12a  Timp1           
*Molecules that decrease significantly between days 4 and 7 and subsequently do not 
change significantly (black line Figure 4C). 
†Molecules that increase significantly between days 7 and 10 and between days 10 and 14 
(orange line Figure 4D).  
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Pathway Analysis 
Based upon the parallel ANOVA analysis, only the genes that exhibited at least 
one significant change between consecutive time points in gene expression during EB 
differentiation were included in the Ingenuity Pathway Analysis (IPA).  Thus, out of the 
171 unique genes included in the ECM and growth factor SuperArrays, 57 genes were 
excluded from the pathway analysis due to their lack of significant fold change during the 
14-day period of differentiation (Figure 3.4B).  Of the 114 genes with significant fold 
change, 89 “focus” genes were eligible for generating “functions” and “networks” in IPA, 
determined by the association of a specific gene to other genes, either by interaction or in 
a functional annotation within IPA’s knowledge base.    
 Using the IPA database that contains information on functions associated with 
specific genes, the top (Figure 3.5A) and bottom (Figure 3.5B) functions were generated 
from genes exhibiting more than two-fold changes in expression compared to ESCs.  The 
functions were ranked highest to lowest according to day 4 EB results.  Among the top 10 
functions for each time point, 8 of the 10 were the same, including “cell growth & 
proliferation”, “tissue development”, “cell movement”, and “cardiovascular system 
development & function”.  The lowest ranking functions (Figure 3.5B) were comprised 
of descriptions generally not directly related to development, such as “metabolic disease” 
or “ophthalmic disease”.  For all the lowest functions listed, the B-H significance was 
only slightly above threshold levels (p < 0.01), and some time points did not contain any 
genes in specific functions that met the fold-change cut-off value.  To examine the 
interaction of certain molecules within the dataset, as well as with other known 
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molecules, IPA generated networks of these interactions based on literature available in 




Figure 3.5. Assessment of EB functions associated with ECM and Growth Factor 
gene expression.  Genes that exhibited at least one significant gene expression change 
between consecutive time points were included in the Ingenuity Pathway Analysis (IPA).  
Using the IPA database that contains information on functions associated with specific 
genes, the highest (A) and lowest (B) ranked functions were generated from genes 
exhibiting more than two-fold changes in expression compared to ESCs.  In distinct 
contrast to the lowest ranked functions, top functions are generally associated with 
development and morphogenesis. 
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Networks at each time point were examined to determine relevant pathways 
involved at different stages of differentiation, with the top ranking network at each time 
point depicted in Figure 3.6.  At day 4 (Figure 3.6A), the top network was generated with 
15 focus molecules.  A few genes within this network could be considered “nodes”, or 
genes with numerous network connections, such as Fn1, Csf1, and Vegfa.  Many of the 
extracellular factors included in this network were related to p53, which is a transcription 
factor that directly acts on the pluripotent marker Nanog by suppressing its expression to 
induce differentiation [131].  The top network at day 7 (Figure 3.6B) was generated using 
17 of the “focus” genes, including nodal genes Mmp9, Il1b, and Il6.  Similar to Figure 
3.6A, several of the extracellular factors in Figure 3.4B were related to p53, which 
consequently affected Nanog.  The top networks for days 10 (Figure 3.6C) and 14 (Figure 
3.6D), used 35 and 39 “focus” genes, respectively.  In the day 10 network, several nodal 
genes included Vegfa, Igf1, and Tgfb1, whereas the nodal genes within day 14’s top 
network include Fn1, Igf1, and Vegfa.  The appearance of Tgfb1, a mediator of ECM 
production, as a nodal gene at day 10, as well as its connection to other ECM molecules, 
such as Col1a1 and Sparc, preceded the changes in day 14’s top network, which included 
several more plasma membrane-associated molecules compared to the other networks, 
especially cell adhesion and ECM receptor molecules, such as Vcam1, Itgb3, and Itgav.   
The differentiation of ESCs within EBs is depicted in the four networks of Figure 
3.6.  In the day 4 and 7 networks, the molecules included appear to be focused on 
decreasing ESC pluripotency based on the high connectivity of nuclear factor p53, which 
decreases Nanog expression, to extracellular molecules.  At day 10, the network includes 
several more nuclear factors linked to extracellular factors, but the connectivity of the 
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nuclear factors is low.  The increased number of nuclear factors with low connectivity 
suggests that the ESCs are continuing to differentiate, but along various lineages.  In the 
day 14 network, the number of extracellular molecules is less than earlier time points, but 
the number of plasma membrane components increased with high connectivity.  Overall 




Figure 3.6. Network analysis over the course of differentiation.  The top networks 
generated for day 4 (A), 7 (B), 10 (C), and 14 (D) EBs are depicted.  Colors of the 
molecules indicate whether the corresponding expression value increased (red) or 
decreased (green) compared to ESCs.  An increase in transcription factors appearing by 
day 10 of culture suggests the progression of heterogeneous differentiation within the EB 
population, while the appearance of cell adhesion molecules in day 14 EBs indicates the 
onset of signal transduction and cell movement. 
 49
Discussion 
The overall objective of this study was  to examine the global expression of ECM, 
receptor, and growth factor expression by differentiating ESCs.  ESCs undergo 
progressive differentiation within EBs and correspondingly express differential amounts 
of a number of ECM and GF genes.  Distinct sets of genes follow diverging patterns over 
the course of differentiation, suggesting that an increase or decrease of specific sub-
groups of matrix molecules may be necessary for certain cell specification events.  
Although not typically used to examine differentiation patterns, variations in ECM and 
growth factor expression were indicative of more global changes occurring within the EB 
microenvironment.  Low density analysis of extracellular factors in dynamic 
environments highlights the importance of such endogenous molecules and their utility in 
assessing the temporal shifts in the system. 
As ESCs differentiate within the 3D EB environment, the expression patterns of 
molecules increase and decrease according to the phenotypic and morphological changes 
occurring within the cells.  By analyzing a large number of molecules simultaneously, 
subtle changes in expression can be used collectively to analyze the system, in contrast to 
the traditional approach of focusing on the gene expression changes of one molecule at a 
time [65].  With a reduction in noise and a focused group of genes that can more readily 
be individually analyzed, low density arrays can offer some advantages over larger-scale 
gene arrays while still providing data for a subset of molecules of interest instead of 
individual ones.  Importantly, ontological assessment of gene arrays can highlight not 
only relationships between the molecules within the array, but also connections to the 
existing literature.  Such analysis of the extracellular genes (ECM and growth factors) 
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included in the arrays underscored key relationships with intracellular genes, such as 
receptors and transcription factors, that were indicative of morphogenic changes 
occurring within the EB microenvironment.   
 A number of analytical tools were used to evaluate the gene expression values 
obtained from the ECM and growth factor arrays: hierarchical clustering, k-means 
analysis, statistical analysis, and gene ontology mapping.  Hierarchical clustering 
highlights general patterns of expression, which is useful for quick detection of subsets of 
genes that are generally increasing, decreasing, or remaining similar to baseline levels (in 
this case, undifferentiated ESCs).  For the time-dependent data set presented here, two-
way hierarchical clustering was useful for assessing whether non-consecutive time points 
exhibited any overall expression pattern similarities.  K-means analysis was able to 
further parse out the temporal relationship across genes by isolating subsets of groups 
with distinct expression patterns.  However, neither of these techniques incorporate 
statistical rigor into their algorithms.  Mapping the results of parallel ANOVAs across all 
genes highlights the overall expression patterns adopted by the molecules over time, with 
each “branch” indicating the significant changes of the group of molecules compared to 
the previous time point.  Apart from analyses based strictly on gene expression values, 
gene mapping tools using Ingenuity Pathways Analysis allows for the identification of 
established relationships between the input molecules and molecules available in the 
software database.  Due to the relatively small number of molecules in the array, 
networks generated for each time point are inherently biased, although the inclusion of 
molecules from the database and external to the array allows for a more expanded 
network view. 
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 These clustering, statistical, and gene mapping tools may be critical to further 
understanding the role of endogenous ECM and growth factors in differentiation.  Some 
studies have begun to elucidate the role that specific molecules play in ESC 
differentiation [63, 65, 132-135], although analyses that include a broader range of 
extracellular factors have thus far been somewhat limited [69, 70].  In order to analyze 
the wide spectrum of matrix molecules in our study, distinct methods were used that 
either highlighted differences in expression patterns through clustering tools or focused 
on the relationships between the molecules via network analysis.  Subsets of genes with 
diverging expression values (gene groups that between multiple time points had opposing 
trends) emerged from k-means and statistical analyses.  The simultaneous increase and 
decrease of different sets of molecules may be necessary for the onset of a particular 
differentiation event, and the identification of these sub-groups could be critical for 
further understanding the coincident cell phenotype specification.  While the clustering 
and statistical algorithms are based on the precise gene expression values, the only 
consideration of expression values when mapping networks in IPA is the fold-change 
threshold cutoff input by the user.  Therefore, the combination of clustering/statistical 
analyses with network mapping provides a multi-faceted approach that enables a more in-
depth understanding of the dynamic system.  In contrast, studies that examine individual 
molecules largely remain one-dimensional and may lose the global view that contributes 
considerably to the fundamental understanding of the system. 
 In the EB system, a combination of the described analyses has provided a higher-
level understanding of the influence of extracellular factors on morphogenic processes 
over the differentiation time course.  The day 4 EB network (Figure 3.6A) was dominated 
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largely by growth factors and not ECM molecules.  Similarly, k-means plots C and J 
(Figure 3.3C,J), which contain molecules that decrease sharply until day 4 prior to 
gradual increases, are composed primarily of ECM molecules.  In addition, the molecules 
that appear in the day 4 network primarily act upon the transcription factor p53 that in 
turn decreases the pluripotent marker Nanog.  Together, these results suggest that in the 
early stages of EB culture, growth factors are the dominant factors necessary to prime the 
system for differentiation.  However, there is likely some minimal matrix present in day 4 
EBs that is absent from the network because the molecules did not meet the fold-change 
threshold cutoff or were not present in/associated with the arrays.  These matrix 
molecules may serve as a reservoir for growth factors in the system.  The ECM molecules 
present in the day 7 EB network are largely proteases, which may serve to remodel the 
little matrix present in the EBs and allow for the subsequent increase in molecules 
necessary for support of the differentiating cell phenotypes.  By day 10, both ECM 
molecules and growth factors appear in the network, along with an increase in the 
number of connected transcription factors, suggesting the onset of signaling related to a 
variety of differentiation events.  Finally, the appearance of a number of integrins by day 
14 emphasizes the onset of cell movement and signal transduction events. 
 In addition to elucidating these global views of dynamic EB processes, low 
density extracellular array analyses offer insight into molecules that may otherwise have 
remained unstudied.  For example, the uniquely sharp increases of molecules such as 
Postn and Col3a1 by day 14 raise speculation as to their importance in EB 
differentiation, and subsequent knock-down studies may elucidate otherwise unknown 
mechanisms.  In addition, with enough replicates, it could be possible to “reverse 
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engineer” networks, or to identify connections previously unknown.  Key insights gained 
into the EB system from the array analyses highlighted that the earliest associated 
endogenous ECM and growth factor molecules are associated with regulators of self-
renewal and differentiation.  Additional array analyses examining matrices synthesized 
from directed differentiation schemes could further parse out the association of molecules 
with particular cell specification events.  In addition to analyses of ESCs, parallel 
examination of induced pluripotent stem cells could highlight environmental cues that 
stimulate the reversion of somatic cells to a pluripotent state and could also identify novel 
candidates to promote or inhibit reprogramming.  Global analysis of low density arrays 
elucidates the role of extracellular factors in modulating dynamic systems, which in turn 




SYNTHESIS AND ORGANIZATION OF HYALURONAN AND 





Pluripotent embryonic stem cells (ESCs), derived from the inner cell mass of pre-
implantation blastocysts, have the ability to differentiate into all somatic cell types, as 
well as germ cells [1-4].  Differentiation of ESCs into ectoderm, mesoderm and 
endoderm derivatives can be induced in vitro via the aggregation of cells into three-
dimensional clusters referred to as embryoid bodies (EBs), which serve as a model of 
peri-implantation development [35, 36].  For nearly 30 years, murine ESCs have 
provided an accessible in vitro model system for studying various aspects of early 
mammalian embryonic morphogenesis [136, 137], including the differentiation of ESCs 
into distinct functional cell types, such as cardiomyocytes, neurons, and endocrine cells 
(among many others) [137-139].  Although genetic and phenotypic changes of 
differentiating ESCs have been the primary focus of most studies, the associated dynamic 
changes in endogenous ECM synthesis and organization that occur coincidentally with 
differentiation have not been as rigorously examined. 
During early development, the epithelial-mesenchymal transition (EMT) is a 
critical process in embryogenesis whereby epithelial progenitor cells transform into 
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mesenchymal cells in order to migrate and facilitate tissue formation.  This transition is 
typically characterized by a decreased expression of adherens junctions responsible for 
coupling the cells tightly together, thereby permitting an increase in cell motility.  In an 
effort to further define the potential of using ESCs as an in vitro model of early 
development, researchers have studied the EMT in ESCs, including mouse [140], rhesus 
monkey [27, 141], and human ESCs [142-144].  ESCs that were differentiated using 
various strategies ranging from feeder-free conditions [142], definitive endoderm 
formation [143], monolayer [144], and spontaneous differentiation [140] have been 
shown to mimic aspects of EMT events, evidenced in part by the loss of E-cadherin and 
the tight junction associated proteins, as well as increased expression of N-cadherin and 
mesenchymal transcription factors.  In addition to the differential expression of these cell 
junction markers and transcription factors, cell differentiation and tissue formation in the 
developing embryo are accompanied by spatially distinct alterations in the composition 
of the extracellular matrix (ECM) [145-147].  However, specific ECM molecules 
associated with EMT processes in ESCs have yet to be defined. 
ECM molecules such as hyaluronan and versican are critically important in 
regulating EMT processes in various tissues [148-153].  Hyaluronan is a high molecular 
weight (106 – 107 Da) glycosaminoglycan (GAG) comprised of repeating disaccharide 
units of glucuronic acid and N-acetylglucosamine that can be synthesized by three 
independent hyaluronan synthases (HAS), HAS-1, -2, and -3 [154].  Hyaluronan has been 
implicated in several morphogenic cell and tissue events involving EMTs, including 
embryonic development, wound healing, and angiogenesis [155-159].  Versican is a 
chondroitin sulfate proteoglycan found in a variety of soft tissues and is capable of 
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binding to hyaluronan [160].  Four different isoforms of versican (V0, V1, V2, V3) exist 
as a result of alternative splicing of the two exons that encode the GAG attachment 
domains (α-GAG and β-GAG) in the core protein.  Versican affects cell phenotypes 
associated with EMT processes, including proliferation and migration [160], suggesting 
that hyaluronan and versican together may play functional roles in EMTs occurring 
during embryonic development. 
 The objective of this study was to examine the temporal and spatial patterns of 
hyaluronan and versican expression, accumulation, and organization by mouse ESCs 
undergoing EB differentiation.  The presence and spatial distribution of hyaluronan and 
versican within differentiating EBs was examined histologically, and hyaluronan and 
versican extracted from EBs were quantified as a function of differentiation time.  The 
temporal gene expression profile of the individual hyaluronan synthase and versican 
isoforms was assessed over the course of early differentiation.  In addition, the presence 
of primitive epithelial and mesenchymal cell populations was assessed relative to the 
spatial distribution of versican and hyaluronan within the ECM of EBs.  These studies 
demonstrate that dynamic changes in hyaluronan and versican occur coincidentally with 
phenotypic changes observed during EB differentiation, indicative of EMT processes.  
 
Materials and Methods 
Cell culture 
Mouse embryonic stem cells (D3 cell line, ATCC) were cultured on 0.1% gelatin-
coated 100 mm polystyrene cell culture dishes (Corning, Corning, NY) with Dulbecco’s 
modified eagle medium (Mediatech, Herndon, VA), supplemented with 15% fetal bovine 
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serum (HyClone, Logan, UT), 2mM L-glutamine (Mediatech), 1x MEM non-essential 
amino acids (Mediatech), antibiotic/antimycotics (Mediatech), and 0.1 mM β-
mercaptoethanol (MP Biomedicals, LLC, Solon, OH).  To maintain the undifferentiated 
cells, 103 U/ml leukemia inhibitory factor (LIF) (ESGRO, Temecula, CA) was added to 
the culture media, and the cells were passaged every 2-3 days before reaching >70% 
confluence.  All of the described studies were performed with ESCs between passages 
18-30.  To initiate embryoid body (EB) cultures, a single cell suspension of 4x105 
ESCs/mL (in 10 mL) was added to 100 mm bacteriological grade Petri dishes (Corning) 
in culture media lacking LIF (differentiation media).  Cultures were placed on rotary 
orbital shakers (Barnstead Lab-Line, Model 2314, Dubuque, Iowa) at 40 rpm at 37oC in 
5% CO2 for the entire duration of suspension culture, similar to previously described 
methods [124].  EBs were re-fed every other day after collecting the EBs via gravity-
induced sedimentation in conical tubes and re-suspended in fresh differentiation media 
for additional culture. 
 
Histological analysis of hyaluronan and versican 
EBs collected at different stages of differentiation (4, 7, or 10 days) were fixed 
with 10% formalin for 30 minutes and embedded in Histogel® (Richard-Allan Scientific, 
Kalamazoo, MI).   Each Histogel® block was processed for histological sectioning 
through a series of xylene and alcohol rinses prior to paraffin embedding.  Sections of EB 
samples (5 μm each) were obtained from different depths (a minimum of 90 μm apart) 
within the paraffin block and stained with hematoxylin and eosin (H&E) using a Leica 
AutoStainer XL.  ESCs fixed with formalin on tissue culture plates were similarly stained 
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for H&E, using the same reagents and incubation times as applied by the autostainer 
protocol.  A minimum of three independent experiments, each containing roughly 3000 
EBs, were examined by histological analyses.  Paraffin-embedded EBs were also stained 
using Movat’s Pentachrome staining procedure after de-paraffinization and hydration to 
distilled water.  Sections were incubated in the following reagents, with intermittent 
rinses performed under running water or ultra-pure water: 1% alcian blue (20 minutes), 
alkaline alcohol (60oC, 10 minutes), Weigert’s stain (60 minutes), Crocein scarlet/acid 
fuchsin (1 minute), 5% phosptungsitic acid (5 minutes), 1% acetic acid (5 minutes), 95% 
ethanol (EtOH; 1 minute), 100% EtOH (2x; 1 minute), alcoholic saffron (7 minutes), and 
absolute EtOH (2x; 1 minute).  Slides were then cleared in xylene and cover-slipped 
using Mount Quick mounting medium (Daido Sangyo Co., Ltd, Tokyo, Japan). 
For immunohistochemical (IHC) staining, endogenous peroxidase activity was 
quenched using 0.75% hydrogen peroxide in 100% methanol (20 minutes), after which 
the samples were hydrated in a graded ethanol series (100% EtOH-35% EtOH) and 
rinsed in phosphate-buffered saline (PBS, pH 7.3).  Slides from each block were then 
incubated in hyaluronidase reaction buffer (50 mM NaOAc, 150 mM NaCl, pH 6.0) for 
one hour at 37oC; with or without hyaluronidase (Hyaluronan Lyase from Streptomyces 
hyalurolyticus, Sigma, St. Louis, MO), which was diluted to 20 U/mL in hyaluronidase 
buffer and added to negative control samples.  Samples were then blocked in 1% bovine 
serum albumin (BSA) in PBS for 30 minutes before adding biotinylated hyaluronan 
binding protein (HABR-B, 2.5 μg/mL, Sigma) and incubating overnight at 4oC.  The 
Vector Elite ABC kit with Vector Red substrate (both from Vector Laboratories, 
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Burlingame, CA) was used to develop color, and the slides were counterstained with 
hematoxylin prior to cover-slipping. 
For versican staining, sections were deparaffinized, rehydrated, and quenched as 
described above, then treated for 1 hour at 37oC with ABCase (Chondroitin ABC Lyase, 
MP Biomedicals; 0.2 U/mL in enriched TRIS buffer stock, final concentrations 50 mM 
TRIS, 60 mM NaAc, 50 mM NaCl, pH 8; with 0.1 mg/ml BSA) as an antigen retrieval 
step to degrade chondroitin sulfate GAGs and expose the versican core protein.  Slides 
were rinsed in TBS and then blocked for one hour at room temperature in 5% Carnation 
non-fat dry milk.  Primary antibody (rabbit anti-mouse versican β-GAG domain, 
Millipore, Billerica, MA; 7 µg/ml in 0.1% BSA in PBS) was added and incubated 
overnight at 4oC.  After three PBS rinses, a biotinylated goat anti-rabbit secondary 
antibody (1:400 in 0.1% BSA/PBS, Invitrogen, Carlsbad, CA) was added for one hour at 
room temperature.  Samples were developed with the Vector Elite ABC kit with Vector 
Red substrate, and the slides were counterstained with hematoxylin prior to cover-
slipping.  Negative control samples were prepared identically, with rabbit IgG isotype 
control (7 µg/ml in 0.1% BSA in PBS; Vector Laboratories) used in place of primary 
antibody. 
To visualize hyaluronan and versican in the same section for co-localization 
studies, immunofluorescence (IF) was performed.  De-paraffinized histological sections 
were blocked for 1 hour using 1.5% normal donkey serum (NDS).  Samples were 
incubated with primary reagents HABR-B (2.5 μg/mL, Sigma) and versican (5 μg/mL 
beta-GAG domain, Millipore) together for one hour at room temperature or overnight at 
4oC. After three PBS rinses, the samples were incubated with Alexa 488-streptavidin 
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(Invitrogen; 1:400 in 1.5% NDS; hyaluronan) and TRITC-labeled donkey anti-rabbit 
secondary antibody (Jackson ImmunoResearch, West Grove, PA; 1:400 in NDS; 
versican) for one hour at room temperature prior to Hoechst (10 μg/mL) counterstaining.  
Samples from all staining batches were then mounted with coverslips using either low 
viscosity mounting medium (IHC samples, Cytoseal™ 60, Richard-Allan Scientific) or 
aqueous mounting medium with anti-fading agents (IF samples, Gel/Mount™, Biomeda 
Corp., Foster City, CA).  Note that antigen retrieval with ABCase was omitted in these 
samples; ABCase has hyaluronidase activity, which completely degraded hyaluronan in 
the samples (data not shown).  Hyaluronidase treatment and incubation with rabbit IgG 
isotype in place of primary antibody served as negative controls for hyaluronan and 
versican staining, respectively.  
 
Immunohistochemical analysis of ADAMTS-5, pan-cytokeratin, and N-cadherin 
For ADAMTS-5 staining, de-paraffinized histological sections were blocked for 1 
hour at room temperature using 2.5% NDS-2.5% BSA in PBS.  Samples were incubated 
with rabbit anti-ADAMTS-5 JSCKNG (4 μg/mL in 0.1% BSA-PBS, Affinity 
BioReagents, Rockford, IL) overnight at 4oC (negative IgG control: 4 μg/mL in 0.1% 
BSA-PBS). After three PBS rinses, the samples were incubated with Alexa Fluor 555 (5 
μg/mL in 0.1% BSA-PBS) for one hour at room temperature prior to Hoechst (10 μg/mL) 
counterstaining.  Samples were then mounted with coverslips using aqueous mounting 
medium with anti-fading agents (Gel/Mount™).  
For pan cytokeratin and N-cadherin staining, the required antigen retrieval 
treatments damaged the versican epitope so that co-localization staining could not be 
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performed.  Therefore, adjacent sections of each sample were stained for versican as 
described above.  For pan cytokeratin, antigen retrieval was performed by incubating 
sections in 40 μg/mL proteinase-K (Fisher Scientific, Pittsburgh, PA) in 10mM Tris-HCl 
pH 8.0 (6 minutes, room temperature). Samples were then blocked for 1 hour at room 
temperature in 2% normal goat serum (NGS), followed by incubation with primary 
antibody recognizing pan cytokeratin (Dako, Carpinteria, CA, 1:10 dilution in 2% NGS; 
skin positive control) overnight at 4oC.  For N-cadherin staining, heat-induced epitope 
retrieval was performed by boiling the samples in 10 mM citrate buffer at pH 6.0 for 20 
minutes.  Samples were blocked for 1 hour at room temperature in 2% NGS, then 
incubated with primary antibody recognizing N-cadherin (BD Biosciences, San Jose, CA, 
1:30 dilution in 2% NGS; whole mouse embryo positive control) overnight at 4oC.  Both 
pan cytokeratin and N-cadherin-stained samples were visualized by incubating with 
FITC-labeled goat anti-mouse secondary antibody (Southern Biotech, Birmingham, AL; 
1:100 in 2% NGS) for one hour at room temperature prior to Hoechst (10 μg/mL) 
counterstaining.  Samples were then mounted with coverslips using aqueous mounting 
medium with anti-fading agents (IF samples, Gel/Mount™, Biomeda Corp.).   
 
Microscopy 
 Histological sections were imaged using a Nikon 80i microscope and a Spot Flex 
camera (Diagnostic Instruments, Inc., Sterling Heights, MI).  For each antigen examined, 
images for all samples were acquired using the same exposure settings.  Slight linear 
adjustments in brightness were made across entire images using SPOT Advanced 
software to enhance the contrast between signal and background. 
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Quantitative hyaluronan expression in EBs 
Hyaluronan was isolated from ESCs, EBs (50,000 cells per sample; n=3 for each 
time point), or the media conditioned by the cells by digesting with Pronase (f.c. 500 
μg/mL; 15 mg/mL stock in 0.5M Tris pH 6.5; Pronase from Streptomyces griseus, Roche 
Applied Science, Indianapolis, IN) at 37oC overnight.  The enzyme was then heat-
inactivated at 100oC for 20 minutes, and the samples were stored at -20oC prior to 
analysis.  Hyaluronan was quantified using the Hyaluronan Test Kit (Corgenix, Denver, 
CO) by diluting the samples in 10 volumes of reaction buffer and adding 100 μL to 
hyaluronic acid binding protein (HABP)-coated micro-wells (1 hour, room temperature).   
Wells were then rinsed with PBS, and 100 μL of horseradish peroxidase (HRP)-
conjugated HABP solution was added (30 minutes, room temperature).  Each well was 
rinsed an additional four times prior to a 30-minute incubation (room temperature) with 
100 μL of substrate solution (3, 3’, 5, 5’ – tetramethylbenzidine and hydrogen peroxide).  
Blue color developed in positive samples, and 100 μL of stopping solution (0.36 N 
sulfuric acid) was added to each well.  The optical density for each well was read at 450 
nm on a spectrophotometer (SpectraMax M2e, Molecular Devices, Sunnyvale, CA).  A 
standard curve created from purified hyaluronan was used to calculate hyaluronan 
concentration in cell samples, which are presented normalized to cell number.  Cell 





Protein was isolated from ESCs and day 4, 7, and 10 EBs with extraction buffer 
(8M urea, 2 mM EDTA, 50 mM Tris, 0.5% Triton X-100, 0.25 M NaCl, Roche protease 
inhibitor cocktail).  Protein concentrations were measured using a MicroBCA Assay 
(Pierce, Rockford, IL), and samples were stored at –80oC prior to analysis.  For versican 
blots, 300 μg total protein per sample were applied to diethylaminoethyl (DEAE) 
Sephacel® (Sigma) columns (0.3 mL bed volume), pre-equilibrated, and washed with 10 
bed volumes wash buffer (8M urea, 2 mM EDTA, 50 mM Tris, 0.5% Triton X-100, 0.25 
M NaCl).  The samples were eluted with 3 bed volumes wash buffer containing 2 M 
NaCl.  Chondroitin sulfate (f.c. 50 μg/mL; 10 mg/mL stock; Sigma) carrier was added, 
and protein was precipitated from the eluate by adding ethanol (95% ethanol/1.3% 
potassium acetate) for 2 hours at –80oC.  Precipitated protein was collected by 
centrifugation for 5 minutes at 14,000 rpm and rinsed twice with ethanol.  Pellets were 
air-dried and then digested with 3 U/mL chondroitinase (10 U/mL stock; Seikagaku, 
Tokyo, Japan) in 20 mM Tris, 3.6 mM sodium acetate, pH 8.0 for 3 hours at 37oC to 
remove chondroitin chains from the core proteins.  Concentrated sample buffer (50 mM 
Tris-HCl pH 6.8, 1% SDS, 10% glycerol, 1.7% v/v 2-mercaptoethanol) was added, and 
the samples were boiled for 3-4 minutes prior to loading on a 15 cm x 12 cm 4-12% 
gradient polyacrylamide gel (3.5% stacking gel) and separated overnight at room 
temperature.  Protein was transferred to nitrocellulose membranes and blocked for 2 
hours at room temperature in blocking buffer (2% BSA in Tris-buffered saline, 0.1% 
Tween-20).  Membranes were incubated overnight in blocking buffer containing 2% calf 
serum and 0.25 μg/mL rabbit anti-mouse versican β-GAG domain antibody (Millipore).  
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Membranes were then washed with TBS-T (Tris buffered saline with 0.1% Tween-20) 
and incubated for 2 hours at room temperature (1:20,000 goat anti-rabbit IgG antibody 
conjugated to alkaline phosphatase in blocking buffer; Jackson ImmunoResearch).  After 
extensive washing in TBS-T, blots were incubated in assay buffer (0.1 M diethanolamine, 
1 mM MgCl2, 0.02% sodium azide, pH 10) for 10 minutes, followed by incubation with 
substrate (1:100 CSPD® substrate, 1:20 Nitro-Block™ enhancer in assay buffer; Applied 
Biosystems, Foster City, CA) for 5 minutes at room temperature.  Blots were exposed to 
autoradiograph film (ISC BioExpress, Kaysville, UT) and developed in a film processor 
(Fischer Industries Inc., Geneva, IL).  For DPEAAE blots, equal amounts of protein from 
each sample were ethanol precipitated and electrophoresed on 8% SDS-Page gel with 
3.5% stacking gel.  Proteins were transferred to nitrocellulose, probed with DPEAAE 
antibody (1 μg/mL, Affinity Bioreagents, Golden, CO), and detected using an enhanced 
chemiluminescence kit as described above.  As a loading control, the same blot was also 
probed with an anti-actin N terminal antibody (Sigma). 
Each lane on the Western blots reported represents protein lysates from an EB 
culture collected at the designated time point.  Lysates from three separate cultures per 
time point were examined for each independent experiment. 
 
Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) 
RNA was extracted from undifferentiated ESCs and EBs at days 4, 7, and 10 of 
differentiation using the RNeasy Mini Kit (Qiagen, Valencia, CA).  Complimentary DNA 
was reverse transcribed from 1 μg of total RNA using the iScript cDNA synthesis kit 
(Bio-Rad, Hercules, CA), and real-time RT-PCR was performed using SYBR Green 
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technology on the MyiQ cycler (Bio-Rad).  Beacon Designer software was used to design 
forward and reverse primers (purchased from Invitrogen; Table 1) for pluritpotency 
markers Oct-4 and Nanog, the three hyaluronan synthase (HAS) isoforms (HAS-1, HAS-
2, HAS-3), the four versican splice variants (V0, V1, V2, V3), and glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), which were then validated with the appropriate 
positive controls.  Gene expression of Oct-4 and Nanog were calculated relative to 
undifferentiated ESC samples using the Pfaffl method [125], while HAS and versican 
concentrations were calculated from standard curves prior to normalization to GAPDH 
expression levels.  GAPDH was used as a normalization tool because it is stably 
expressed in ESCs over time, as demonstrated not only in literature [161], but when 
analyzed independently in these cultures.  Gene expression data from two independent 
batches of ESCs and EBs each containing three replicates cultured at different times (n=6 
for each time point) were combined prior to statistical analyses. 
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Table 4.1. qRT-PCR primer information. 
Primer Forward Sequence Reverse Sequence Hybridization T (oC) 
GAPDH GCC TTC CGT GTT CCT ACC 
GCC TGC TTC ACC 
ACC TTC  55.0 
Oct-4 CCG TGT GAG GTG GAG TCT GGA G 
GCG ATG TGA GTG 
ATC TGC TGT AGG 64.0 
Nanog GAA ATC CCT TCC CTC GCC ATC 
CTC AGT AGC AGA 
CCC TTG TAA GC  64.0 
V0 TTG AGG TCA GAG AAA ACA AGA CAG 
TCT GTT TCT TCA 
CTG CAA GGT TCC 55.0 
V1 AGC AGA TTT GAT GCC TAC TGC TTT 
TCT TCA CTG CAA 
GGT TCC TCT TCT 55.0 
V2 GAC CAA GTT CCA CCC TGA CAT AAA 
GGT TTG TTT TGC 
AGA GAT CAG GTC 55.0 
V3 AGC AGA TTT GAT GCC TAC TGC TTT 
TGC ACA CAT AGG 
AAG TCT CGG TAG 55.0 
HAS-1 ATG ACA GGC ACC TCA CCA AC 
AAC CAA CGA AGG 
AAG GAG GA 55.0 
HAS-2 CAA AAA TGG GGT GGA AAG AG 
GAG GCA GGG TCA 
AGC ATA GT 55.0 
HAS-3 GGC AAC TCA GTG GAC TAC 
CAA CAC CTC CTA 
CTT GGG 55.0 
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For SuperArray RT2 Profiler™ PCR array analysis, cDNA synthesis was 
performed using the SuperArray RT2 First Strand kit (SABiosciences, Frederick, MD).  
First, the genomic DNA elimination mixture was prepared by mixing 0.5 μg RNA with 
the 5x gDNA Elimination Buffer and RNase-free water and incubating at 42oC for 5 
minutes.  The RT cocktail (5x RT Buffer 3, Primer & External Control Mix, RT Enzyme 
Mix 3, and RNase-free water) was prepared (10 μL) and added to the elimination buffer 
mixture.  Each sample was then placed in the iCycler Thermal Cycler (Bio-Rad) for 
synthesis (15 minutes at 42oC, 5 minutes at 95oC) and diluted with RNase-free water.  
RT-PCR was performed by first preparing the experimental cocktail (1275 μL 2x 
SuperArray RT2 qPCR Master Mix, 102 μL diluted first strand cDNA synthesis reaction, 
1173 μL RNase-free water) and then distributing it across all wells of the PCR 96-well 
array.  The array was tightly sealed with optical thin-wall 8-cap strips and run in the 
MyiQ cycler (Bio-Rad) with a two-step cycling program (1 cycle, 10 minutes, 95oC; 40 
cycles, 15 seconds, 95oC; 40 cycles, 1 minute, 60oC) and melt curve.  Fold changes in 
gene expression were analyzed using the ΔΔCt method of quantitation, whereby samples 
of EBs from different time points (days 4, 7, and 10) were compared relative to 




 For paired comparisons, Student t-tests assuming unequal variances were used to 
determine statistical significance (p < 0.05).  For comparisons across multiple groups, 
analysis of variance (ANOVA) was performed using a 95% confidence interval followed 
 68
by post-hoc Tukey analysis to determine significant (p < 0.05) differences between the 
different experimental groups. 
 
Results 
Embryoid body differentiation 
Adherent colonies of undifferentiated mESCs were dissociated into single cells 
and re-aggregated in suspension culture to form cell spheroids constituting putative EBs 
(Figure 4.1).  As expected, the resulting EBs increased in size and adopted a more 
differentiated morphology over the course of differentiation, indicated by the formation 
of a primitive endoderm layer on the periphery of EBs (denoted by solid arrows in Figure 
4.1) as well as cystic cavities (hollow arrows, Figure 4.1) that developed in the interior of 
the EBs.   
Phenotypic differentiation of the EBs was evidenced by a reduction in the 
expression of the pluripotent transcription factors Oct-4 and Nanog by EBs (Figure 4.2) 
and by opposing trends of E-cadherin and N-cadherin gene expression with time (Figure 
4.3).   
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Figure 4.1. Embryoid body differentiation.  Phase images were taken and histological 
staining was performed on ESCs and EBs cultured for 4, 7, and 10 days.  EBs increased 
in size over the course of differentiation culture, and H&E staining showed pockets of 
differentiating cells visibly emerging by day 7.  Solid arrows highlight differentiated 
endoderm layer, and hollow arrows indicate development of cystic cavities, both 




Figure 4.2. Pluripotency marker mRNA expression.  Quantitative RT-PCR was 
performed to assess transcript abundance of two transcription factors, Oct-4 and Nanog.  
Both genes decrease steadily over the course of differentiation, indicating the expected 
loss of pluripotent markers as the ESCs differentiate. * indicates significant differences 
from ESCs, † from day 4, p < 0.05. 
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Figure 4.3. EMT marker mRNA expression.  The gene expression of E-cadherin and 
N-cadherin was examined in ESCs and EBs differentiating for 4, 7, and 10 days.  The 
opposing trends of E-cadherin and N-cadherin expression indicated the presence of an 
epithelial-mesenchymal transition in the differentiating EBs.  The left scale on the y-axis 




Movat’s pentachrome staining of EBs revealed intense cytoplasmic staining (red) 
of densely-packed epithelial-looking cells at early stages of differentiation (days 4 and 7).  
After 10 days, a majority of cells within many EBs adopted a more mesenchymal 
appearance, and GAGs were detected in the extracellular space (light blue) throughout 




Figure 4.4. Embryoid body ECM synthesis.  EBs were evaluated using Movat’s 
pentachrome staining procedure, in which nuclei stain dark purple/black, cytoplasm 
stains pink/red, elastic fibers stain purple/black, collagen stains yellow/green, and non-
collagenous ECM (primarily sulfated GAGs and proteoglycans) stains blue/green.  EBs 
were primarily positive for cytoplasm (pink/red) staining, with some diffuse blue staining 
observed by day 10. 
 
 73
Hyaluronan and versican accumulation and distribution within differentiating EBs 
In order to specifically examine the spatial distribution of hyaluronan and 
versican within EBs, immunohistochemistry was performed to examine EBs at different 
stages of differentiation (days 4, 7, 10).  After only 4 days of differentiation, very little 
hyaluronan was detected in EBs (Figure 4.5A,D,G), but that which was present was 
predominantly localized around the periphery of most of the cell aggregates.  By 7 days 
of differentiation, hyaluronan was clearly detectable more extensively throughout EBs 
and most often appeared to be enriched primarily on one side of an EB (Figure 
4.5B,E,H).  After 10 days, hyaluronan was found to be distributed throughout almost the 
entire interior of EBs (Figure 4.5C,F,I).  Interestingly, the accumulation of hyaluronan 
appeared to be greatest in areas of lower cell density within EBs.   
Similarly, versican (detected with an antibody recognizing the V0/V1 isoforms of 
versican) was minimally present within EBs at day 4 of differentiation (Figure 
4.6A,D,G), but was distributed throughout a large portion of EBs by 7 days of 
differentiation (Figure 4.6B,E,H).  After 10 days of differentiation, versican was detected 
throughout the majority of EBs and appeared most concentrated within less dense areas 
of cells (Figure 4.6C,F,I), similar to the patterns of hyaluronan localization observed.  
Thus, the expression of hyaluronan and versican within EBs exhibited similar temporal 
and spatial patterns over the course of differentiation. 
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Figure 4.5. Hyaluronan accumulation during EB formation.  Sections (5 μm) from 
day 4, 7, and 10 EBs were stained with hyaluronan binding protein (dark red color); 
hematoxylin-stained nuclei are shown in blue.  Hyaluronan was increasingly prominent 
with differentiation time.  Localized pockets of hyaluronan staining can be seen by day 7 
(B,E), and higher magnification images (D-F, magnified view of boxes outlined in A-C) 
show hyaluronan surrounding individual cells.  The magnification for each row is 





Figure 4.6. Versican accumulation during EB formation.  Sections (5 μm) from day 4, 
7, and 10 EBs were stained with an anti-versican antibody (dark red color); hematoxylin-
stained nuclei are shown in blue.  Some versican expression can be seen by day 4 (A,D), 
with increased quantities observed by days 7 (B,E) and 10 (C,F).  Versican appears to 
localize in areas of lower cell density, while higher magnification images (D-F, 
magnified view of boxes outlined in A-C) reveal versican staining within acellular 





Accumulation of hyaluronan during EB formation 
 To quantify the amount of hyaluronan synthesized and retained within EBs, and 
released into the media over the course of differentiation, hyaluronan produced by EBs 
was assessed using a hyaluronan binding protein quantification kit (Figure 4.7).  
Hyaluronan accumulated within EBs as a function of time, such that the relative amount 
of hyaluronan by day 10 of differentiation increased significantly compared to earlier 
time points (ESCs: p = 0.002; day 4: p = 0.003; 7: p = 0.006).  The quantity of 
hyaluronan produced per cell and retained within day 10 EBs was almost 30-fold greater 
than the amount of hyaluronan retained in the cell layer by undifferentiated ESCs (0.090 
± 0.07 pg/cell to 2.680 ± 1.11 pg/cell) (Figure 4.7A).  Likewise, the concentration of 
hyaluronan secreted into the culture media increased almost four-fold from 0.898 ± 0.13 
μg/mL at day 2 to 3.572 ± 0.59 μg/mL by day 10 of EB culture.  For the first six days of 
differentiation, ESC- and EB-conditioned media contained similar concentrations of 
hyaluronan, between 0.898 ± 0.13 μg/mL and 1.594 ± 0.32 μg/mL (Figure 4.7B).  
However, hyaluronan content significantly increased at days 8 and 10 of differentiation 
(2.769 ± 0.42 μg/mL and 3.572 ± 0.59 μg/mL, respectively) compared to the earlier time 
points examined.  On a per cell basis, proportionally less hyaluronan was secreted into 
the media than retained within the EBs over time.  Media conditioned by day 4 and 7 EBs 
contained 0.354 ± 0.072 pg hyaluronan/cell and 0.157 ± 0.0058 pg hyaluronan/cell, 
respectively, compared to 0.167 ± 0.06 pg hyaluronan/cell (day 4) and 0.480 ± 0.22 pg 
hyaluronan/cell (day 7) retained within the EBs.  Altogether, these results indicate that 
EBs synthesize and secrete increasing amounts of hyaluronan as a function of 
differentiation and an increasing amount of hyaluronan is retained within EBs over time. 
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Figure 4.7. Quantification of hyaluronan synthesis by EBs.  A quantitative hyaluronan 
(HA)-binding protein-based kit was used to measure hyaluronan retained within ESCs 
and day 4, 7, and 10 EBs (A) as well as hyaluronan secreted in media conditioned by 
ESCs and day 2, 4, 6, 8, and 10 EBs (B).  Hyaluronan content in ESCs, EBs, and 
conditioned media samples progressively increased over the course of differentiation.   
Day 10 EBs and day 8- and 10-conditioned media samples contained significantly greater 
amounts of hyaluronan than samples collected from all other time points examined.  # in 
(A) indicates significant differences from ESCs, day 4, and day 7, p < 0.01; ‡ in (B) 
indicates significant differences from ESCs and days 2 – 6, p < 0.01. 
 
 78
Versican accumulation and proteolytic processing during EB formation 
To further analyze versican synthesis by differentiating EBs, proteoglycans were 
isolated and examined by Western blot analysis using a primary anti-mouse versican β-
GAG domain antibody, which detects only the V0 and V1 versican isoforms.  V0 and V1 
appear as two high molecular mass products that migrate in the 350-450 kDa range on 
SDS PAGE gels [162-164].  V0 and V1 were not detected in the ESCs or EBs after 4 
days of differentiation.  However, V1 appeared at day 7 in the EBs and persisted at day 
10 (Figure 4.8A).  Although a distinct band for V0 was not clearly visible, positive 
immunoreactivity was detected at a higher molecular weight than the V1 product.  
Several bands also appeared at lower molecular weights than V1 in the 10 day EB 
cultures, which most likely represent degradation products of versican [162-164], such as 
the 70kDa DPEAAE neoepitope generated by proteolytic cleavage of versican by 
ADAMTS-1 [163].  Therefore, to assess whether versican proteolysis occurred during EB 
differentiation, immunoblotting was performed using an antibody that specifically 
recognizes DPEAAE.  Parallel to the expression patterns of V0 and V1, the neoepitope 
was not detected in undifferentiated ESCs, but appeared at day 4 of differentiation, and 
increased in signal intensity through day 10 (Figure 4.8B).  Similarly, gene expression of 
ADAMTS-1 [163] and ADAMTS-5 [165] (known versicanases) increased significantly 
by 10 days of differentiation compared to ESCs (Figure 4.8C), particularly for 
ADAMTS-5.  In contrast, gene expression of ADAMTS-8, which is not implicated in 
versican degradation, did not change significantly during EB differentiation.  
Immunostaining for ADAMTS-5 indicated minimal expression in day 4 EBs (data not 
shown), but the protease was distributed throughout different regions of day 7 and day 10 
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EBs (Figure 4.8D,E).  Altogether, these results indicate that increased expression and 
proteolytic processing of versican occurs during EB differentiation. 
 
Hyaluronan synthase and versican gene expression 
To evaluate the potential sources of hyaluronan and versican in differentiating 
EBs, gene expression analysis was performed.  The relative expression levels of the 
different hyaluronan synthase genes remained fairly consistent over the course of early 
EB differentiation (Figure 4.9A), with expression of HAS-2 significantly greater than 
either HAS-1 or HAS-3 at each of the time points examined (undifferentiated ESCs and 
days 4, 7 and 10 of EB differentiation).  In contrast, no significant differences were found 
between HAS-1 and HAS-3 expression at any stage of ESC differentiation.  In addition, 
by 10 days of differentiation, HAS-2 expression was significantly increased (p < 0.01) 
compared to the levels measured at all of the earlier time points of analysis. 
Similar to the patterns of HAS expression, the relative expression levels of the 
different versican isoforms were consistent over time (Figure 4.9B).  Undifferentiated 
ESCs and differentiating EBs expressed relatively high levels of V0 and V1 that were 
each significantly greater than V2 and V3 at all of the time points examined (p ≤ 0.003 in 
all cases), except for 10 days, when V0 and V3 were not statistically different.  The 
expression of V0, V1 and V3 increased significantly by day 10 of EB differentiation 
compared to any of the earlier time points (p < 0.01).  However, the expression of V2 
remained relatively low compared to the other versican isoforms and did not change 




Figure 4.8. Analysis of versican synthesis and proteolysis in differentiating EBs.  
Purified, chondroitinase-treated protein lysates from triplicate samples of ESCs and day 
4, 7, and 10 EBs were probed with rabbit anti-mouse versican β-GAG domain antibody 
(A).  Versican core proteins V0 and V1 (~450 and 350 kDa respectively) were apparent 
after 7 and 10 days of differentiation in triplicate samples and were not detected in ESCs 
and EBs after 4 days of differentiation.  Protein lysates were also examined for the 
versican cleavage product, known as the DPEAAE fragment, generated by ADAMTS-1 
over the course of EB culture (B). The 70 kDa DPEAAE fragment was present at day 4 
and appeared to increase with differentiation time through day 10.  Beta actin was used as 
a loading control.  ADAMTS-1 and -5, known versicanases, were examined via 
SuperArray RT-PCR arrays, and each gene was found to increase significantly by day 10 
compared to day 4 of differentiation, while ADAMTS-8, a protease unrelated to versican 
degradation, remained unchanged (C).  ADAMTS-5 immunofluorescent staining detected 
protease expression with day 7 (D) and day 10 (E) EBs.  † indicates significant 




Figure 4.9. Quantification of hyaluronan synthase and versican gene expression.  
Quantitative RT-PCR was used to compare expression levels of hyaluronan synthase 
(HAS) isoforms 1, 2, and 3 and versican splice variants V0, V1, V2, and V3 during the 
course of EB differentiation.  HAS-2 increased with time and was consistently expressed 
at significantly higher levels than either HAS-1 or HAS-3.  V0, V1, and V3 increased by 
10 days of differentiation, while V2 was consistently expressed at relatively low levels.  # 
indicates significant differences from ESCs, day 4, and day 7, p < 0.02;  indicates p < 
0.01,  p < 0.02, and  p < 0.05. 
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Hyaluronan and versican co-localization 
Immunofluorescent affinity labeling of both hyaluronan and versican within the 
same sections confirmed that hyaluronan and versican were not detectable in most EBs at 
4 days of differentiation, although when present, hyaluronan co-localized with versican 
(Figure 4.10A,D,G,J).  By day 7, hyaluronan and versican co-localized in regions of the 
EBs that primarily contained a lower density of cells (Figure 4.10B,E,H,K).  The 
appearance of a largely fibrillar network of overlapping hyaluronan and versican was 
clearly distinguishable by 10 days of differentiation throughout much of the interior of 
EBs (Figure 4.10C,F,I,L).  Thus, at each of the time points examined, hyaluronan and 




Figure 4.10. Hyaluronan and versican co-localization.  EBs were stained for both 
hyaluronan (green; A-C) and versican (red; D-F); merged images show co-localization of 
the two molecules in yellow (G-I; higher magnifications J-L).  Hyaluronan and versican 
appear to co-localize in areas of lower cell density, and deposition of both molecules 
increases over the course of differentiation.  Images A-I are shown at the same 
magnification, with the scale bar shown in the upper left image; the scale bar for J-L is 
shown in J. 
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Epithelial and mesenchymal phenotypes within EBs 
Based on the observed accumulation and co-localization of hyaluronan and 
versican in EBs during differentiation, as well as differences in cell morphology in 
regions containing hyaluronan and versican, the spatial distribution of epithelial 
(cytokeratin+) and mesenchymal (N-cadherin+) cells within EBs were examined relative 
to versican-rich regions.  After 10 days of differentiation, EBs clearly contained distinct 
populations of cytokeratin+ and N-cadherin+ cells.  Cytokeratin+ cells were primarily 
localized around the periphery of EBs, and versican appeared to be completely excluded 
from such areas within the same EB (Figure 4.11A,B).  In contrast, N-cadherin+ cells 
were predominantly found within the interior of EBs in regions that overlapped with the 
presence of versican (Figure 4.11C,D).  Taken together, these results suggest that 
versican (and likely hyaluronan based on their apparent co-localization and known 
binding interactions) may influence epithelial-mesenchymal transitions that occur within 
EBs during ESC differentiation.   
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Figure 4.11. Cellular expression of epithelial-mesenchymal phenotypic markers 
relative to versican localization.  Adjacent 5 μm sections from day 10 EBs were 
fluorescently stained with pan-cytokeratin or N-cadherin primary antibody (FITC-labeled 
secondary; green) and versican (TRITC-conjugated secondary antibody; red); nuclei were 
counterstained with Hoechst dye (blue).  Cytokeratin localized primarily in the periphery 
of the EBs, with some evidence of invasion into the EB interiors, while versican was 
localized exclusively in cytokeratin-negative areas (A,B).  In contrast, N-cadherin 
localized to areas occupied by versican (C,D).  Staining was performed on adjacent 
sections of the same EBs, which were matched based on morphology and location on 




 These studies provide evidence that spatial and temporal patterns of hyaluronan 
and versican accumulation and organization by ESCs within EBs are associated with 
epithelial-mesenchymal transitions occurring within the aggregates of differentiating 
cells.  ESCs express several hyaluronan synthase and versican isoforms throughout the 
course of EB differentiation, concomitant with increasing accumulation of hyaluronan 
and versican over the first ten days of differentiation.  The overlapping spatial patterns of 
expression suggest that hyaluronan and versican are physically associated within EBs, 
and moreover, the overlapping patterns of accumulation of these molecules are found 
predominantly in regions of EBs containing cells actively undergoing EMT 
differentiation.  Overall, these results not only suggest a specific role for hyaluronan and 
versican in the morphogenesis of primitive pluripotent stem cells, but also demonstrate 
that dynamic changes in the endogenous expression, accumulation, and processing of 
ECM molecules by differentiating ESCs occur coincidentally with cell phenotype 
changes.  These results indicate that an improved understanding of the molecular 
composition of embryonic extracellular matrices could yield new insights into 
developmental biology and provide novel strategies for the directed differentiation of 
stem cells. 
The most significant and novel finding of the present study is that the timing and 
spatial distribution of hyaluronan and versican expression within EBs correlates with the 
appearance and localization of mesenchymal (N-cadherin+) cell phenotypes and is 
excluded from regions of epithelial (cytokeratin+) cells (Figure 4.11).  Previous studies 
have demonstrated that ESC differentiation within EBs recapitulates many aspects of 
 87
gastrulation, including the transformation of epithelial pluripotent cells (resembling 
primitive ectoderm) into migratory mesenchymal cells (resembling primitive streak) [27, 
140-144].  Thus far, however, dynamic changes in prevalent ECM molecules produced 
within EBs, such as hyaluronan and versican, have not been directly examined or 
correlated with distinct populations of cells.  It has been previously demonstrated that 
coincident expression of hyaluronan and versican can stimulate cell migration by creating 
a visco-elastic, hyaluronan-versican-rich, malleable extracellular environment [155, 160], 
[166, 167].  Furthermore, a hyaluronan-versican matrix may influence cell fate by 
enriching for signaling molecules and growth factors that regulate cell proliferation and 
differentiation.  The importance of hyaluronan and versican in directing EMT processes 
is clear from a number of examples in cell and developmental biology.  Whereas HAS-2-/- 
mouse embryos fail to undergo EMT during cardiac morphogenesis [153], over-
expression of hyaluronan by HAS-2 recombinant adenoviral infection of normal 
epithelial cells induces an EMT [150].  In addition, versican plays an essential role in the 
EMT of the endocardial mesenchymal cushion [148, 152], as well as mesenchymal 
condensation and hair induction [168].  Thus, hyaluronan and versican appear to regulate 
the transformation of epithelial cells to mesenchymal phenotypes at various stages of 
development. 
 As noted above, the expression of HAS isoforms, in particular HAS-2, and the 
synthesis of hyaluronan play important roles in early embryological development of 
numerous tissues.  Although targeted inactivation of both HAS-1 and HAS-3 genes result 
in viable animals [169], knock-out of the HAS-2 gene is embryonic lethal by E9.5.  In 
addition, HAS-2-/- E9.5 embryos almost completely lack hyaluronan, suggesting that 
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HAS-2 is the primary isoform responsible for hyaluronan synthesis during early 
organogenesis [153].  In the present study, HAS-2 was the dominant synthase isoform 
expressed by ESCs in EBs, and HAS-2 expression increased significantly by ten days of 
differentiation.  The distribution of hyaluronan within murine EBs increased over time 
such that after ten days, differentiating cells produced ~30-fold more hyaluronan than 
undifferentiated ESCs (Figure 4.7A).  Similar results have been reported in 
differentiating human EBs.  Specifically, HAS-2 and its binding receptor RHAMM were 
highly up-regulated in human EBs and pre-implantation human embryos compared to 
ESCs, and a 24-fold enhancement of total hyaluronan was found in day 4 EBs (17.2 
ng/106 cells) compared to ESCs (0.7 ng/106 cells) [69, 170].  However, compared to both 
HAS-1 and HAS-3, increased expression of HAS-2 by human ESCs only occurred upon 
EB differentiation, whereas in the present study, HAS-2 expression was significantly 
greater than HAS-1 or HAS-3 in undifferentiated mESCs, as well as in EBs at all time 
points examined.  These subtle differences in HAS expression could be due to different 
culture methods utilized for the propagation and differentiation of mouse and human 
ESCs, as well as intrinsic differences between pluripotent cells derived from the two 
species [171]. 
 In addition to changes in HAS expression and hyaluronan synthesis, 
differentiating ESCs also exhibit temporal changes in versican isoform expression, 
associated with increasing versican content within EBs over the course of differentiation.  
In the developing embryo, versican plays an important role in early cell migration events 
during neural crest formation and cardiac morphogenesis [172], [151]; thus it is not 
surprising that versican is expressed by EBs undergoing similar differentiation processes 
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in vitro.  Compared to several other hyaluronan-binding proteoglycans, including 
aggrecan, neurocan and brevican, previous work demonstrated that versican (unspecified 
variant, presumably V0) was the only transcript to show a considerable enhancement in 
EBs compared to ESCs [69].  In the present study however, gene expression of each of 
the four different versican isoforms was independently examined.  V0 and V1 were 
consistently expressed at greater levels than V2 and V3 throughout EB differentiation, 
and by ten days of differentiation, expression of V0 and V1 was significantly increased 
compared to earlier stages of differentiation.  V0 and V1 isoforms uniquely contain the β-
GAG chain, and immunostaining and Western blotting results with an anti-β-GAG 
antibody clearly indicated accumulating versican (V0, V1) protein within EBs after 7 
days of differentiation.  Specific expression of β-GAG isoforms (V0, V1) has previously 
been linked to developmental processes such as chondrogenic differentiation and neural 
crest migration [172-175], thus V0 and V1 could be exerting similar effects in early ESC 
morphogenesis.  Furthermore, proteolytic cleavage of versican by ADAMTS enzymes to 
expose the DPEAAE epitope has been associated with EMT during cardiac cushion 
formation in the mouse embryo [148] and has been reported to play an important 
signaling function in EMT processes in various tissues [176], [177].  In addition, 
expression of ADAMTS-5 was limited prior to 11.5 days (E11.5) of mouse 
embryogenesis, but specifically found in developing nerves and limbs after E11.5, 
suggesting the potential importance of ADAMTS-5 in mid-stage development [178].  
Therefore, the coincident increase in DPEAAE epitope exposure with the expression of 
ADAMTS-1 and ADAMTS-5 during EB differentiation indicates that similar remodeling 
processes are involved in pluripotent stem cell morphogenesis. 
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 Differentiating embryonic stem cells offer a unique model system for studying 
various aspects of developmental biology.  Analyzing the dynamics of ECM synthesis, 
accumulation, and organization during development may yield new insights into the 
molecular regulatory mechanisms responsible for stimulating morphogenic processes, 
such as EMT, important for embryonic cell differentiation and organ development.  In a 
broader context, these results also indicate that phenotypic differences between 
differentiating ESCs may be associated with the local composition of the ECM, reflecting 
either the differentiation of specific cell types or the possibility of regulating endogenous 
ECM production within EBs to provide a novel approach to directing ESC fate. 
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CHAPTER 5 
EFFICACY OF SOLVENT EXTRACTION METHODS FOR 





 Embryonic stem cells (ESCs) are pluripotent cells with the ability to self-renew 
indefinitely in vitro and differentiate into all cell types comprising the ectoderm, 
endoderm, and mesoderm lineages.  The pluripotent differentiation capacity of ESCs 
suggests that these cells may be used for a variety of different regenerative cell therapies.  
However, in experimental models of ESC transplantation, tissue repair has been observed 
even in the absence of significant cell differentiation [179-182].  This suggests that in 
addition to the differentiated cells ESCs may become, they may also be capable of 
producing molecular factors that might alter the local tissue microenvironment and 
modulate tissue repair processes.  This notion is further supported by in vivo studies 
wherein delivery of local soluble factors by exogenous embryonic stem cells was capable 
of treating genetic defects or injuries in rodents [47, 48].  In order to determine the exact 
mechanisms whereby stem cells contribute to tissue morphogenesis (i.e. cell 
differentiation versus molecular delivery), it is vital to be able to physically separate the 
cells from their extracellular microenvironment. 
One approach commonly used to extract extracellular matrices from cells and 
                                                 
 
 
* Modified from: 
R Nair, AV Ngangan, and TC McDevitt, Efficacy of solvent extraction methods for acellularization of 
embryoid bodies.  J Biomater Sci Polym Ed., 2008, 19(6): 801-819. 
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tissues is decellularization.  Various types of tissues have successfully been 
decellularized, including intestine [71], bladder [183, 184], nerve grafts [83, 185], 
esophagus [84], heart valves [92, 186-188], placenta [77], skin [75], and pericardium 
[74].  Typical decellularization protocols include a variety of means to eliminate cellular 
components and retain extracellular matrix, including physical disruption, chemical 
treatments, and enzymatic digestions.  Decellularization procedures typically yield 
extracellular matrices consisting of structural and adhesive proteins, such as collagens, 
laminins, elastin and fibronectin, other proteoglycans and growth factors, and 
glycosaminoglycans.  These native ECM components retain bioactivity even after the 
decellularization process, evidenced by the ability of exogenous cells to invade, 
proliferate within, and remodel the acellular tissue [189-192].  Acellular products have 
been broadly applied to regenerate a variety of tissues, including infarcted myocardium 
[193], ruptured Achilles tendon [80], and injured skin [81], as well as to replace vascular 
grafts [71, 194] and tissues of the lower urinary tract [190].  Acellular tissues are capable 
of stimulating neovascularization, eliciting a minimal host immune response, and 
promoting functional tissue regeneration in vivo [83-85].  Several acellular products 
approved by the FDA for regenerative therapies and presently in clinical use include 
Surgisis® (Cook Surgical) [195], Alloderm® (LifeCell, Corp.) [196] and Synergraft® 
(CryoLife, Inc.) [186].  However, none of the currently commercially available acellular 
products are derived from tissue sources dynamically undergoing morphogenic processes.  
On the other hand, acellular matrices derived from embryonic stem cells could provide a 
robust clinical product capable of being tailored for different regenerative therapies due 
to the pluripotent nature of the cells and their ability to be differentiated towards different 
 93
lineages.  The development of different acellular products requires individual 
optimization of treatment conditions, such as combinations of chemical concentrations 
and durations, in order to efficiently inhibit cell viability while preserving extracellular 
matrix composition of the native tissue. 
Inherent biochemical and structural differences between diverse tissues 
necessitate the use of different decellularization chemical solvent regimens that vary in 
their ability to disrupt and extract cellular elements.  The chemicals that have been used 
to decellularize different tissues can be generally categorized into alkaline or acid 
solvents, non-ionic or ionic detergents, and enzymatic treatments [86].  Acid/alkaline 
treatments, including acetic acid, peracetic acid (PAA), and ammonium hydroxide, are 
intended to solubilize cellular cytoplasmic components and disrupt nuclei.  PAA in 
particular has been found to be effective as a disinfectant and at removing cellular 
material while maintaining ECM proteins, GAGs, and growth factors of thin tissues [80, 
89, 197, 198].  Ionic detergents, such as sodium dodecyl sulfate (SDS), can efficiently 
solubilize nuclear and cytoplasmic membranes; however, SDS can also solubilize 
proteins, such as native ECM components [91].  Non-ionic detergents, which disrupt 
lipid-lipid and lipid-protein interactions, can also disrupt cell membranes, yet perturb 
protein-protein interactions less than ionic detergents.  One of the most common non-
ionic detergents, Triton X-100, has exhibited variable success in removing cellular 
material without significantly disrupting ECM composition [91-93].  Finally, enzymatic 
treatments, such as trypsin and DNase, have been used to cleave peptide bonds or digest 
nucleotides [85, 92].  The varying success of comparable decellularization treatments on 
dissimilar tissues suggests that reagent protocols must be optimized for each tissue by 
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controlling the concentrations and durations of treatments and analyzing the effects on 
the composition and function of the acellular product obtained. 
The objective of this study was to determine the ability of different types of 
chemical solvent extraction methods to effectively decellularize aggregates of mouse 
embryonic stem cells undergoing differentiation, commonly referred to as “embryoid 
bodies” (EBs).  By directly comparing chemical reagents previously used to decellularize 
other types of tissues, a set of conditions capable of yielding acellular matrices from 
mouse EBs was established.  Initially, treatment with peracetic acid, SDS, and Triton X-
100, either alone or in combination with DNase, were compared directly.  Based on 
quantitative assays of cell viability, DNA content, mass retention, protein content, and 
qualitative histological analysis, a combination of Triton X-100 and DNase was found to 
effectively yield an acellular product derived from EBs.  Subsequent studies therefore 
focused solely on the concentration and duration of Triton X-100 and DNase treatment, 
as well as ratios of the volumetric amounts of each reagent to the number of EBs in an 
attempt to optimize conditions for EB decellularization.  These results provide the initial 
proof-of-principle that acellular proteinaceous matrices can be derived from 
differentiating ESCs and establish the basis for future studies to examine the molecular 
composition and biological function of novel stem cell-derived acellular matrices, which 




Materials and Methods 
Cell Culture 
Mouse embryonic stem cells (D3) were cultured on gelatin-coated dishes with 
ESGRO Complete™ Clonal Grade Medium (Millipore). Cells were passaged every two 
to three days before reaching ~70% confluence.  For the described studies, cells were 
used between passages 20-30.  To initiate embryoid body (EB) culture, ESCs were 
dissociated using ESGRO Complete™ Accutase™ and removed from the gelatin-coated 
dishes.  A density of 400,000 cells/mL was used to inoculate 10 mL EB cultures in 
differentiation media composed of Dulbecco’s modified eagle medium (Mediatech), 
supplemented with 15% fetal bovine serum (HyClone), 2 mM L-glutamine (Mediatech), 
non-essential amino acids, antibiotic/antimycotics, and 0.1 mM β-mercaptoethanol.  The 
EB suspension cultures were inoculated in 100 mm  bacteriological grade polystyrene 
Petri dishes (Corning) on day “0” of differentiation and placed on rotary orbital shakers 
(Barnstead Lab-Line, Model 2314) at 40 rpm at 37oC in 5% CO2.  Recent work from our 
lab has indicated that placing a suspension culture of mESCs in differentiation media on a 
rotary shaker at 40 rpm results in greater yields of homogeneously-sized EBs [199].  EBs 
were re-fed every other day by collecting the EBs via gravity sedimentation in 15 mL 
conical tubes, aspirating the old media, and replenishing the cultures with 10 mL of fresh 





For all of the described studies, embryoid bodies were collected at day 7 of 
differentiation.  Input EB number was determined by performing a 10x dilution of one 
culture plate of EBs into 8 wells of a 24-well plate and counting the EBs under a 
microscope.  Analysis performed on triplicate samples indicated an average of ~6200 
EBs/100 mm plate (inoculated with 4x106 cells initially).  Unless otherwise specified, 
approximately 2000 EBs (~1/3 culture plate) were aliquoted into individual samples in 
1.5 mL microcentrifuge tubes for decellularization assays.  For mass retention analyses, 
each tube was weighed before addition of the sample.  Untreated EBs were either rinsed 
in phosphate buffered saline (PBS) and stored in 4oC for subsequent analyses or kept in 
serum-free media for up to three hours at 37oC for cell viability measurements.  Reagents 
tested were combinations of peracetic acid (PAA, Aldrich), sodium dodecyl sulfate (SDS, 
Fisher), Triton X-100 (VWR), and DNase (~2,000 Kunitz units/mg, Worthington 
Biochemical Corp.).  Treatment groups were centrifuged at 18,000 × g (Microfuge® 18 
Centrifuge, Beckman-Coulter) for two minutes before addition of the reagent being 
tested.  Samples were rotated in a LabQuake Rotisserie for 30 – 90 minutes, spun down at 
18,000 × g for two minutes, rinsed twice with PBS, and, if applicable, rotated in DNase 
between 15-60 minutes.  At the end of the treatment, samples were centrifuged for two 
minutes at 18,000 × g and rinsed twice in PBS prior to additional analysis. 
 
Histology 
EBs were harvested from suspension by gravity-induced sedimentation within a 
15 or 50 mL conical tube.  EBs or acellular products were incubated in formalin fixative 
 97
for 30 minutes, rinsed twice with PBS, and embedded in Histogel®.  Samples were then 
processed for histological sectioning through a series of xylene and alcohol rinses and 
embedded in paraffin.  Embedded samples were sectioned into 5 μm slices and de-
paraffinized prior to staining.  Histological samples were either stained with hematoxylin 
and eosin (H&E) using a Leica Autostainer XL, or incubated in Hoechst fluorescent dye 
(10 μg/mL) for five minutes to stain for nuclei.  Coverslips were mounted on each sample 
using either low viscosity mounting medium (H&E samples, Cytoseal™ 60, Richard-
Allen Scientific) or aqueous mounting medium with anti-fading agents (fluorescent 
samples, Gel/Mount™, Biomeda Corp.) and imaged using a Nikon 80i Upright 
Microscope and a Sony Cyber-shot (DSC-W1) camera. 
 
Cell Viability 
Immediately after collection and decellularization treatment, untreated EBs and 
acellular samples were incubated in a 10% alamarBlue (Biosource) solution in serum-free 
media for four hours at 37oC with 5% CO2.  A 100 μL sample of the sample-conditioned 
alamarBlue solution was added to a 96 well plate, and fluorescent measurement values 
were taken (ex: 545 nm, em: 590 nm) using a SpectraMax M2e plate reader.  Fluorescent 
measurements of the treated samples were normalized to values obtained for untreated 
EBs collected prior to decellularization treatment from the same batch of EBs.  The 
acellular sample values were reported as the relative percent reduction of alamarBlue 





DNA content of untreated EBs and acellular samples was quantified using the 
Quant-iT™ PicoGreen® dsDNA Assay kit (Molecular Probes).  Samples were 
solubilized using 6M GuHCl for two hours in a sonicating water bath and added to 20x 
TE buffer (200mM Tris-HCl, 20mM EDTA, pH=7.5) and PicoGreen dye solutions at a 
ratio of 43 μL sample : 107 μL buffer : 150 μL dye.  Fluorescent measurements of 
experimental samples were taken using a SpectraMax M2e plate reader (ex: 485 nm, em: 
528 nm), and the absolute DNA concentrations were determined by comparing 
experimental values to standard curve readings obtained using calf thymus DNA 
solutions ranging between 30 – 5000 ng/mL. 
 
Mass Retention 
The percent mass of the EBs retained after decellularization treatment was 
determined for both hydrated and lyophilized samples.  Hydrated samples were weighed 
after removing excess liquid with a micropipette prior to and after treatments.  For greater 
accuracy, dry weight measurements were also taken for untreated and decellularized EBs 
after rinsing the samples twice in distilled water and storing overnight at -80oC.  Samples 
were then freeze-dried for 24 hours using a lyophilizer (Freezone® 4.5, Labconco), and 
the final mass was weighed (AX205 DeltaRange®, Mettler Toledo).  For both hydrated 
and lyophilized samples, individual tube mass was subtracted from total mass to obtain 
the net sample weight.  Mass retention was recorded as the percent of the average 




In order to assay total protein content, the untreated EBs and acellular samples 
were solubilized with 6M guanidine hydrochloride (GuHCl), and total protein content 
was assessed using the bicinchoninic acid (BCA) assay kit (Pierce).  A standard titration 
curve using bovine serum albumin (BSA) was generated for concentrations ranging from 
20 − 2000 μg/mL. Samples were incubated in the BCA solution for 30 minutes at 37oC, 
and absorbance readings were taken at 562 nm on a SpectraMax M2e plate reader. The 
protein concentrations of the experimental samples were normalized to the BSA titration 
standard curve. 
   
Statistics 
For paired comparisons, student t-tests assuming unequal variances were used to 
determine statistical significance (p<0.05).  For comparisons across multiple 
experimental groups, analysis of variance was used with post-hoc Tukey analysis to 
determine significant (p<0.05) differences between the different groups. 
 
Results 
Solvent extraction comparison 
 Multiple reagents were analyzed for their effects on EB decellularization.  
Peracetic acid (PAA, 0.1%, v/v), sodium dodecyl sulfate (SDS, 0.1% w/v), and Triton X-
100 (1%) were used alone, and in conjunction with 1 mg/mL DNase, based on their 
reported ability to decellularize other types of tissues [71, 75, 77, 78, 84, 200].  Relative 
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cell viability was significantly decreased by all of the different solvent treatments 
(typically < 1% of untreated EBs), indicating that each of the chemicals effectively 
inhibited cell viability within the EBs (Figure 5.1A).  Addition of DNase reduced DNA 
retention in both PAA- and Triton-treated samples on average by ~55-65% (p = 0.02 and 
p = 0.09, respectively), but did not have a significant effect (p = 0.19) when combined 
with SDS (Figure 5.1B).  SDS alone, sequential treatments of SDS and DNase (S+D), 
and Triton and DNase (T+D) were most effective at removing DNA, resulting in only ~3-
9% retention, compared to the initial, viable EBs.  Mass retention (relative to the starting 
mass of EBs) varied amongst the different treatments, with PAA (70.3±1%) and its 
combination with DNase (P+D, 48.8±7%) demonstrating significantly greater retention 
(p = 1.46E-4 compared to S+D; p = 9.62E-5 compared to T+D) than treatment with other 
decellularization reagents (Figure 5.1C).  For all groups treated with DNase, the 
additional treatment appeared to reduce the final mass of acellular material retained by 
~30-60%, presumably due to enzymatic digestion of cellular DNA.  On average, ~2000 
untreated EBs contained a total of 745 μg of protein.  Treatment with PAA resulted in the 
greatest amount of residual protein content (508.6±56 μg/2000 EBs) and was not affected 
by DNase treatment (501.2±92 μg/2000 EBs) (Figure 5.1D).  Triton and T+D treatments 
maintained lower, but moderate concentrations of protein (132.7±2 μg/2000 EBs and 
92.2±52 μg/2000 EBs, respectively), while SDS and S+D had the least protein retention 
(on average, ~14-31 μg/2000 EBs). 
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Figure 5.1. Solvent comparison.  Cell viability (A), DNA retention (B), mass retention 
(C), and protein content (D) were assessed in samples treated for 30 minutes with 0.1% 
peracetic acid (PAA), 0.1% sodium dodecylsulfate (SDS), 1% Triton X-100, and 
combinations of these reagents with 1 mg/mL DNase (15 minutes) in order to assess their 
relative decellularization potential (* indicates significance across paired comparisons, 
p≤0.03).  PAA was the least effective at reducing DNA content; the Triton X-100 and 
DNase combination was able to eliminate appreciable quantities of DNA, while 
maintaining a significantly higher mass:protein ratio than SDS-treated samples (p = 
0.02).  The inset in (A) depicts the identical set of data with a smaller y-axis range to 
more clearly demonstrate the lack of differences in cell viability between the different 
experimental groups.  
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In addition to the quantitative population assays, histological analysis was 
performed to directly assess the morphological effects of the different solvent treatments 
on individual EBs (Figure 5.2).  PAA-treated EBs looked most similar to untreated EBs 
and exhibited a relatively high number of distinct cell nuclei, both with and without 
DNase treatment.  The PAA treatment also did not appear to cause the agglomeration of 
individual EBs into a compact, continuous mass, as observed for both SDS and Triton X-
100 treatments.  SDS treatment appeared to completely extract cell nuclei (corroborating 
the PicoGreen DNA assay results, Figure 5.1B), even without the addition of DNase.  
EBs treated with Triton X-100 alone resulted in a complete disruption of intact cell 
nuclei, although DNA appeared to remain bound to the acellular material, as indicated by 
relatively bright Hoechst staining throughout the material.  However, DNase treatment 
following Triton X-100 exposure reduced most of the Hoechst signal from the acellular 
material, suggesting that the cellular DNA associated with the matrix could be efficiently 
degraded and removed by enzymatic DNase treatment.  Hematoxylin and eosin staining 
(Figure 5.2 insets) corroborated the results of the Hoechst staining, showing mostly 
basophilic staining (nuclear material) for PAA-, P+D-, and Triton-treated samples, 
whereas SDS, S+D, and T+D treatments lacked such staining.  Furthermore, SDS-treated 
EBs histologically showed little evidence of structural or material complexity.  Thus, 
based on the sum of these quantitative and qualitative measures, a combination of Triton 
and DNase treatment appeared to most effectively inhibit cell viability and remove DNA, 





Figure 5.2. Histological analysis.  Hoechst staining of cell nuclei was used for 
qualitative assessment of the various acellular samples treated for 30 minutes with 0.1% 
peracetic acid (PAA), 0.1% sodium dodecylsulfate (SDS), and 1% Triton X-100 (top 
row), or combinations of these reagents with 1 mg/mL DNase for 15 minutes (bottom 
row).  Hematoxylin and eosin staining of adjacent sections of the corresponding acellular 
samples was also performed (inset images).  Scale bar = 100 μm.  PAA-treated samples 
retained DNA, while the addition of DNase to SDS and Triton samples reduced DNA 
content.  Untreated EBs and PAA samples looked similar, while SDS and Triton 
treatments resulted in a compact, continuous mass of material. 
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Variable Triton and DNase Concentrations and Durations  
 To further optimize the efficiency of EB decellularization, additional experiments 
were performed using variations of Triton X-100 and DNase combinations.  A matrix of 
different Triton concentrations (0.1%, 1%, 10%) and durations (30, 60, 90 minutes) were 
applied in combination with different DNase concentrations (0.5 mg/mL, 1 mg/mL, 2 
mg/mL) and durations (15, 30, 60 minutes) in order to assess the effects of varying the 
extraction conditions on cell viability, mass retention, and DNA and protein content.  Cell 
viability (Figure 5.3) and mass retention (Figure 5.4) did not change appreciably across 
the different treatment groups.  In all samples, viability was inhibited to less than ~1% of 
the untreated EB values, while in some cases, trends suggested a slight increase in mass 
retention with an increase in DNase concentration.  For the concentration ranges 
examined, there were few noticeable differences between the treatments, although 10% 
Triton resulted in significantly greater DNA retention (Figure 5.5) and protein content 
(Figure 5.6), as did 0.5 mg/mL DNase-treated samples.  Although a higher total protein 
content may reflect a greater retention of desired ECM protein components, the 
corresponding higher DNA values do not meet the criteria of low cellular remnant levels 
expected for acellular tissues.  Under most conditions, an increase in DNase 
concentration resulted in a slight decrease in DNA (Figure 5.5).  For the treatment 
durations examined, increasing the length of Triton treatment significantly decreased the 
total protein content of the final acellular material (Figure 5.6).  DNase duration did not 
have a significant effect on protein content (as expected); however, for 30- and 60-minute 
treatments, total protein increased slightly as DNase duration increased for all 
concentrations examined.  Values from all concentration and duration analyses are listed 
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in Table 5.1.  Overall, Triton- and DNase-treated samples typically retained less than 
7.5% of the original DNA content and possessed an average of 14.2±6% of the initial 
protein content.  Based on these findings, a 30-minute treatment of 0.1-1% Triton and 15 
minutes of 1-2 mg/mL DNase provided the most efficient and convenient method of 
removing DNA while maintaining protein content from mouse EBs. 
 
Ratios of Triton and DNase to EBs 
The effect of different ratios of reagent volume to the input number of EBs was 
also analyzed by fixing the input of EBs and varying the volume of reagent used, and also 
by varying the EB input with a fixed solution volume.  Similar to the previously 
described types of multi-parametric analyses, cell viability, DNA retention, mass 
retention, and protein content of acellular EBs were assessed with 1% Triton X-100 (30 
minutes) and 1 mg/mL DNase (15 minutes).  Neither cell viability nor mass retention 
varied significantly with the different volumetric ratios of Triton X-100 and DNase 
examined (Figure 5.7A,C), but increasing the volumes of Triton X-100 and DNase 
generally decreased the amount of DNA and protein remaining in the treated samples 
(Figure 5.7B,D).  With a fixed volume of 0.25 mL of 1% Triton, both protein content and 
DNA retention significantly decreased with an increase in DNase volume (p = 0.018 and 
p = 0.001, respectively).  A combination of 0.25 mL of 1% Triton X-100 and 0.25 mL of 
1.0 mg/mL DNase resulted in 11.9±1% relative cell viability, 3.4±0.4% DNA retention, 
and 772.9±88 μg/2000 EBs protein content, while a four-fold increase in Triton X-100 
and DNase volume decreased cell viability to 3.1±5%, DNA retention to 0.81±0.5%, and 
protein content to 29.1±192 μg/2000.  As EB input increased (from ~1500 to 6200 EBs) 
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with constant treatment volumes of Triton X-100 (1 mL) and DNase (0.5 mL), no 
significant differences were observed in relative cell viability, mass retention, or protein 
retention with the varying input number of EBs (Figure 5.8), although these values 
increased steadily for untreated EBs (Figure 5.9).  These results suggested that a 
minimum of 1.0 mL of 1% Triton X-100 and 0.5 mL of 1 mg/mL DNase were sufficient 
to decellularize ~3000-6000 EBs. 
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Figure 5.3. Relative cell viability analysis.  Relative cell viability was assessed for 
combinations of sequential Triton X-100 and DNase treatments.  Triton X-100 (0.1%, 
1%, 10%) durations varied between 30, 60, and 90 minutes, while DNase  (0.5 mg/mL, 1 
mg/mL, 2 mg/mL) was varied between 15, 30, and 60 minutes.  All of the experimental 




Figure 5.4. Mass retention analysis.  Mass retention was assessed for combinations of 
sequential Triton X-100 and DNase treatments.  Triton X-100 (0.1%, 1%, 10%) durations 
varied between 30, 60, and 90 minutes, while DNase  (0.5 mg/mL, 1 mg/mL, 2 mg/mL) 
was varied between 15, 30, and 60 minutes.  No noticeable differences between the 
groups were observed for different treatment durations, but increases in concentration of 




Figure 5.5. DNA retention analysis.  DNA retention was assessed for combinations of 
sequential Triton X-100 and DNase treatments.  Triton X-100 (0.1%, 1%, 10%) durations 
varied between 30, 60, and 90 minutes, while DNase (0.5 mg/mL, 1 mg/mL, 2 mg/mL) 
was varied between 15, 30, and 60 minutes.  In general, increasing DNase concentrations 
led to slight decreases in DNA retention, but no statistically significant trends between 





Figure 5.6. Protein content analysis.  Protein content was assessed for combinations of 
sequential Triton X-100 and DNase treatments.  Triton X-100 (0.1%, 1%, 10%) durations 
varied between 30, 60, and 90 minutes, while DNase (0.5 mg/mL, 1 mg/mL, 2 mg/mL) 
was varied between 15, 30, and 60 minutes.  Overall, increases in Triton duration led to 
significant decreases in total protein content (p<0.05), but no significant trends were 
observed for the different Triton concentrations. 
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Table 5.1. Values from concentration and duration optimization analyses. 

















0.1 0.5 0.28 0.14 12.62 2.91 0.58 0.11 231.12 18.00 
0.1 1 0.37 0.11 8.69 1.20 0.45 0.31 214.50 20.93 
0.1 2 0.30 0.06 16.48 6.81 0.14 0.06 206.73 22.80 
1 0.5 0.26 0.06 18.29 0.50 0.37 0.33 198.36 66.00 
1 1 0.18 0.16 19.27 2.80 0.13 0.05 165.97 33.91 
1 2 0.21 0.06 16.27 3.47 0.08 0.00 162.39 24.17 
10 0.5 0.51 0.14 7.34 1.21 0.70 0.14 296.60 40.18 





10 2 0.41 0.13 18.13 7.99 0.14 0.04 229.89 30.30 
0.1 0.5 0.12 0.06 13.84 8.91 0.85 0.48 360.89 15.26 
0.1 1 0.40 0.39 5.77 0.50 0.32 0.11 235.49 49.29 
0.1 2 0.17 0.05 14.02 1.81 0.15 0.03 242.63 31.90 
1 0.5 0.25 0.15 18.42 2.63 0.34 0.12 189.84 22.71 
1 1 0.23 0.02 15.74 3.26 0.09 0.03 139.71 24.81 
1 2 0.21 0.12 20.76 6.50 0.08 0.01 170.83 35.83 
10 0.5 0.17 0.06 9.33 3.06 0.61 0.09 292.68 11.58 





10 2 0.24 0.10 19.03 4.11 0.15 0.06 248.71 43.08 
0.1 0.5 0.59 0.20 13.04 4.04 0.19 0.12 112.95 48.28 
0.1 1 0.51 0.15 5.04 0.77 0.18 0.08 118.89 47.20 
0.1 2 0.65 0.42 8.02 0.81 0.13 0.05 124.03 101.49 
1 0.5 0.45 0.21 13.74 4.73 0.05 0.05 38.10 3.83 
1 1 0.26 0.14 7.31 0.69 0.05 0.03 82.93 34.94 
1 2 0.30 0.18 14.36 3.05 0.10 0.03 107.93 7.19 
10 0.5 0.32 0.16 10.64 5.95 0.05 0.00 12.96 0.00 





10 2 0.36 0.18 16.95 6.03 0.21 0.08 201.95 35.60 
0.1 0.5 0.97 0.22 13.35 1.17 0.38 0.24 187.35 43.53 
0.1 1 1.37 0.17 6.07 0.74 0.09 0.10 118.14 31.37 
0.1 2 0.74 0.28 9.67 1.37 0.04 0.02 124.31 26.31 
1 0.5 0.60 0.10 24.66 3.04 0.01 0.01 111.35 40.38 
1 1 0.74 0.00 12.30 2.89 0.02 0.02 117.20 35.72 
1 2 0.73 0.11 19.12 3.34 0.01 0.01 118.02 5.60 
10 0.5 0.93 0.08 14.43 5.61 0.17 0.08 189.30 22.83 





10 2 0.92 0.16 6.87 3.18 0.13 0.03 234.80 23.45 
0.1 0.5 0.65 0.19 8.60 0.94 0.30 0.22 223.13 74.15 
0.1 1 0.66 0.15 6.08 2.37 0.13 0.05 168.28 29.65 
0.1 2 0.37 0.34 8.62 2.60 0.22 0.10 281.33 82.78 
1 0.5 0.29 0.15 14.95 6.57 0.15 0.03 177.36 21.50 
1 1 0.36 0.05 18.20 6.00 0.14 0.02 180.82 21.79 
1 2 0.49 0.22 20.75 5.05 0.11 0.05 170.01 71.34 
10 0.5 0.33 0.09 18.57 11.19 0.23 0.04 206.15 14.52 





10 2 0.61 0.53 18.41 12.13 0.16 0.05 223.27 57.15 
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0.1 0.5 0.61 0.29 10.07 1.85 0.23 0.10 222.08 44.56 
0.1 1 0.55 0.05 7.07 0.33 0.11 0.03 124.02 9.21 
0.1 2 0.70 0.12 9.16 3.85 0.14 0.05 222.51 44.92 
1 0.5 0.57 0.18 12.65 1.86 0.16 0.08 229.22 44.68 
1 1 0.62 0.25 10.77 2.25 0.11 0.03 192.78 63.84 
1 2 0.71 0.18 21.80 0.96 0.09 0.01 188.13 10.46 
10 0.5 0.61 0.05 13.00 1.48 0.16 0.03 215.45 9.84 





10 2 0.66 0.18 26.26 18.36 0.12 0.02 219.45 21.92 
0.1 0.5 0.83 0.38 8.30 0.73 0.09 0.04 81.05 22.43 
0.1 1 0.92 0.07 8.87 3.06 0.09 0.02 78.54 7.27 
0.1 2 0.78 0.15 12.77 2.93 0.09 0.03 90.60 36.07 
1 0.5 0.80 0.08 10.19 4.19 0.09 0.03 73.70 28.65 
1 1 1.14 0.03 16.49 4.52 0.08 0.03 73.56 10.03 
1 2 1.19 0.26 9.41 0.68 0.09 0.03 73.63 25.56 
10 0.5 0.87 0.18 12.21 5.07 0.18 0.06 129.40 31.85 





10 2 0.76 0.13 12.16 3.51 0.08 0.01 100.60 3.75 
0.1 0.5 -0.02 0.08 9.72 2.29 0.10 0.05 54.11 16.02 
0.1 1 0.20 0.12 6.59 0.96 0.11 0.06 56.01 19.82 
0.1 2 0.40 0.09 15.70 5.15 0.07 0.03 57.67 22.14 
1 0.5 0.32 0.10 17.07 1.59 0.10 0.04 65.63 25.77 
1 1 0.44 0.07 20.70 3.15 0.08 0.02 59.50 9.64 
1 2 0.36 0.11 32.06 5.76 0.08 0.03 94.03 27.26 
10 0.5 0.38 0.20 36.71 44.29 0.11 0.04 77.02 17.04 





10 2 0.25 0.02 7.89 0.91 0.06 0.01 65.02 11.25 
0.1 0.5 0.18 0.23 8.09 1.52 0.27 0.27 172.53 38.06 
0.1 1 -0.14 0.21 6.05 0.24 0.11 0.03 140.76 21.41 
0.1 2 0.20 0.28 11.43 4.74 0.12 0.04 133.95 16.41 
1 0.5 -0.47 0.38 15.50 0.93 0.32 0.22 138.00 11.44 
1 1 0.21 0.30 14.54 1.59 0.11 0.04 121.21 31.79 
1 2 0.20 0.32 31.10 5.37 0.12 0.06 128.86 33.22 
10 0.5 0.14 0.28 16.20 4.85 0.22 0.10 200.18 14.45 





10 2 0.20 0.29 21.60 7.82 0.18 0.06 217.38 92.02 
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Figure 5.7. Reagent volume:EB ratio.  The effect of reagent volume on 
decellularization efficiency was assessed by assaying for cell viability (A), DNA 
retention (B), mass retention (C), and protein content (D).  Combinations of 0.25 mL, 
0.50 mL, and 1 mL of both Triton and DNase were analyzed, with a fixed input of 
approximately 2000 EBs.  The combination of 0.25 mL of each reagent resulted in 
significantly greater protein content and DNA retention than EBs treated with larger 
volumes. # indicates significant differences from 0.25 mL Triton/0.25 mL DNase; † 
indicates significant differences from 0.25 mL Triton/1 mL DNase; ‡ indicates 
significant differences from 1 mL Triton/1 mL DNase; p < 0.05. Note: different bar graph 




Figure 5.8. Variable EB input.  The effect of EB input with a fixed reagent volume on 
decellularization efficiency was assessed by assaying for relative cell viability and DNA, 
mass, and protein retention.  The number of initial EBs varied from 1500 – 6200, with all 
samples treated with 1 mL of Triton and 0.5 mL of DNase.  With the exception of DNA 
removal, no statistically significant trends were observed in the parameters examined.  
*indicates significance (p < 0.05) compared to ~2000 and 6200 EB samples (Note: Error 




Figure 5.9. Variable native EB input.  DNA, mass, and protein were analyzed as a 
function of increasing number of EBs.  As expected, each of the different measures 
increased with increasing EB input.  DNA content increased from 4.47±1.4 μg/mL to 
15.94±2.9 μg/mL, mass increased from 5.50±1.0 mg to 21.46±1.7 mg, and protein 
increased from 1.32±0.1 mg/mL to 5.32±0.4 mg/mL as EB input was varied from 1550 to 





In these studies, multiple chemical solvents were examined for their ability to 
effectively decellularize differentiating ESCs.  A combination of Triton X-100 and 
DNase was found to reduce cell viability and DNA content while maintaining a greater 
protein:mass ratio more so than PAA or SDS treatments.  Further optimization studies 
indicated that longer Triton durations significantly reduced protein content, and lower 
DNase concentrations were less efficient at removing DNA.  In addition, for a fixed 
number of EBs, larger solvent volumes were more effective for decellularization, 
although significant differences were not detected when EB input was varied with 
constant solvent treatment volumes.  The combination of lower concentrations of Triton 
X-100 (0.1 -1 %) and higher concentrations of DNase (1 - 2 mg/mL) applied for 
relatively short durations (15 – 30 minutes) was found to be sufficient for decellularizing 
thousands of EBs at once. 
Decellularization technologies have evolved using a variety of reagents, 
depending largely on their suitability to effectively treat different tissue sources.  The 
choice of solvent is critical, as it can eliminate desirable components in addition to the 
intended removal of cellular elements.  The judicious selection of chemical solvents and 
the net effects on the composition and yield of the final acellular product must be defined 
experimentally since most common solvents, such as detergents, cannot accurately 
discriminate between cell and non-cell material.  In these studies, a combination of cell 
viability, mass and DNA retention, and protein content were assessed to determine 
conditions for successful decellularization of EBs.  Cell viability was used to globally 
examine residual cellular activity after chemical treatment, while DNA retention studies 
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provided a specific measure of nuclear material remaining.  Analysis of mass retention 
was essential to evaluate the relative amount of non-specific material retained after 
decellularization treatment of the EBs.  Total protein content was examined to obtain 
more specific information about the final content of the acellular material, and to 
potentially reflect the amount of ECM protein retained, although the non-specific nature 
of the assay renders it incapable of discriminating between intracellular and extracellular 
proteins.  Additional properties, such as specific biomolecule content and bio-
functionality are logical parameters to analyze after the aforementioned assays and are 
the focus of ongoing studies.  Although the range of experimental conditions and values 
examined in the current study could be viewed as somewhat limited, they provided 
sufficient information about the trends to be expected with varying concentrations, 
durations, and ratios of solvent volumes to EBs.  Many cell parameters are interrelated 
such that they uniformly decrease with chemical treatment, suggesting the need to 
prioritize, for example, the importance of DNA removal versus protein retention if both 
are to be considered essential metrics to evaluate the effectiveness of decellularization 
treatments.  Despite such limitations, the comprehensive nature of studying multiple 
parameters of decellularization efficiency in parallel is clearly advantageous compared to 
assessing single parameters individually. 
During the initial studies, multiple reagents typically used in various 
decellularization protocols were investigated, both alone and in conjunction with DNase.  
Use of peracetic acid (PAA) was found to maintain a higher level of protein content than 
all other treatments investigated, but PAA was also ineffective at removing DNA 
compared to other solvent treatments.  These results differ from published reports where 
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PAA was used to successfully decellularize tissues such as SIS and urinary bladder [80, 
201], although it has also been used primarily as a sterilization agent at the end of 
decellularization procedures by others [200].  This difference, however, simply attests to 
the variable effectiveness of different solvents based on the original tissue source and 
type of matrix attempting to be obtained.  Sodium dodecyl sulfate (SDS), as well as 
successive treatments of Triton X-100 and DNase, significantly reduced DNA content, 
but both also reduced total protein content.  However, EBs treated with Triton and DNase 
retained a significantly larger percentage of protein when related back to initial hydrated 
weight (30.0±17%) than those treated with SDS (1.4±2%) (p = 0.018).  This result is 
relatively consistent with previously published reports that SDS significantly disrupts 
native extracellular matrix tissue composition and structure [75, 202].  Based on these 
criteria, the additional optimization studies conducted focused on varying combinations 
of Triton X-100 and DNase as an effective means to decellularize EBs.  
The initial solvent comparisons provided a broad contrast of the effects that 
different reagents can have on the decellularization of EBs at fixed concentrations, 
durations, and ratios of the various chemicals to EBs.  Thus, in order to develop a more 
refined decellularization protocol, the duration, concentration, and ratios of Triton X-100 
and DNase to the original mass of EBs were systematically analyzed.  Cell viability 
(Figure 5.3) and mass retention (Figure 5.4) did not change appreciably across the 
different treatment groups.  Increasing the duration of Triton treatment, independent of 
the Triton concentration, decreased the total protein content retained in the final acellular 
product.  On the other hand, increasing the duration of DNase treament appeared to 
increase protein content, suggesting that DNase was possibly becoming incorporated 
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within the acellular material with prolonged exposure time.  These data suggested that 
minimizing the duration of solvent treatments would most likely yield the greatest 
amount of endogenous extracellular protein content, while still effectively inhibiting cell 
viability and extracting cellular DNA. 
All combinations of Triton and DNase reduced DNA content significantly.  In an 
attempt to investigate differences resulting from possible variances in initial conditions, 
the effect of either a solvent volume or EB input change on cell viability, and the 
retention of mass, DNA, and protein was examined.  While increasing the volume 
resulted in lower DNA retention and protein content, varying the number of input EBs 
did not significantly affect cell viability, protein content, or mass retention.  The larger 
solvent volumes presumably enhanced the access of the reagents to act on the EB 
samples.  Although DNA, total mass, and protein of untreated EBs increased with an 
increase in input EB number, the decellularized mass maintained similar values 
regardless of initial conditions, suggesting that the combination of centrifugation and 
solution treatments was sufficient for the range of input EBs tested (1500-6000).  Thus, 
based on the summation of the various studies performed, efficient decellularization of up 
to ~6200 EBs can be achieved using 1 mL of 0.1 - 1% Triton X-100 for 30 minutes and 1 
mL of 1 - 2 mg/mL DNase for 15 minutes. 
The combination of Triton X-100 and DNase treatment described by these studies can 
now be used to assess the specific molecular composition and function of acellular 
matrices derived from differentiating ESCs.  This step is especially important as it has 
been suggested that excessive disruption of the native ECM is the primary cause of poor 
cellular repopulation and ultimate bioactivity of acellular tissues [203].  Further 
refinements could be integrated within the developed protocol, including the use of 
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protease inhibitors to prevent degradation of the final acellular product or antibiotics to 
minimize potential bacterial contamination [91].  Additional experiments could also be 
performed to develop methods for increasing ECM production by ESCs, possibly through 
the addition of soluble factors, such as ascorbic acid, or other means [204, 205].  These 
studies demonstrate that it is possible to decellularize differentiating aggregates of 
embryonic stem cells and retain protein content, suggesting that such methods could yield 
a novel biomaterial containing a complex assembly of morphogenic molecules naturally 
produced and localized within the embryoid body microenvironment.  The ability of the 
initial pluripotent source to differentiate into cells comprising the three germ layers, as 
well as the homogeneity resulting from the EB rotary suspension culture [199], suggests 
that decellularization of differentiating ESCs could yield a unique, complex mixture of 
morphogenic cues that could be clinically relevant for a number of different regenerative 
medicine applications.  The development of a decellularization protocol could also permit 
functional analysis of the molecular cues present in an embryonic environment actively 
undergoing cell differentiation and tissue morphogenesis and potentially have direct 
applications in efforts to regenerate diseased and injured tissues. 
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CHAPTER 6 
ACELLULAR MATRICES DERIVED FROM DIFFERENTIATING 





Embryonic stem cells (ESCs), derived from the inner cell mass of pre-
implantation blastocysts [1-4], are pluripotent cells capable of differentiating into all 
somatic cell types.  The ability of ESCs to differentiate into various phenotypes, such as 
cardiomyocytes, neurons, and endocrine cells [137-139] suggests they could be useful in 
a number of applications where cells are irreversibly lost due to injury or disease.  
Therefore, ESCs are being investigated in a number of regenerative therapies including 
myocardial repair, neurodegenerative diseases, and diabetes [206-212].  Conventional 
methods of initiating ESC differentiation in vitro rely on suspension culture systems in 
which the cells spontaneously aggregate to form clusters of differentiating cells typically 
referred to as embryoid bodies (EBs) [35, 36].  Individual EBs recapitulate the temporal 
sequence of molecular signaling and cell differentiation events of embryonic pre-
gastrulation tissues, culminating in the differentiation of the cells into the three germ 
lineages (ectoderm, endoderm, and mesoderm) from which all other somatic cells are 
subsequently formed [6, 37-40].   
                                                 
 
 
* Modified from: 
R Nair, S Shukla, and TC McDevitt, Acellular matrices derived from differentiating embryonic stem cells.  
J Biomed Mater Res A, 2008.  87(4): 1075-1085. 
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In addition to their ability to differentiate into progenitor and somatic cells, recent 
studies have suggested that molecular factors synthesized and released locally by ESCs in 
vivo may be primarily responsible for observed tissue regenerative events [47, 48].  This 
significant observation suggests that biomolecules produced by stem cells may be at least 
as important as differentiation of the cells to achieve cell restoration and functional tissue 
repair.  In order to separate cells from the natural biomolecules present locally in the 
tissue microenvironment, decellularization protocols have been developed to successfully 
extract extracellular matrix (ECM) from an array of tissue sources.  The variety of tissues 
that have been decellularized include, but are not limited to, small intestinal submucosa, 
skin, pericardium, gall bladder, placenta, and tendon [71, 74, 75, 77, 213, 214], but thus 
far acellular matrices derived directly from stem cells and tissues actively undergoing 
morphogenic differentiation have not been reported. 
The objective of this study was to develop a decellularization technique to isolate 
the biomolecules produced by embryonic stem cells actively undergoing tissue 
morphogenesis at different stages of differentiation.  Previous studies were performed to 
establish an efficient method of extracting cells from EBs by assessing a combinatorial 
matrix of different chemicals and enzymes, reagent concentrations, and treatment 
durations.  Such studies found that sequential treatment of Triton X-100 and DNase could 
effectively decellularize EBs differentiated for seven days, supported by multi-parametric 
analyses of cellularity [215].  Based on those previous findings, additional studies were 
performed to decellularize EBs at different stages of differentiation in order to potentially 
temporally regulate the molecular composition of acellular matrices.  Decellularization of 
EBs differentiated for different periods of time was examined via histological analysis of 
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cellularity and quantitative assessments of cell viability, total mass, DNA, and protein 
content.  The retention of ECM molecules produced by ESCs undergoing differentiation 
was assessed by immunohistochemical detection of adhesive ECM proteins and 
glycosaminoglycans before and after decellularization of EBs.  This novel approach 
provides a unique method to examine the composition of the ECM produced by cells 
undergoing morphogenesis and could have significant implications in the development of 
future regenerative medicine therapies to stimulate tissue repair. 
 
Materials and Methods 
Cell Culture 
Mouse embryonic stem cells (D3) were cultured on 0.1% gelatin-coated 100 mm 
polystyrene cell culture dishes (Corning) with Dulbecco’s modified eagle medium 
(Mediatech), supplemented with 15% fetal bovine serum (HyClone), 2 mM L-glutamine 
(Mediatech), 1x MEM non-essential amino acid solution (Mediatech), 
antibiotic/antimycotics (Mediatech), and 0.1 mM β-mercaptoethanol (MP Biomedicals, 
LLC).  To maintain the cells in their undifferentiated state, 103 U/mL leukemia inhibitory 
factor (LIF) (ESGRO) was added to the culture media upon each re-feeding.  Cells were 
passaged every two to three days before reaching ~70% confluence.  For the described 
studies, cells were used between passages 20-30.  To initiate embryoid body (EB) culture, 
ESCs were dislodged from the gelatin-coated dishes and dissociated with 0.05% 
Trypsin/0.53 mM EDTA (Mediatech).  A density of 400,000 cells/mL was used to 
inoculate 10 mL EB cultures in 100 mm bacteriological grade polystyrene Petri dishes 
(Corning) using differentiation media (media without LIF).  Cultures were placed on 
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rotary orbital shakers (Barnstead Lab-Line, Model 2314) at 40 rpm at 37oC in 5% CO2 
for the entire duration of suspension culture.  Previous work from our lab has 
demonstrated that rotary orbital suspension culture methods result in greater yields of 
homogeneously-sized EBs [124].  EBs were cultured in suspension for up to 10 days and 
re-fed every other day by collecting the EBs via gravity sedimentation in 15 mL conical 
tubes.  Old media was aspirated and the cultures were replenished with 10 mL of fresh 




Embryoid bodies were harvested after 4, 7, or 10 days of differentiation in rotary 
orbital suspension culture.  The number of EBs at the different time points was 
determined by performing a 10x dilution of one culture plate of EBs into 8 wells of a 24-
well plate and counting the number of EBs with an inverted phase microscope (Nikon 
Eclipse TS100).  Analysis performed on triplicate samples indicated an average of ~6200 
EBs/100 mm plate (inoculated with 4x106 cells initially).  Unless otherwise specified, 
approximately 3000 EBs (~1/2 culture plate) were distributed into individual samples in 
1.5 mL microcentrifuge tubes for decellularization assays (Figure 6.1).  For mass 
retention analyses, each tube was weighed before addition of the experimental sample.  
Native EBs were rinsed in phosphate buffered saline (PBS) and stored at 4oC for 
subsequent mass, DNA, and total protein content analyses or kept in serum-free media 
for up to three hours at 37oC for cell viability measurements.  Experimental samples were 
centrifuged at 18,000 × g (Microfuge® 18 Centrifuge, Beckman-Coulter) for two minutes 
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before addition of 1% Triton X-100 (VWR).  Samples were rotated on a LabQuake 
Rotisserie for 30 minutes, spun down at 18,000 × g for two minutes, rinsed twice with 
PBS, and rotated in 1 mg/mL DNase (~2,000 Kunitz units/mg, Worthington Biochemical 
Corp.) for 15 minutes at room temperature.  At the end of the Triton X-100/DNase 
treatments, samples were centrifuged for two minutes at 18,000 × g to obtain the final 
acellular product and rinsed twice in PBS prior to additional characterization studies.  
EBs were deemed “acellular” based upon significant reductions of cell viability (<1%) 
and DNA content, compared to equivalent numbers of native EBs. 
 
 
Figure 6.1. Decellularization protocol steps.  (A) Equal numbers of native EBs were 
distributed into separate microcentrifuge tubes.  Samples were then centrifuged (18,000 x 
g) and treated with (B) 1% Triton X-100 (30 minutes) followed by (C) treatment with 1 
mg/mL DNase (15 minutes).  The resulting viscous mass of consolidated EBs (D) could 
be easily held and manipulated with a pair of tweezers.  Scale bar = 3 mm. 
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Immunostaining and Histology 
Native or Triton/DNase-treated EBs were fixed in Methyl Carnoy’s fixative (for 
collagen IV staining) or formalin (for all other staining) for 30 minutes, rinsed twice with 
PBS, and embedded in Histogel® (Richard-Allan Scientific).  Samples were processed 
through a series of xylene and alcohol rinses and embedded in paraffin.  Paraffin-
embedded samples were sectioned into 5 μm slices, placed onto glass slides and de-
paraffinized prior to staining.  Samples to be analyzed for histology and nuclei content 
were either stained with hematoxylin and eosin (H&E) using a Leica Autostainer XL, or 
incubated in Hoechst fluorescent dye (10 μg/mL) for five minutes to stain for nuclei.  For 
immunofluorescent staining, sections were permeabilized and blocked for 45 minutes 
using 0.05% Triton X-100 and 2% goat serum.  Samples were incubated with collagen 
IV, laminin, or fibronectin primary antibodies (polyclonal rabbit) overnight at 4oC (1:80 
dilution), rinsed with PBS, and then incubated with FITC-conjugated goat anti-rabbit 
secondary antibody (1:100 dilution) before counterstaining using Hoechst.  For 
immunohistochemistry analysis of hyaluronan, endogenous peroxidase activity of EB 
sections was quenched using hydrogen peroxide (0.75% in 100% methanol) after de-
paraffinization and before staining.  IHC samples were incubated in 1% bovine serum 
albumin for 30 minutes before addition of the hyaluronan binding protein (2-4 μg/mL 
PBS/0.1% BSA, overnight, 4oC).  The Vector Elite ABC kit (Vector Labs) was used for 
color staining development prior to counterstaining in hematoxylin.  All samples were 
mounted with coverslips using either low viscosity mounting medium (H&E and IHC 
samples, Cytoseal™ 60, Richard-Allan Scientific) or aqueous mounting medium with 
anti-fading agents (fluorescent samples, Gel/Mount™, Biomeda Corp.) and imaged using 
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a Nikon 80i Upright Microscope and a Spot Flex camera (Diagnostic Instruments, Inc.).  
Sections stained with Hoechst dye were then analyzed quantitatively for intact nuclei by 
counting punctate fluorescent cells in three fields from at least three sections in triplicate 
samples.  The cross-sectional area of the EBs or acellular samples being counted was 




Native and Triton/DNase-treated EBs were incubated in a 10% alamarBlue 
(Biosource) solution in serum-free media for four hours at 37oC with 5% CO2 to assess 
cell viability.  A 100 μL sample of each of the sample-conditioned alamarBlue solutions 
was individually added to a 96 well plate, and fluorescent measurement values were 
taken (ex: 545 nm, em: 590 nm) using a SpectraMax M2e plate reader.  The 
Triton/DNase-treated samples’ fluorescent values were reported as the relative percent 
reduction of alamarBlue normalized to the native EB values (assumed to be 100% 
relative viability) from within the same experimental batch. 
 
Mass Retention 
The mass of the EB samples before and after decellularization treatment was 
determined from dry weight measurements of the different samples.  Native and 
Triton/DNase-treated EBs were rinsed twice in distilled water and stored overnight at -
80oC prior to lyophilization.  Samples were then freeze-dried for 24 hours using a 
lyophilizer (Freezone® 4.5, Labconco), and the final mass of the dry samples was taken 
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(AX205 DeltaRange®, Mettler Toledo).  The mass of each of the empty tubes was 
recorded prior to lyophilization and subtracted from the final mass of each sample to 
obtain an accurate measure of the net sample weight.   
 
DNA Quantification 
DNA content of native EBs and Triton/DNase samples was quantified using the 
Quant-iT™ PicoGreen® dsDNA Assay kit (Molecular Probes).  Samples were completely 
solubilized in a 6M guanidine hydrochloride (GuHCl) solution for two hours in a 
sonicating water bath and added to 20x TE buffer (200mM Tris-HCl, 20mM EDTA, 
pH=7.5) and PicoGreen dye solutions at a ratio of 43 μL sample : 107 μL buffer : 150 μL 
dye.  Fluorescent intensity values of experimental samples were acquired using a 
SpectraMax M2e plate reader (ex: 485 nm, em: 528 nm), and the absolute DNA 
concentrations were determined by comparing experimental values to standard curve 
readings obtained using a range of calf thymus DNA solutions (30 – 5000 ng/mL). 
 
Protein Quantification 
Native EBs and Triton/DNase EBs were solubilized with 6M GuHCl (as 
described above), and total protein content was quantified using the bicinchoninic acid 
(BCA) assay kit (Pierce).  A standard titration curve using bovine serum albumin (BSA) 
was generated for concentrations ranging from 20 − 2000 μg/mL. Samples (25 μL) were 
incubated in the BCA solution (200 μL) for 30 minutes at 37oC, and absorbance readings 
were taken at 562 nm on a SpectraMax M2e plate reader. The reported protein 
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concentrations of the experimental samples were obtained from the BSA titration 
standard curve. 
 
Scanning Electron Microscopy 
Native and Triton/DNase-treated EBs were fixed in gluteraldehye (2.5% in 0.2M 
cacodylate buffer) and post-fixed in 1% osmium tetroxide (Electron Microscopy 
Sciences).  Samples were rinsed three times in 0.2M cacodylate buffer and transferred 
into acetone immediately prior to drying using a critical point dryer (E3000 series, 
Quorum Technologies).  Native and acellular EBs were impregnated for one hour with 
liquid CO2 and passed through the CO2 critical point (31.5oC, 1100 psi).  Each sample 
was gold sputter coated for 90 seconds in a Polaron Sputter Coater SC 7640 (Quorum 
Technologies) and examined using the Hitachi S800 Field Emission Gun Scanning 
Electron Microscope and iXRF EDS2004 image acquisition software. 
 
Statistics 
For paired comparisons, student t-tests assuming unequal variances were used to 
determine statistical significance (p<0.05).  For comparisons across multiple groups, 
analysis of variance was performed followed by post-hoc Tukey analysis to determine 





EBs were equally distributed among different microcentrifuge tubes (Figure 6.1A) 
prior to decellularization using the previously optimized combination of Triton X-100 
and DNase treatment [215].  After high speed (18,000 x g) centrifugation and 1% Triton 
X-100 treatment for 30 minutes, the original population of individual EBs agglomerated 
into a compacted mass of tissue (Figure 6.1B).  Subsequent treatment with 1 mg/mL 
DNase for 15 minutes yielded a pellet of consolidated EBs of comparable size (Figure 
6.1C).  The resulting acellular product of Triton/DNase-treated EBs was able to be easily 
handled and manipulated with tweezers prior to further analyses (Figure 6.1D). 
 
Histological Assessment 
Native EBs adopted a more differentiated morphological phenotype over the 
course of differentiation (Figure 6.2, top row), as expected.  EBs from days 4 and 7 were 
comprised of cells that were more densely packed than those from day 10 of 
differentiation, but localized regions of more differentiated cells began to appear at about 
day 7 of differentiation (note black rectangles outlining such areas in Figure 6.2).  At 
each of the time points examined, the individual EBs were relatively homogeneous in 
size and shape as a result of the rotary orbital suspension culture method [124] (Figure 
6.2, top row insets).  In contrast, Triton/DNase-treated EBs at each of the time points 
consistently showed a lack of distinct cell nuclei and formed a continuous mass of 
acellular tissue with a dissimilar appearance to that of individual native EBs.  The 
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macroscopic shape of the acellular matrix (Figure 6.2, bottom row insets) was dictated by 
the shape of the microcentrifuge vessel in which the EBs were decellularized and 
compacted, which suggested that the inherent pliability of the acellular matrix enables it 
to be potentially manipulated into various geometric configurations. 
 
Figure 6.2. Histological analysis.  Native and Triton/DNase-treated EBs from days 4, 7, 
and 10 of differentiation were stained with hematoxylin and eosin.  Pockets of 
differentiated cells were present in untreated (native) EBs by day 7 (black rectangular 
outlines).  Individual EBs agglomerated with decellularization treatment, and little 
evidence of intact nuclei was observed.  Insets show a broader view of the samples; 
image and inset scale bars = 100 μm. 
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As noted in the hematoxylin and eosin stained sections, native EBs stained with 
Hoechst dye exhibited slightly greater nuclei density at days 4 and 7 of differentiation 
than at 10 days of differentiation (Figure 6.3A).  For Triton/DNase-treated EBs, all 
remnants of Hoechst fluorescent signal were included in nuclei quantification (Figure 
6.3B), although most spots in acellular samples were much smaller than native intact cell 
nuclei.  Nuclei content was significantly decreased in all acellular EB samples (Figure 
6.3B, p < 1E-24), with only some diffuse fluorescence observed in EBs decellularized at 
day 10 of differentiation culture.  Quantitative analysis indicated that the decellularization 
treatment removed approximately 95% of the total nuclei content in day 4 samples, 97% 
in day 7, and 99% in day 10.   
 
 
Figure 6.3. Quantification of cell nuclei.  Native and acellular EBs from days 4, 7, and 
10 of differentiation were stained with Hoechst (A) for nuclei quantification (B).  
Hoechst staining was negligible in acellular EBs, with only some diffuse staining 
observed at day 10.  Quantification of punctate nuclei was performed on triplicate 
sections per experimental sample (n=3) and a minimum of three fields of view per 
section.  The number of intact cell nuclei was significantly reduced for each of the 
acellular samples examined at different time points of differentiation (*p<1E-24).  
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Quantitative Multi-Parametric Analysis 
A multi-parametric approach was used to quantify the extent of decellularization 
as a function of time, based on cell viability and DNA content, as well as the final 
amount of material retained.  Cell viability was completely inhibited (>99%) in all 
treatment groups, suggesting efficient decellularization at all of the time points examined 
(Figure 6.4A).  The mass of native EBs increased significantly with differentiation (p = 
0.002), along with a mass increase of the corresponding acellular matrix from the same 
time points (Figure 6.4B).  The lyophilized mass of the acellular samples indicated that a 
sizable portion of the original EB mass was retained after the cellular extraction process 
after 4 (17±3%), 7 (22±5%), and 10 days of differentiation (31±12%) (Figure 6.4B).  
DNA content of native EBs increased slightly, but not significantly (p = 0.055), over the 
course of differentiation, while protein content increased significantly (p = 0.001) 
between days 4 and 10 of differentiation.  DNA content was significantly reduced by 
decellularization at each time point (69-75% removed; p ≤ 0.002; Figure 6.4C).  Despite 
some loss presumably due to extracted cellular protein elements, a fraction (15-25%) of 
the original protein content was retained in each of the Triton/DNase-treated EB samples 
(Figure 6.4D).  The summation of the results from the quantitative assays demonstrated 
that populations of EBs at different stages of differentiation can be effectively 




Figure 6.4. Multi-parametric characterization.  Native EBs and decellularized samples 
from days 4, 7, and 10 of differentiation were analyzed for cell viability (A), mass 
retention (B), DNA content (C), and protein content (D).  Cell viability was inhibited 
(>99%) in all treated samples.  As expected, lyophilized mass, DNA and protein content 
gradually increased with time in the native EBs.  While mass of the acellular sample 
increased along with the native EBs, DNA and protein content maintained similar values 






Scanning electron microscopy (SEM) was performed to elucidate differences 
between the ultrastructure of native EBs and acellular EB-derived matrices at a range of 
magnifications (Figure 6.5).  At low magnification, distinct, individual EBs were clearly 
observed (Figure 6.5A), whereas the acellular EBs formed a larger cohesive material with 
a relatively smooth exterior appearance (Figure 6.5D).  Higher magnification views 
clearly indicated that tightly aggregated cells comprised the individual native EBs (Figure 
6.5B,C), while the cross-sectional morphology of the acellular EBs lacked distinct cells 
(Figure 6.5E,F).  EBs and acellular samples from days 4 and 10 of differentiation were 
also analyzed by SEM (data not shown) and exhibited comparable morphological 
attributes to day 7 differentiated samples. 
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Figure 6.5. Ultrastructure analysis.  Scanning electron micrographs (SEM) display 
ultrastructural details of the surfaces of day 7 native EBs and cross-sections of the 
acellular material at magnifications of 40x (A), 200x (B), and 1000x (C).  Individual cells 
were clearly seen in magnified untreated EBs, while distinct cells were not visible in the 
acellular EBs.   
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ECM Component Retention 
In order to confirm the presence and retention of extracellular matrix components 
synthesized within EBs, immunostaining analysis of EBs and acellular EB-derived 
matrices was performed for samples collected after 4, 7 and 10 days of differentiation.  
Although the spatial distribution of different ECM components varied over time with 
differentiation of the native EBs (Hiatt, Shukla, et al., unpublished observations), 
acellular matrices derived from EBs retained ECM molecules that were present at each of 
the time points examined (Figure 6.6 – day 7; days 4 & 10, data not shown).  For 
example, ECM molecules such as collagen IV, laminin, fibronectin, and hyaluronan were 
all expressed within native EBs differentiated for 7 days and were retained following 
decellularization (Figure 6.6).  In general, positive immunostaining of ECM molecules 
appeared more diffuse throughout native EBs, whereas the intensity of immunostaining 
seemed more concentrated in particular regions of the acellular EB-derived matrices. 
 
Scalability 
The scalable production of acellular matrices derived from EBs was assessed as a 
function of the input number of EBs used for decellularization (Figure 6.7).  As expected, 
an increase in the final mass and total protein content was achieved by increasing the 
initial numbers of EBs.  The increasing amounts of acellular EB-derived matrix linearly 
correlated with the input number of EBs for both overall mass (r2 = 0.982) and total 
protein content (r2 = 0.993).  This evidence strongly suggested that the quantity of 
acellular matrix material derived from EBs can be simply controlled by the initial batch 
size of EBs. 
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Figure 6.6. ECM molecule immunostaining.  Immunostaining for collagen IV, laminin, 
fibronectin, and hyaluronan was performed in day 7 native and acellular EBs. Each of the 
ECM components was present in the native EBs as well as the acellular matrix, indicating 
that the solvent extraction process does not completely remove ECM components from 
the final acellular matrix product.  All images are shown at the same magnification (scale 




Figure 6.7. Protein and mass scale-up.  Lyophilized dry mass (A) and total protein 
content (B) were analyzed for increasing initial numbers of EBs.  The input number of 
EBs ranged from 3000±640 to 13,006±2800, which corresponded to a mass range of 
77±21 to 383±142 μg and a protein range of 14±13 to 148±37 μg.  Both parameters 
scaled linearly with starting EB number, suggesting that derivation of acellular matrices 
from EBs is amenable to scalable batch processes. 
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Discussion 
These studies indicate that it is possible to successfully decellularize embryoid 
bodies in a scalable manner at different points of differentiation to yield ESC-derived 
extracellular matrices.  The combination of Triton X-100 and DNase treatment efficiently 
inhibited cell viability, reduced DNA content, and retained a substantial portion of the 
initial EB mass and corresponding protein content.  Histological and ultrastructural 
analysis clearly indicated a lack of cellularity within acellular matrices compared to 
native EBs, and immunostaining results confirmed the retention of extracellular matrix 
components, such as collagen IV, laminin, fibronectin, and hyaluronan in the EB-derived 
acellular matrices. 
Effective removal of cellular elements was used as the primary criterion to deem 
EBs “acellular” at the different stages of differentiation.  The cell nuclei content of 
acellular EB-derived matrices (Figures 6.2, 6.3) was comparable to levels previously 
reported in other acellular tissues [72-75, 91, 188, 216, 217].  The ultrastructure of 
different acellular tissues often varies drastically depending on the original tissue source 
and acellular processing methods; some treatments largely preserve the original matrix 
architecture, while others disrupt native ECM structure [74, 75, 188, 217, 218].  Acellular 
EB matrices (Figure 6.5) exhibited a vastly different morphology that appeared devoid of 
cells compared to native EBs, which were comprised of tightly clustered intact individual 
cells.  Complete inhibition of cell viability (>99%) indicated successful decellularization 
at each of the time points of differentiation examined (Figure 6.4).  This metric is 
commonly used as the minimal decellularization criteria based on current industrial 
standards.  Although the final mass of the acellular matrices increased with 
 139
differentiation time, the residual amounts of DNA and protein content in EB-derived 
acellular matrices remained relatively constant, despite the fact that both parameters 
increased with time in the native EBs.  This trend potentially suggests that acellular 
matrices from more differentiated EBs may contain an increasing amount of non-protein 
content, such as glycosaminoglycans (GAGs), while at the same time retaining a small 
portion of cellular DNA. 
A number of different ECM proteins and GAGs present in native EBs at various 
stages of differentiation were also found in the acellular matrices derived from EBs at the 
same time points (Figure 6.6).  Although the design of the present study only examined a 
select few ECM molecules commonly synthesized by cells and found in many acellular 
tissue products, the results indicated that ESCs within EBs are capable of producing ECM 
that can be retained following decellularization.  The relative abundance and spatial 
distribution of adhesive extracellular matrix proteins, like collagen IV, laminin, and 
fibronectin, varied as a function of time in the native EBs, and the relative amounts and 
distribution in the final acellular matrices varied similarly.  The production of specific 
ECM components temporally varies throughout the stages of embryonic development 
[145-147, 219, 220], and ESCs mimic this phenomenon by dynamically regulating ECM 
composition during the course of EB differentiation.  Therefore, the composition of the 
acellular matrix may be controlled by varying the stage of differentiation at which EBs 
are decellularized (Figure 6.8), resulting in a novel method of examining matrix 
production by cells at varying states of maturation.  In addition to adhesive ECM 
proteins, hyaluronan, a non-sulfated GAG, was present in native EBs and acellular EB-
derived matrices.  Sulfated GAG content was assayed quantitatively (WieslabTM sGAG 
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quantitative kit, Alpco DiagnosticsTM) and qualitatively (toluidine blue staining), but 
appeared to be minimally present in native EBs and acellular EB-derived matrices (data 
not shown).  Although sulfated GAGs are commonly present during embryogenesis, 
hyaluronan has been particularly noted to exert a significant influence on cell 
morphogenesis during development [145, 221, 222], potentially accounting for its 
relative abundance in differentiating EB microenvironments relative to sulfated GAGs.  
This preliminary assessment of ECM molecules indicates the preservation of naturally 
synthesized molecules after decellularization of EBs, suggesting that this novel approach 
could be used to separate extracellular matrices from embryonic cells undergoing 
differentiation in order to study ECM composition and bioactivity. 
 
 
Figure 6.8. Acellular EB matrix modulation.  Embryonic stem cells can be induced to 
differentiate via EB formation.  As time progresses over the course of EB differentiation, 
increasing numbers of cells within the three-dimensional aggregates differentiate into 
cells of the endoderm, ectoderm, and mesoderm lineages.  Decellularizing the EBs at 
different time points along their differentiation pathway allows for modulation of the 
acellular matrix, with its composition reflecting the ECM components present in the EB 
at the time of decellularization. 
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Despite the fact that individual EBs constitute very small amounts of neo-tissue 
formation, the summation of larger numbers of EBs could be used to generate larger 
quantities of acellular matrices.  Numerous groups are developing methods to 
significantly scale-up the production of ESCs and EBs using a variety of different 
bioreactor systems [223-225].  Since the results of the present study indicate that acellular 
matrix production is related to the number of EBs (Figure 6.7), increasing the initial 
number of EBs using bioreactors could serve as a simple means to increase the amounts 
of acellular EB-derived matrices by orders of magnitude.  In addition, the “potency” of 
EB-derived acellular matrices is likely a more important outcome measure than the actual 
quantity of material (in terms of mass) that can necessarily be produced.  Although the 
“potency” of acellular EB matrices remains to be determined, it is possible that complex 
combinations of biomolecules present in the acellular matrix at relatively low 
independent concentrations could elicit pronounced synergistic biological effects. 
Decellularization of EBs serves as a direct route to obtain ECM from embryonic 
stem cells actively undergoing differentiation and implies that acellular matrices derived 
from EBs may hold several distinct advantages over those derived from somatic tissue 
sources.  One unique benefit of a matrix isolated from a pluripotent embryonic stem cell 
source is the potential to alter the final ECM composition by modulating cellular 
maturation (as discussed above) or by directing differentiation of the cells towards a 
particular phenotype.  The molecular composition of acellular matrices derived from EBs 
may be tailored towards more specific types of tissues by directing the differentiation of 
the initial EB population prior to decellularization procedures.  Various 
microenvironmental factors are capable of regulating the differentiation of ESCs into 
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different cell phenotypes by enhancing lineage-specific cell signaling pathways [40, 62], 
implying that the presence of particular ECM elements in the EB microenvironment 
likely change with ESC differentiation.  Although current schemes of directed 
differentiation do not result in completely homogeneous populations, it is entirely 
possible that improved strategies for directed differentiation could be easily implemented 
prior to decellularization of EBs.  Thus, decellularization of EBs subjected to directed 
differentiation protocols could theoretically yield acellular matrices composed of 
biomolecules associated primarily with a specific type of tissue. 
 The application of stem cells to treat a variety of different injuries and diseases is 
a central tenet of regenerative medicine therapies; however, the mechanisms whereby 
stem cells elicit structural and functional improvements in tissue regeneration remain 
largely unknown.  In addition to direct cell replacement via differentiation, stem cell-
derived molecules may stimulate endogenous host processes leading to functional tissue 
restoration.  In an initial attempt to examine the composition and bioactivity of 
biomolecules derived from ESCs undergoing differentiation, we have established 
methods to decellularize EB microenvironments in order to separate the cells from the 
ECM they synthesize.  If in fact, ECM derived from differentiating ESCs harbors 
morphogenic factors, acellular matrices derived from EBs could represent a novel manner 
of extracting molecular elements of embryonic morphogenic environments and could 
lead to the development of new acellular strategies to stimulate functional tissue 
regeneration in adult mammalian organisms. 
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CHAPTER 7 
EMBRYONIC STEM CELL-DERIVED MATRICES IMPROVE 





 Investigations into improved regenerative therapies for adult wounds have led to 
an increasing emphasis on understanding the mechanisms behind regeneration occurring 
in the embryonic environment.  For example, it is well-documented that early gestational 
dermal wounds can regenerate completely, while adults wounds heal imperfectly, 
resulting in a visible scar and decreased tensile strength of the healed skin [97, 226, 227].  
Researchers are therefore seeking to apply insights from embryonic regeneration 
mechanisms to improve or develop novel treatments for adult wounds.  Studies 
investigating distinctions between embryonic and adult wound healing environments 
have highlighted significant differences relating to matrix composition within the wound 
[100, 228], potentially leading to altered signaling from the endogenous cells.  To 
investigate mechanisms of wound repair, researchers have long used rodent models in 
which the healing process after full-thickness dermal wounding is analyzed using a 
variety of quantitative and qualitative metrics [96, 229] that can evaluate the effect of the 
treatment on wound healing when compared to control groups.  In particular, higher rates 
of wound closure and re-epithelialization as well as increased concentrations of blood 
vessels, specifically those that extravasate towards the epithelial layer, are commonly 
associated with improved healing [230]. 
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 Embryonic stem cells (ESCs) are derived from the inner cell mass of the pre-
implantation blastocyst [1], and their differentiated counterparts may provide an ideal cell 
source for investigating embryonic mechanisms of wound healing.  ESCs can 
differentiate in vitro through the aggregation of cells into three-dimensional aggregates 
termed embryoid bodies (EBs).  EBs recapitulate aspects of early embryonic 
development, including the dynamic synthesis and remodeling of matrix molecules 
present in the embryo during early stages of morphogenesis, as discussed previously 
(Chapters 3, 4).  In particular, array data from chapter 3 and more specific analyses 
presented in chapter 4 demonstrate that EBs are actively synthesizing molecules that have 
been shown to positively influence wound healing, including hyaluronan [231], 
transforming growth factor (Tgf)-β3 [232], and vascular endothelial growth factor (Vegf) 
[233].  The methods developed for isolating the matrix synthesized by differentiating 
ESCs (Chapters 5, 6) allows for investigations to determine whether an embryonic-
derived matrix can improve adult wound healing.  
 Therefore, in order to examine the effect of ESC-derived ECM on wound healing, 
acellular EBs were investigated in an acute dermal wound healing model and were 
compared to fibrin, a commonly used material in dermal injury surgeries.  C57Bl/6 mice 
were subjected to bilateral full thickness 6-mm wounds.  Each wound was treated with 
the ESC-derived matrix alone, matrix along with fibrin that was used as a delivery 
vehicle (referred to as “matrix-fibrin”), fibrin alone, or the wounds were left untreated.  
Wounds treated with matrix, either alone or with fibrin, significantly impacted wound 
closure and blood vessel extravasation towards the epithelial layer.  Application of an 
embryonic-derived matrix to an adult wound can positively affect wound healing, 
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suggesting that ESCs and their endogenous matrix are critical for improved adult 
therapies. 
 
Materials and Methods 
Cell Culture 
Mouse embryonic stem cells (D3) were cultured on 0.1% gelatin-coated 100 mm 
polystyrene cell culture dishes (Corning) with Dulbecco’s modified eagle medium 
(Mediatech), supplemented with 15% fetal bovine serum (HyClone), 2 mM L-glutamine 
(Mediatech), 1x MEM non-essential amino acid solution (Mediatech), 
antibiotic/antimycotics (Mediatech), and 0.1 mM β-mercaptoethanol (MP Biomedicals, 
LLC).  To maintain the cells in their undifferentiated state, 103 U/mL leukemia inhibitory 
factor (LIF) (ESGRO) was added to the culture media upon each re-feeding.  Cells were 
passaged every two to three days before reaching ~70% confluence.  For the described 
studies, cells were used at passage 26.  To initiate embryoid body (EB) culture, ESCs 
were dissociated from the gelatin-coated dishes with 0.05% Trypsin/0.53 mM EDTA 
(Mediatech).  A density of 400,000 cells/mL was used to inoculate 10 mL EB cultures in 
100 mm bacteriological grade polystyrene Petri dishes (Corning) using differentiation 
media (media without LIF).  Cultures were placed on rotary orbital shakers (Barnstead 
Lab-Line, Model 2314) at 40 rpm at 37oC in 5% CO2 for the entire duration of 
suspension culture.  EBs were cultured in suspension for 10 days and re-fed every other 
day by collecting EBs via gravity sedimentation in 15 mL conical tubes.  Spent media 
was aspirated and the cultures were replenished with 10 mL of fresh differentiation media 
before being placed back in the Petri dishes and onto the rotary orbital shakers. 
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Decellularization  
Embryoid bodies were harvested after 10 days of differentiation in rotary orbital 
suspension culture, and ~5000 EBs were distributed into individual samples in 1.5 mL 
microcentrifuge tubes.  EBs were centrifuged at 18,000 × g (Microfuge® 18 Centrifuge, 
Beckman-Coulter) for two minutes before addition of 1% Triton X-100 (VWR) under a 
cell culture hood.  Samples were rotated on a LabQuake Rotisserie for 30 minutes, spun 
down at 18,000 × g for two minutes, rinsed twice with sterile PBS, and rotated in 1 
mg/mL DNase (~2,000 Kunitz units/mg, Worthington Biochemical Corp.) for 15 minutes 
at room temperature.  At the end of the Triton X-100/DNase treatments, samples were 
centrifuged for two minutes at 18,000 × g to obtain the final acellular product and rinsed 
twice in sterile PBS.  To verify that the matrices were decellularized with some retention 
of total protein, native and acellular EBs were evaluated for total mass, protein content, 
and DNA.  Consistent with previous studies, acellular EBs retained 20.3 ± 2% of the 
native EB mass and 36.1 ± 4% of the total protein while exhibiting 97.0 ± 0.4% DNA 
removal compared to untreated EBs. 
 
Dermal Wound Surgeries 
Male mice (C57Bl/6, ~10 weeks old; Charles River Laboratories) were used for 
these studies according to the protocol approved by the Institutional Animal Care and 
Use Committee (IACUC; approval date July 22, 2009).  Mice were briefly anesthetized 
with isoflurane (5% isoflurane and 1.0 LPM CO2) prior to intraperitoneal injection of an 
anesthesia cocktail containing ketamine (50 mg/kg), xylazine (5 mg/kg), and 
acepromazine (2 mg/kg).  A square measuring ~2 cm x 2 cm on the upper back of each 
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mouse (extending from the base of the skull to approximately the mid-spine) was shaved 
and then treated with Veet for complete hair removal.  The exposed skin was disinfected 
with three alternate treatments of 2% chlorhexidine (Dermachlor™, Butler Animal 
Health Supply) and alcohol (70% isopropanol, The Butler Company) prior to actual 
wounding.  With the mouse positioned on its side, the skin was pinched together at the 
dorsal midline using sterile tweezers and pulled ~1-1.5 cm away from the torso.  A 6 mm 
dermal biopsy punch was then used to create bilateral full thickness dorsal wounds 
simultaneously.  The center of each wound was approximately 1.5 cm from the base of 
the skull and 0.5 cm on either side of the dorsal midline to prevent the mouse from 
physically perturbing the wound with their hind legs post-operatively.  Wounds were 
treated with matrices derived from ~1x104 day 10 decellularized EBs (lyophilized dry 
weight ~0.32 mg, ~36 μg protein/sample); matrices were applied to wounds alone (n = 8 
for each time point) or using fibrin gel yielded by 15 μL of a 75 mg/mL fibrinogen (from 
bovine plasma, Sigma) and 15 μL of a 25 U/mL thrombin (from bovine plasma, Sigma)) 
as a delivery vehicle (n = 7 for each time point).  Power analysis (α = 0.05, β = 0.2) using 
preliminary wound closure data determined that a minimum sample size of six 
animals/group would be sufficient to obtain statistically significant results.  However, 
additional mice were included in each group due to the frequency at which mice 
perturbed their wounds and compromised the wound site.  For matrix-fibrin treatments, 
the acellular matrices were placed on the wounds immediately prior to the application of 
fibrinogen and thrombin solutions to fill the remaining wound bed volume.  Treated 
wounds were compared to wounds applied with fibrin alone (n = 7) or those left untreated 
(n = 8).  Treatments were randomly assigned to each wound.  
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Wound Closure Analysis 
 Wounds were measured daily for two weeks post-injury.  Mice were briefly 
anesthetized (5% isoflurane and 1.0 LPM CO2) in order to take images.  Pictures were 
taken using a Sony Cyber-shot camera placed approximately six inches above the mice so 
that the entire mouse could be imaged.  In each image, a circular piece of paper with a 
reference diameter of 6 mm was placed near the wounds on the back of the mouse.  NIH 
ImageJ was used to quantify the wound area, using the reference length as a scale for 
each image to obtain the pixels/mm ratio.  Each wound was traced with a freehand 
selections tool and the area quantified.  Percent wound closure was calculated as [(area of 
original wound – area of actual wound)/area of original wound] x 100. 
  
Histology 
Mice were euthanized at either 7 or 14 days post-injury according to IACUC 
approved protocols.  Mice were individually placed in a chamber, which was 
subsequently filled with CO2.  After successful euthanasia was verified, wounds were 
excised for histological analyses.  The skin from the area of the back that had initially 
been shaved prior to injury was removed, and 10 mm biopsy punches (Acu Punch) were 
used to specifically excise the wound and surrounding normal tissue.  Each biopsy was 
then sliced in the middle of the wound; one half was fixed in 10% formalin overnight for 
paraffin embedding, and the other half was soaked overnight in 30% sucrose solution at 
4oC for cryo analysis.  Formalin-fixed samples were rinsed in PBS and processed for 
histological sectioning through a series of xylene and alcohol rinses.  Wounds were then 
embedded (wound side down) in paraffin and sectioned at 5 μm.  Samples that were 
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soaked in 30% sucrose were embedded the following day in O.C.T. compound (Tissue 
Tek) and stored at -80oC until being sectioned at 8 μm each.  Formalin-fixed paraffin-
embedded samples were stained with hematoxylin and eosin (H&E) using a Leica 
AutoStainer XL and with Masson’s Trichrome.  For Masson’s staining, slides were 
incubated in Bouin’s solution for 1 hour at 56oC after de-paraffinization and hydration to 
distilled water.  After the samples were cooled to room temperature, they were incubated 
in Weigert’s hematoxylin (2 minutes), Biebrich’s scarlet-acid fuchsin (5 minutes), 
phosphomolybdic-phosphotungstic acid (1 minute), aniline blue (5 minutes), and 1% 
acetic acid (5 minutes), with intermittent water rinses.  Slides were then dehydrated in 
95% and 100% alcohol, cleared in xylene, and cover-slipped using Cytoseal™ mounting 
medium (Richard Allen Scientific). 
 
Immunostaining 
For immunofluorescent staining, slides obtained from cryo-sectioning were 
warmed to room temperature and fixed in acetone (10 minutes, -20oC).  Samples were 
rinsed three times in PBS, then blocked and permeabilized for 45 minutes at room 
temperature in 2% normal donkey serum (NDS-PBS) in 0.05% Triton X-100-PBS.  After 
three PBS rinses, slides were incubated with polyclonal goat anti-PECAM-1 primary 
antibody (1:200 in 2% NDS-PBS) overnight at 4oC.  Samples were rinsed three times in 
PBS and incubated with donkey anti-goat Alexa Fluor 488 (1:200 in 2% NDS-PBS) for 
one hour at room temperature prior to Hoechst (10 μg/mL) counterstaining.  Samples 
were then mounted with coverslips using aqueous mounting medium with anti-fading 
agents (Electron Microscopy Sciences).  
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Blood Vessel Quantification 
Blood vessels from day 7 and day 14 samples were identified by positive 
PECAM-1 immunostaining.  Individual sections from each sample were imaged (n ≥ 5 
for each group) using a 40x objective.  The number of images examined was dependent 
on the total number of independent fields needed to capture the entire wound bed (2-7 
fields, depending on the size of the wound bed).  Total area of blood vessels and total 
number of blood vessels were quantified per area.  Each blood vessel was traced with a 
freehand tool on NIH ImageJ imaging software, and the image scale bar was used to 
determine pixels/mm so that area of the outlined region could be measured.  Total area of 
the wound was measured by tracing the region between the normal tissue flanking the 
lateral borders and above the underlying panniculus carnosus muscle layer.  Blood 
vessels that extravasated towards the epithelial layer were also quantified using ImageJ.  
Prior to analysis of blood vessel extravasation, each image was oriented such that the 
epithelial layer was positioned horizontally (zero degrees) at the top of the field of view.  
The angle of each blood vessel relative to the epithelial layer was calculated in ImageJ by 
tracing a straight line through the center of the vessel, and the number of those with a 
direction of at least 45o relative to the horizontal axis was quantified per area.  
 
Statistics 
 For comparisons across multiple groups, analysis of variance (ANOVA) was 
performed using a 95% confidence interval followed by post-hoc Tukey analysis to 





 Dermal wounds were quantified daily and compared to the original area of each 
starting wound.  For all wounds included in the analyses, wounds on each side of the 
mouse remained separated and undisturbed by the mice.  Within the first week of healing, 
wounds subjected to all treatment conditions exhibited scab formation, and in all groups, 
the scab was no longer present by day 11.  By the end of the two week study, all wounds 
healed with some evidence of scar formation, or small area of skin that appeared healed, 
but with no hair re-growth.  Overall, the rate of wound closure occurred most rapidly 
between days 5-9 post-injury and changed nominally between days 10-14.  Wounds 
treated with matrix, either alone or with fibrin, appeared to close at a faster rate than 
those left untreated (Figure 7.1).  Untreated wounds consistently exhibited the lowest 
percent wound closure over time, while groups treated with fibrin (with or without the 
addition of matrix) appeared to close especially quickly within the first four days of 
healing, possibly due to some dehydration and contraction of the fibrin gel itself.  
However, only the wounds treated with the combination of matrix and fibrin exhibited a 
significantly higher percent wound closure (p ≤ 0.04) than untreated wounds at days 1, 2, 




Figure 7.1. Wound closure analysis. Qualitatively, wounds generally closed faster in 
wounds treated with matrix or a matrix-fibrin combination.  When quantified, wounds 
treated with matrix-fibrin demonstrated exhibited significantly greater percent wound 
closure than untreated wounds, particularly within the first week of healing.  
*Significantly different from untreated wounds, p ≤ 0.04, # significantly different from 




 Wounds excised at 7 and 14 days post-wounding were stained with Masson’s 
Trichrome stain (Figure 7.2).  Scabs were evident in day 7 wounds, noted in particular by 
the bright red staining in matrix-fibrin and fibrin samples.  At day 7, little collagen (blue 
stain) was present in the wound bed, but was more abundant by day 14 in all samples.  
For most treated (fibrin, matrix, matrix-fibrin) wounds, the width of the wound bed 
(indicated by arrows) was noticeably smaller (at least 30% of the original width) after 
two weeks compared to the one week time point, indicative of the progressive healing 
process.  In addition, wound bed widths across groups were not significantly different at 
either days 7 or 14 (data not shown), which corroborates macroscopic would closure rates 
assessed at those time points.  Re-epithelialization was evident in all groups by day 14 
post-injury, but there was no indication of gland or hair follicle development. 
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 When viewed at a higher magnification, differences in collagen deposition were 
noted among treated and control groups (Figure 7.3).  Wounds left untreated or those 
treated with fibrin alone had sparse, thin strands of collagen bundles.  In contrast, wounds 
treated with matrix or matrix-fibrin exhibited more densely packed, thicker bundles of 
collagen that are typically associated with reduced scar formation.  Across all sections 
examined, wounds treated with matrix (with or without fibrin) appeared to have a higher 
cellular infiltrate in the wound bed, although the phenotypes across the groups were 
similar. 
   
 
 
Figure 7.2. Wound histology.  Wounds excised at days 7 and 14 post-wounding were 
stained with Masson’s Trichrome.  Collagen is stained in blue and has noticeably greater 
deposition by day 14 compared to day 7 wounds in all groups.  Wound edges are 




Figure 7.3. Wound bed matrix histological analysis.  Magnified images of wound beds 
stained with Masson’s Trichrome show distinct differences in the appearance of collagen 
(blue) in day 14 wounds.  Untreated and fibrin samples exhibit thinner bundles while 
matrix- and matrix-fibrin-treated samples had thicker, more loosely packed collagen. 
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Blood vessel quantification 
 Frozen sections (8 μm) were stained with a PECAM-1 antibody to identify blood 
vessels.  By day 14, there were 118 – 135 total blood vessels/area in all control and 
experimental groups, while the percent total area occupied by blood vessels ranged from 
1.25% – 1.46% (Figure 7.4).  This analysis indicated no significant differences across the 
groups and suggested that angiogenesis was not significantly enhanced or disrupted in 
treated wounds.  Blood vessels that extravasated towards the epithelial layer were 
quantified at days 7 (Figure 7.5) and 14.  By day 7, blood vessels in matrix and matrix-
fibrin wounds appeared to extravasate towards the epithelial layer, while blood vessels in 
fibrin and untreated wounds remained largely parallel to the epithelial layer (Figure 7.3).  
Blood vessels directed towards the epithelial layer (greater than 45o compared to the 
horizontal) were quantified per wound area.  Matrix-treated wounds had significantly 
more extravasating blood vessels (30.7 ± 13 vessels/area) than both fibrin (8.6 ± 9; p = 
0.03) and untreated (13.0 ± 5; p = 0.01) wounds, again suggestive of an improved healing 
response over control groups.  By day 14 (data not shown), matrix-treated groups no 
longer had a significantly different number of extravasating blood vessels and had 






Figure 7.4. Blood vessel quantification.  Total number of blood vessels per area (A) and 
percent of the total area occupied by blood vessels (B) were quantified at 14 days post-




Figure 7.5. Extravasating blood vessel quantification.  Blood vessels extravasated 
towards the epithelial layer in matrix-treated wounds significantly more than those 
treated with fibrin alone or those left untreated 7 days after wounding.  Each image was 
taken with the epithelial layer horizontal and facing up.  Scale bars for inset images are 
125 μm.  * p = 0.03; # p = 0.01. 
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Discussion 
 The intrinsic machinery that allows for early fetal wound regeneration is not 
activated in the adult environment, resulting in imperfect repair responses and scar 
formation.  In this study, the ability of an embryonic-derived matrix to elicit an improved 
healing response in an adult was evaluated by examining acellular EBs applied to a 
murine excisional dermal wound healing model.  Wounds treated with a combination of 
matrix and fibrin exhibited significantly increased wound closure, primarily within the 
first week of healing, compared to untreated wounds.  In addition, collagen within the 
wound beds appeared thicker and more loosely packed in matrix-treated wounds, a 
phenotype typically associated with scarless healing [97], in contrast to the thin, parallel 
bundles in untreated or fibrin-treated wounds.  Although the total number of blood 
vessels per area were not significantly different across control and experimental groups, 
the number of vessels extravasating towards the epithelial layer was significantly greater 
in matrix-treated wounds.  Overall these results suggest that EB-derived matrices can 
improve healing in an adult, possibly due to the wound repair-enhancing factors naturally 
synthesized by differentiating ESCs and retained within the acellular matrices.   
 The differences in rates of wound closure observed within the first week of 
healing may be primarily due to the presence of additional matrix in the wound bed.  
During the course of wound healing, provisional matrix is typically deposited by the local 
cell population after several days post-injury [234, 235].  In contrast, wounds treated with 
acellular EBs (alone or with fibrin) received exogenous matrix molecules that potentially 
provided stability in the site of injury and offered a substrate for host cell migration and 
subsequent wound contraction immediately after injury.  Applying matrix at such an 
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early time point likely affected the kinetics of wound healing, resulting not only in 
differences in percent wound closure, but possibly also affecting the time course of cell 
infiltration and movement.  The addition of fibrin to the matrix resulted in a greater 
volume that covered the wound bed completely, which, unlike matrix-only treated 
wounds, provided a substrate for cells that extended between wound edges and could 
allow for infiltration of host cells residing in the adjacent normal tissue.  Therefore, the 
combination of exogenous matrix along with a physical substrate covering the wound 
likely resulted directly in significant effects on wound closure.   
The differences observed in collagen thickness and density may have been due to 
differential signaling responses elicited by the presence of the EB-derived matrix.  
Several in vitro and in vivo wound healing studies have shown that changes in the local 
environment from exogenous matrix, cytokine, or growth factors can alter host cell 
responses, indicating the possibility that factors captured within the acellular EB matrix 
may elicit similar behaviors [236-238].  This difference in histological collagen 
observations may be directly related to differences in blood vessel morphology between 
treated and untreated wounds.  Since the total number of blood vessels per area is 
consistent among all experimental and control groups, angiogenic factors synthesized by 
differentiating ESCs were perhaps masked in the acellular EBs.  However, since 
differences were noted in the number of blood vessels extravasating towards the 
epithelial layer, it is possible that the observed differences in collagen deposition and the 
looser conformation of the collagen allowed for extravasation of the blood vessels, 
leading to improved nutrient delivery to the upper dermal and epidermal layers and 
subsequent enhanced wound healing.   
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In these studies, ECM derived from ~10,000 EBs (~36 μg protein) was applied 
directly to the wound at the time of injury.  For future studies, more potent effects from 
the matrices may be observed with an increase in dosage.  Besides offering a greater 
quantity of ESC-derived molecules, a dose increase would provide greater coverage for 
the wound and reduce the air-wound interface, which could further accelerate wound 
closure [239].  In addition, the application of matrices at multiple time points throughout 
the healing process could provide a steady supply of ESC-derived molecules that may 
enhance the quality of wound repair through continuous stimulation of the host cells.   
In the studies presented here, significant differences were observed in some of the 
examined parameters between matrix-treated wounds as compared to control wounds.  
Subtle differences in healing and wound bed composition may have been masked, 
however, due to the choice of an acute wound healing animal model.  The excisional 
dermal wound healing model used in these studies provides a good test bed to examine 
the acute effects of acellular matrices on healing in vivo.  Within the two week time 
course evaluated, untreated wounds healed such that hair around the wound had re-
grown, no scabs were present, and the scar was the only visible remainder of the wound 
site.  Because of the relatively quick healing response undergone by control wounds, 
subtle effects elicited by the presence of the acellular matrix may have gone undetected.  
Therefore, to further parse out differences between groups, future studies could involve 
examination of the EB matrices in a chronic model, for example in a diabetic mouse 
[240, 241].  While the wound healing response can be more complex to interpret, subtle 
differences may be more easily identified, thereby elucidating additional and presently 
unknown effects of the acellular EBs.  But in addition to simply providing a more robust 
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model for examining the role of acellular matrices in wound healing, chronic models are 
considered more relevant to injuries (e.g. burns) and diseases (e.g. diabetes mellitus) 
commonly present within the population of developed countries.  There has been some 
indication that therapy using fetal tissue can contribute to chronic wound repair [242], so 
examining the EB matrices in a chronic wound healing model could further elucidate 
mechanisms by which embryonic-derived ECM can alter macroscopic and microscopic 
features of severe dermal injuries. 
The results presented here encourage further investigation into the mechanisms by 
which extracellular matrix derived from ESCs can alter wound healing.  Upon 
stimulation with exogenous factors, fetal and adult dermal fibroblasts exhibit distinctly 
different signaling responses in vitro that may, in part, translate into differences in wound 
healing outcomes in vivo [237, 243-245].  In addition, differences in wound bed 
composition between adult and fetal wounds are a result of distinct responses by 
endogenous fibroblasts [101, 226, 227, 246].  An acellular embryonic-derived matrix 
may provide morphogenic cues to which host fibroblasts respond in a manner similar to 
fetal fibroblasts, thereby resulting in enhanced wound healing compared to untreated 
wounds.   
 Importantly, the results of these studies encourage examination of other types of 
injury where healing may benefit from stem cell derived matrices.  For such 
investigations, ESCs that have been differentiated into defined phenotypes could 
synthesize matrix specific for the injury’s environment.  Directing the differentiation of 
ESCs into a specific cell type may induce the synthesis of ECM relevant to that particular 
tissue, which in turn could be more applicable to treatment of the tissue in its diseased 
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state. Such embryonic matrices could stimulate endogenous cells to undergo the 
morphogenic processes typically seen during early development and may therefore 





This work has examined the dynamic nature of ECM synthesized by ESCs and its 
relevance to differentiation events.  Novel techniques were developed to isolate the 
potent extracellular factors within the EB microenvironment, and the resulting 
embryonic-derived acellular matrix significantly enhanced wound healing in an adult 
environment in vivo.  While other work has highlighted the importance of the 
extracellular matrix (ECM) and growth factors synthesized by differentiating ESCs, no 
other studies have derived matrices that harness the potency of these molecules for 
therapeutic applications.   
 Gene array analysis provided an initial examination into the range of matrix 
molecules expressed by differentiating ESCs in EBs.  Clustering and pathway analyses 
emphasized expression trends in subsets of molecules and highlighted specific molecules 
that were either highly expressed or that served as nodes in differentiation networks.  
Upon closer examination, expression and localization of the glycosaminoglycan 
hyaluronan (HA) and the proteoglycan versican were found to be associated with EB 
differentiation.  The results presented here provided evidence that HA and versican have 
roles in the epithelial-mesenchymal transition in EBs, but future studies should further 
explore these patterns.  For example, while studies where HA and versican are knocked 
down could directly assess their effects on differentiation, parallel studies where the 
molecules are delivered exogenously or cells are genetically modified to over-express the 
ECM components could assess HA and versican’s ability to rescue specific phenotypes or 
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differentiation events.  Additional studies with other molecules highlighted in the gene 
array analysis, such as collagen III, vitronectin, and periostin, could similarly identify key 
roles in EB development and ESC differentiation.   
Other investigations that deconstruct elements of the ECM must also be 
performed to further identify the molecular regulators of ESC differentiation.  In addition 
to global gene analysis, differential expression in cell populations exhibiting distinct 
morphological characteristics could be assessed using laser capture microdissection 
technologies to identify the composition of localized matrix deposition associated with 
specific cell phenotypes.  In addition to gene expression analyses, proteomic analysis of 
differentiating ESCs should be assessed using mass spectrometry to identify actual 
protein species present in the complex mixture.  Resulting data from global and local 
gene expression analyses, proteomic assessments, and examination of specific molecules, 
could not only contribute to the understanding of self-regulated differentiation patterns in 
ESCs, but would also lend insight into directed differentiation schemes essential for 
developing robust regenerative medicine therapies.  The addition of specific molecules 
known to be necessary for a particular cell specification event could potentially drive a 
heterogeneous cell population towards a more defined phenotype.  Therefore, identifying 
which molecules are relevant for the differentiation of specific lineages is critical for the 
development of such protocols. 
The studies presented in this dissertation begin to identify endogenously 
expressed matrix molecules playing key roles in ESC differentiation.  These advances, 
however, were realized through analysis of one cell line.  Therefore, a deeper 
understanding of the role of ECM within EBs could benefit from the examination and 
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comparison of gene expression profiles from other ES cell lines, thereby elucidating how 
genetic differences between cell populations may affect the underlying stem cell biology.  
Since no directed differentiation schemes were performed prior to the global matrix 
analysis studies, it is possible that other ES cell lines, possibly tending towards a 
particular germ lineage when spontaneously differentiated, may exhibit altered matrix 
molecule and growth factor production.  Direct comparisons of such studies with those 
presented here may elucidate which factors are predominantly expressed by a specific 
cell line as opposed to those that play more global roles in stem cell biology. 
In this work, a novel means of isolating the matrix produced by differentiating 
ESCs was investigated through comparisons of a variety of reagents capable of disrupting 
cell membranes and removing cell components.  While a portion of the original protein 
content was found to be maintained after decellularization, these findings warrant more 
in-depth proteomic analysis of the acellular matrix composition through mass 
spectrometry.  Direct comparisons of protein profiles in EBs and acellular matrices 
derived from the EBs would provide critical information regarding classes of molecules 
that are maintained after decellularization treatments.  Such information could be useful 
as additional methods of decellularizing EBs are developed to include more mechanical 
means of cell disruption that may preserve intact matrix molecules better than chemical 
treatments.  For example, present studies are investigating lyophilized EBs as a purely 
mechanical means of harboring the potent morphogenic cues synthesized by 
differentiating ESCs.  Along those lines, however, future investigations into any 
decellularization method should involve analysis of host immune responses to the matrix, 
as purely mechanical treatments are more likely to retain potentially immunogenic cell 
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components.  The relative level of immunogenicity in ESCs is reduced compared to non-
stem cell populations because of the comparatively small amounts of major 
histocompatibility complex (MHC) class I molecules produced and lack of MHC class II 
molecules [247].  Class I molecules are up-regulated in EBs [248], however, so the 
immunogenicity of EB-derived products is an important consideration to evaluate. 
One benefit of the protocol developed is the high percentage of DNA removal 
resulting from the chemical and enzymatic treatments.  However, since the “sticky” 
nuclear material is largely removed, these matrices do not offer high mechanical integrity 
and are therefore difficult to examine in vitro and to apply to wounds in vivo.  For in vitro 
cell seeding studies, it is extremely challenging to retrieve seeded matrices from culture 
in tact for subsequent histological analyses.  Further, although possible, due to the 
diminished mechanical integrity of the matrices, they are also difficult to remove from 
their storage tubes and place on wounds in vivo.  Ongoing studies are presently 
evaluating the ability of acellular matrices to be chemically cross-linked and have thus far 
successfully shown that treatment of the EB matrices with a natural cross-linking agent 
improves its ease of handling.  Subsequently, studies wherein histological analyses and 
metabolic assays were successfully performed on seeded EB matrices resulted in 
confirmation that cells could infiltrate and survive in the matrices in vitro.  Additional 
formulations, such as an injectable solubilized matrix or a lyophilized powdered matrix, 
may also facilitate application in vivo by providing matrices that are more easily handled.  
A soluble matrix may be directly injected into the site of injury, while a powdered matrix 
could be physically interspersed on the surface of the wound.  While the studies 
presented have laid the foundation for examining EB-derived matrices in vivo, other 
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formulations may enhance the ease with which these matrices are handled and possibly 
lead to improved dosage reproducibility by ensuring that pieces of matrix are not left 
behind because of mechanical instability. 
Furthermore, the promising in vivo results presented in this work encourages in-
depth analysis of the mechanisms by which host cells respond to acellular EB matrices 
during wound healing processes.  Initially, in vitro studies that investigate the signaling 
pathways activated when dermal fibroblasts are seeded on the acellular EB-derived 
matrix as compared to an adult fibroblast matrix could begin to elucidate differential 
responses exhibited by host cells that are critical for the resulting wound healing 
responses.  In addition, examining the potency of the EB matrix in vivo compared to an 
adult fibroblast-derived matrix would more rigorously examine the hypothesis that it is 
the unique reservoir of embryonic cues harbored in the EB matrix is essential for 
enhanced wound healing, and not simply the presence of more promiscuous matrix 
molecules possibly available in a number of tissue matrices.  Since the extracellular 
matrix of fetal wounds is distinctly different from adult wounds, in vivo studies 
comparing embryonic and adult treatments should also involve analysis of the wound bed 
composition to identify whether application of an embryonic matrix can stimulate host 
cells to secrete a more embryonic-like provisional matrix. 
Motivated by studies suggesting that matrix factors secreted by transplanted ESCs 
are primarily responsible for observed regenerative events (fraidenraich, chen 2009), the 
work presented in this thesis analyzed the expression profile of molecules synthesized by 
ESCs in vitro and subsequently evaluated the effect of an extracted portion of these in an 
in vivo model.  However, since proteomic or gene expression profiles of factors secreted 
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in vivo by differentiating ESCs are presently unavailable, it is unknown whether the range 
of factors synthesized during in vitro culture of the cells and captured in the acellular EBs 
are similar to the matrix secreted by transplanted cells in vivo.  The presence of central 
host systems that result in immune and inflammatory responses likely contributes to 
signaling patterns that are not present in the controlled in vitro environment.  However, 
molecules such as collagen III and transforming growth factor (Tgf)-β3 that are present 
in increasing quantities in EBs differentiating in vitro are also known to play key roles in 
the regenerating fetal wound [97].  The presence of these molecules in ES cell cultures 
suggests that an isolated EB matrix applied to wounds could induce healing responses 
similar to those seen in scarless fetal repair. 
In addition, the observed regulation of molecules related to EB differentiation 
lends insight into possible expression patterns necessary for improved in vivo healing.  
For example, the array data presented in chapter 3 showed a decrease in a subset of 
molecules that appeared to be necessary prior to subsequent differentiation, which raises 
the possibility that a similar decrease in specific factors during wound healing may allow 
(or be necessary for) enhanced repair.  Specifically, collagen I, which is present in greater 
amounts in adult scarring tissues compared to embryonic tissues, was found to decrease 
at early time points of ESC differentiation in vitro.  Although in the present studies EB 
matrices were applied only once at the time of wounding, future investigations could 
involve re-application of the matrix at different time points along the healing time course 
in order to provide a constant dose of embryonic-derived matrix molecules.  Preliminary 
studies investigating the persistence of the matrices in the wound bed have indicated that 
by one week post-injury, the acellular EBs are no longer present in the wound site.  
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Therefore, re-application of the treatment after 5-7 days would provide a prolonged 
exposure of the host cells to the embryonic matrix.  In addition, it may be interesting to 
apply matrices derived from early EBs at the time of wounding, but to then deliver 
matrices derived from progressively more mature EBs at subsequent time points during 
the healing process in order to present a dynamic range of molecules similar to those 
necessary for the progression of differentiation in vitro.  As a result, the wound 
environment would be subjected initially to low doses of collagen I, followed by 
increasing doses of collagen III and Tgf-β3.  This expression pattern is naturally observed 
during regenerative wound healing [97, 226] and may induce improved responses in the 
adult. 
As discussed previously, one unique feature of ESC-derived matrices is the 
potential to tailor them for specific applications by directing the differentiation of the 
cells prior to decellularization.  Directed differentiation schemes have remained a 
significant challenge for stem cell researchers, but analysis of cell-specific matrices in 
addition to work currently ongoing in our lab that allows for more homogeneous 
distribution of exogenous factors in EBs may considerably drive the research forward.  
Matrices derived from a population that is primarily one cell type could subsequently be 
examined in the corresponding in vivo model system to examine tissue-specific effects.  
In the future, it will be essential to evaluate the translational applicability of the EB-
derived acellular matrices.  Appropriate formulation and ease of handling are necessary 
for ultimate clinical use, as is batch culture ESC propagation, which has already been 
under investigation by numerous researchers.  Therefore, an acellular EB matrix could 
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provide a novel, clinically translatable means of accessing the therapeutic potential of 
ESCs.  
In summary, this research has established the groundwork for investigating the 
potency of matrices derived from a stem cell source and has shown the significance of 
such matrices in improving wound healing in vivo.  The complex mixture of extracellular 
factors entrapped within the EB microenvironment contribute to the bioactive efficacy of 
the acellular matrix, and additional understanding and identification of the specific 
molecules involved could further elucidate the utility of the matrix.  Future work that 
further examines the composition of complex extracellular matrices synthesized by 
differentiating ESCs and explores the potential of this isolated matrix will undoubtedly 
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